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ABSTRACT 
Evidence from the 20
th
 century demonstrated that early life stress (ELS) produces 
long lasting neuroendocrine and behavioral effects related to an increased 
vulnerability towards psychiatric illnesses such as major depressive disorder, post-
traumatic stress disorder, schizophrenia, and substance use disorder. Substance use 
disorders (SUDs) are complex neurological and behavioral psychiatric illnesses. The 
development, maintenance, and relapse of SUDs involve multiple brain systems and 
are affected by many variables, including socio-economic and genetic factors. Pre-
clinical studies demonstrate that ELS affects many of the same systems, such as the 
reward circuitry and executive function involved with addiction-like behaviors. 
Previous research has focused on cocaine, ethanol, opiates, and amphetamine, while 
few studies have investigated ELS and methamphetamine (METH) vulnerability. 
METH is a highly addictive psychostimulant that when abused, has deleterious 
effects on the user and society. However, a critical unanswered question remains; 
how do early life experiences modulate both neural systems and behavior in 
adulthood? The emerging field of neuroepigenetics provides a potential answer to this 
question. Methyl CpG binding protein 2 (MeCP2), an epigenetic tag, has emerged as 
one possible mediator between initial drug use and the transition to addiction. 
Additionally, there are various neural systems that undergo long lasting epigenetics 
changes after ELS, such as the response of the hypothalamo-pituitary-adrenal (HPA) 
axis to stressors. Despite this, little attention has been given to the interactions 
between ELS, epigenetics, and addiction vulnerability. The studies described herein 
investigated the effects of ELS on METH self-administration (SA) in adult male rats. 
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Next, we investigated the effects of ELS and METH SA on MeCP2 expression in the 
nucleus accumbens and dorsal striatum. Additionally, we investigated the effects of 
virally-mediated knockdown of MeCP2 expression in the nucleus accumbens core on 
METH SA, motivation to obtain METH under conditions of increasing behavioral 
demand, and reinstatement of METH-seeking in rats with and without a history of 
ELS. The results of these studies provide insights into potential epigenetic 
mechanisms by which ELS can produce an increased vulnerability to addiction in 
adulthood. Moreover, these studies shed light on possible novel molecular targets for 
treating addiction in individuals with a history of ELS. 
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CHAPTER 1 
GENERAL INTRODUCTION 
Early Life Experiences 
 Visionary psychologists of the 20
th
 century produced findings that prompted a 
movement of research investigating how early life experiences help shape an individual’s 
development into maturation. At the turn of the 20
th
 century, pioneering psychologist 
Elmer Gates (1904) referred to early life experiences mediating brain development as a 
“process of brain-building”. A few decades later, Donald Hebb (1947) demonstrated that 
cognitive performance in rats was enhanced by different, particularly more enriched, 
rearing environments. The next decade produced literature from Victor Denenberg’s 
laboratory demonstrating a lasting neuroendocrine effect of early life handling in rodents 
(Levine et al., 1967). Around the same time, Harry Harlow demonstrated that decreased 
quality of maternal care had long lasting detrimental effects on behavior in non-human 
primates (Harlow et al., 1965). Michael Meaney (1985) elaborated on Denenberg’s 
findings by establishing a relationship between early life handling experience and adult 
hippocampal glucocorticoid receptor expression. Meaney expanded upon this work in a 
seminal paper (Plotsky & Meaney, 1993) in which a group of animals with extended 
maternal separation was added to the paradigm. Soon after, it was discerned that maternal 
care, specifically licking, grooming, and arch back nursing (LG or LG-abn), was driving 
the differences observed in handling groups (Liu et al., 1997). The majority of rodent 
paradigms modeling ELS used today are modified versions of paradigms based on this 
collection of work.  
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 Exposure to ELS such as traumatic events, abuse, and neglect is highly related to 
one’s health in adulthood. Multiple variables within the home such as parenting style and 
the quality of the parent/child relationship can affect a child’s physical and intellectual 
development (Anda et al., 2006; Bremne & Vermetten, 2001; Lovallo et al., 2012; 
Schimmenti & Bifulco, 2013). For example, in individuals with a history of ELS, there is 
an increased risk for the development of physical illnesses such as obesity, diabetes, 
seizures, and cardiovascular diseases (Gluckman et al., 2008; Gunstad et al., 2006; 
Huang, 2014). Additionally, aggressive and suicidal behaviors are strongly associated 
with ELS (McEwen, 2003). Furthermore, ELS is a risk factor for the development of 
various psychiatric illnesses such as personality disorders, major depression, post-
traumatic stress disorder, schizophrenia, and SUDs (De Bellis, 2002; Pechtel & 
Pizzagalli, 2011; Teicher et al., 2003).   
 ELS is a prevalent phenomenon with highly detrimental costs to societies 
worldwide (De Bellis & Zisk, 2014) such as the increased propensity towards SUDs. 
Clinical research has shown ELS, particularly childhood abuse and neglect, is a reliable 
risk factor that influences adult drug abuse (Anda et al., 2006; Messina et al., 2008). 
Childhood abuse or neglect is highly prevalent with ~1.5 million cases reported in 2010 
(Child Maltreatment 2010, US Department of Health and Human Services) and there is 
substantial evidence that ELS produces long-lasting changes in the brain, including 
regions that mediate reward-seeking and executive control, which may ultimately 
predispose the individual to increased propensity toward illicit drug use and addiction 
(Matthews et al., 2001; Meaney et al., 2002). To understand the relationship between 
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ELS and addiction vulnerability, we first must briefly discuss the etiology and pathology 
of addiction. 
Addiction 
 Drug addiction, or more formally SUD, is a serious and chronic disease wherein 
the afflicted individual has difficulty limiting drug intake, exhibits high motivation to 
take one or more drugs, continues using the drug despite negative consequences, and 
experiences negative emotional states when the drug is withheld, leading to frequent 
relapse (American Psychiatric Association, 2013). In the United States, the 2010 
prevalence rates (current and past month use, in persons 12 years or older) for illicit drug 
use (including marijuana, cocaine, and heroin) reached 22.6 million (8.9%) (SAMHSA, 
2010). The 2010 prevalence rate for alcohol use was 131.3 million (51.8%), binge 
alcohol use was 58.6 million (23.1%) while tobacco use was 69.6 million (27.4%) 
(SAMHSA, 2010). The estimated number of persons 12 years or older classified with 
substance dependence (including illicit drugs and alcohol) in 2010 was 22.1 million, 
representing 8.7% of the population (SAMHSA, 2010). Furthermore, 20.5 million 
Americans were classified as needing treatment for an illicit drug or alcohol use problem 
(SAMHSA, 2010). These astonishingly high numbers clearly indicate that drug addiction 
and substance dependence remain significant problems in the United States. 
     Theories of addiction. 
 The transition from drug use to drug dependence is impacted by a number of 
factors, including genetics, environmental influences (such as stress), neurochemical, and 
neuroanatomical modifications in the brain that result from repeated drug use (Li et al., 
2011; Sinha, 2008). Several theoretical frameworks have been put forward in order to 
 
  
4 
 
understand the complexities of this transition. Initial drug use can be attributed to the 
ability of the drug to act as a reward (i.e. induce a pleasurable emotional state) or positive 
reinforcer (a stimulus that causes the behavior preceding its obtainment to increase), both 
of which can lead to repeated drug use and dependence (Wise, 1980; Stolerman, 1992). A 
great deal of research has focused on the molecular mechanisms underlying the initial 
rewarding or reinforcing effect of drugs of abuse. However, more recent research on 
long-term neuroanatomical and molecular changes in the brain that result from chronic 
drug use have revealed drug addiction to be highly complex and involve brain systems 
beyond the reward circuitry.   
 Several parallel and intersecting theories of drug addiction include shifts in 
behavior that are supported by various changes in the underlying neurocircuitry of 
addiction. Robinson and Berridge hypothesized the incentive sensitization theory, 
whereby repeated drug use produces alterations in brain reward and associative learning 
systems, so that the drug user becomes increasingly sensitive to both the drug and drug 
associated cues, resulting in pathological drug seeking or wanting (Robinson & Berridge, 
1993; Berridge & Robinson, 1995). Koob and colleagues have postulated the allostasis 
theory, which asserts that repeated drug use and dependence are a result of the decreased 
function of the brain’s reward system coupled with an increase in the engagement of the 
brain’s anti-reward or stress circuitries (Koob & Le Moal, 1997; Koob & Le Moal, 2008). 
These two opposing neurocircuitries are hypothesized to interact in a cyclical manner that 
ultimately manifest in addiction (Koob & Le Moal, 2008). Everitt and colleagues have 
theorized that drug addiction is the result of transitions from initial, voluntary drug use 
governed by stimulus-response relationships towards habitual and eventually compulsive 
 
  
5 
 
drug use, which result from a hypothesized switch in the relative engagement of the 
neurocircuitries underlying these behaviors (Everitt & Robbins, 2005). It has also been 
suggested that addiction is a disorder of learning and memory, characterized by the 
ability of drugs to “hijack” normal learning and memory processes that regulate reward 
seeking (Hyman, 2005).   
Another common theory of addiction is cortical 'hypofrontality', specifically 
referring to reduced baseline activity of the prefrontal cortex which results in an inability 
to exert executive control over self-regulation. In contrast, many regions become 
hypersensitive to drugs of abuse as well as drug-associated cues. Several regions of 
frontal cortex, including the prefrontal cortex, anterior cingulate cortex and orbitofrontal 
cortex have glutamatergic projections to the nucleus accumbens (NAc) and ventral 
tegmental area (VTA), and control various aspects of executive function such as working 
memory, attention, and behavioral inhibition (Nestler, 2005).  
 These theories all agree that drug addiction is characterized by a progression or 
shift from initial stages where the drug user is in control of drug intake, to the end stages 
where the user has lost control over drug intake. Furthermore, this continuum of 
behavioral adaptation is proposed to be mediated by drug-induced alterations in the 
neurocircuitry underlying reward, learning and memory and decision-making. Despite 
these recent advances in our understanding of the addicted brain, the majority of Food 
and Drug Administration (FDA) approved treatments for drug addiction (few as there 
are) aim to intervene at the level of the acute rewarding effects of drugs of abuse. 
Moreover, there are currently no FDA-approved medications for the treatment of 
addictive disorders involving psychostimulants such as METH. 
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     Neuroanatomy and neurochemistry of addiction. 
 The brain reward circuitry underlies motivated behavior for both natural rewards 
(e.g., food, drink and sex) as well as drug rewards. Some of the key brain regions of the 
reward circuitry include the VTA, NAc, prefrontal cortex (PFC), dorsal striatum (DS) 
and amygdala (AMG). The rewarding effects of drugs and the progression from initial 
drug use to dependence are highly dependent on complex interactions between these 
regions. Dopamine (DA) has historically been thought of as the primary neurotransmitter 
mediating reward. However, many drugs of abuse also increase extracellular levels of 
glutamate (Glu), norepinephrine (NE), serotonin (5-HT) and other neurotransmitters 
within this neurocircuitry, which also play a key role in the long-term molecular and 
behavioral features of addiction (Kalivas, 2009; Hyman & Malenka, 2001).  
     Reward.  
     Ventral tegmental area. 
 The brain reward circuit functionally begins with the VTA, which contains a 
cluster of dopaminergic neurons with efferent projections to the NAc in addition to the 
PFC, basal ganglia and AMG. Many natural rewards and drugs of abuse activate (either 
directly or indirectly) dopaminergic neurons of the VTA to release dopamine (DA) in 
these forebrain regions (Robinson & Berridge, 1993; McClure et al., 2003; Berridge & 
Robinson, 1998; Di Chiara & Imperato, 1988). Drugs of abuse also induce DA release at 
the level of the terminal fields in the NAc, PFC and AMG (Koob & Volkow, 2010). The 
release of DA in the NAc is crucial for the rewarding effects of drugs of abuse. In 
addition, drug-induced DA release in the NAc and other brain regions of the reward 
circuitry is modulated by other neurotransmitter systems including GABA, Glu, 
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endogenous opioids, 5-HT and NE (Doherty & Gratton, 1997; Kalivas, 2009; Koob, 
1992; Mermelstein & Becker, 1995; Mitchel & Gratton, 1991).  The VTA is modulated 
by glutamatergic inputs from the PFC and AMG in addition to a subpopulation of 
inhibitory GABAergic interneurons within the VTA (Johnson & North, 1992). Repeated 
drug use or exposure results in numerous cellular and molecular changes that contribute 
to reward associated learning and the development of addiction (Jay, 2003).  
     Nucleus accumbens.  
 All drugs of abuse increase extracellular levels of DA in the NAc (Di Chiara & 
Imperato, 1988). The NAc, which is contained within the ventral striatum, is composed 
primarily of GABAergic medium spiny neurons. The NAc can be functionally divided 
into two distinct subregions, the core and shell, which respond to rewarding stimuli 
differently and are thought to mediate distinct aspects of addictive processes. The release 
of DA in the NAc shell is believed to contribute to the initial rewarding and reinforcing 
effects of drugs and the assignment of salience to rewarding stimuli (Sellings & Clarke, 
2003; Bassareo & Di Chiara, 1999; Everitt et al., 2008), whereas DA release in the NAc 
core is thought to be more associated with the expression of learned behaviors in 
response to rewarding stimuli, such as drug-seeking (Kelley, 2004; Di Ciano & Everitt, 
2001).  
     Executive function. 
  The PFC is a key regulator of cognitive and emotional processes, and contains 
many functionally distinct subregions. The dorsolateral PFC, orbitofrontal cortex and 
anterior cingulate cortex are involved the assignment of saliency, decision-making, 
inhibition of inappropriate behaviors, behavioral and cognitive flexibility, and the 
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regulation of emotion (Volkow et al., 2011; Breiter et al., 1997). These regions of the 
PFC have dense populations of glutamatergic cell bodies with efferent pathways that 
synapse onto the same cell populations in the NAc that receive dopaminergic afferents 
from the VTA (Sesack & Pickel, 1992). In addition, glutamatergic efferents from the PFC 
also project to the AMG and VTA (Kalivas & Volkow, 2005). Thus, the PFC is situated 
to modulate the rewarding effects of drugs of abuse, drug-seeking behavior, as well as 
relapse to drug taking. Furthermore, the PFC is itself modulated by DA input from the 
VTA and other input from subcortical structures such as the striatum (Taber et al., 1995; 
Karreman & Moghaddam, 1996; Brake et al., 2000; Feil et al., 2010).   
     Action and inhibition. 
     Basal ganglia circuitry. 
 While the PFC coordinates the flexibility with which an organism adapts its goal-
directed behavior, it is modulated by inputs from other cortical and subcortical regions 
(Blasi et al., 2006). The basal ganglia are a complex subcortical network of nuclei, 
consisting of the ventral (Nac) and DS (a.k.a. caudate putamen), the globus pallidus 
(internal and external segments), substantia nigra, and subthalamic nucleus (Kopell & 
Greenberg, 2008). The output of the basal ganglia is predominantly via the thalamus 
which then projects back to the prefrontal cortex, to form cortico-striatal-thalamo-cortical 
(CSTC) loops. Three CSTC loops are proposed to modulate executive function, action 
selection and behavioral inhibition.  In the dorsolateral prefrontal circuit, the basal 
ganglia primarily modulate the identification and selection of goals, including rewards 
(Feil et al., 2010). The orbitofrontal circuit modulates decision-making and impulsivity 
and the anterior cingulate circuit modulates the assessment of consequences (Feil et al., 
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2010). These circuits are modulated by dopaminergic inputs from the VTA to the ventral 
striatum (NAc) and PFC to ultimately guide behaviors relevant to addiction including 
persistent drug seeking, impulsive and compulsive drug taking, and the continued drug 
use despite negative consequences (Feil et al., 2010; Kopell & Greenberg, 2008; Sesack 
et al., 2003).  
     Dorsal striatum.  
 The DS (caudate putamen) is part of the basal ganglia. The DS is further 
associated with transitions from goal-directed to habitual drug use, due in part to its role 
in stimulus-response learning (Everitt et al., 2008; Yin et al., 2004). As described above, 
the initial rewarding and reinforcing effects of drugs of abuse are mediated by increases 
in extracellular DA in the ventral striatum (NAc shell and after continued drug use, the 
NAc core) (Di Chiara et al., 2004; Ito et al., 2004). After prolonged drug use, drug 
associated cues produce increases in extracellular DA levels the DS and less so in the 
ventral striatum (Ito et al., 2002). This lends to the notion that a shift in the relative 
engagement from the ventral to the DS underlies the progression from initial, voluntary 
drug use to habitual and compulsive drug use (Everitt et al., 2008). 
     Conditioned learning. 
    The AMG plays a prominent role in the conditioned learning, where strong 
associations between environmental stimuli and the rewarding of effects of drug use are 
made. Glutamatergic efferents from the AMG to the PFC and NAc mediate behavioral 
responses to these stimuli (Cardinal et al., 2002). The AMG is involved in two circuits 
that mediate stimulus-reward associations. The AMG-mediodorsal thalamus-PFC 
subcircuit has been implicated in the formation of stimulus-reward associations (Gaffan 
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& Murray, 1990). The second subcircuit between the AMG, VTA and NAc is more 
closely linked with the unconditioned rewarding effects of natural and drug rewards, in 
addition to the expression of stimulus-induced drug-seeking (Everitt et al., 1991). Within 
this circuit, the basolateral AMG is critical for cue-induced relapse (Everitt et al., 1991; 
Everitt & Wolf, 2002).  In addition, the central nucleus of the AMG is a particularly key 
neural substrate underlying stress-induced relapse (Shalev et al., 2002; Shaham et al., 
2003).  
     Subjective effects of drugs of abuse. 
 Some of the most frequently abused substances include alcohol, nicotine, 
cannabis (marijuana, hashish), psychostimulants (e.g., cocaine and amphetamines) and 
opioids (e.g. morphine, heroin, and prescription opioids).  Drugs of abuse produce 
pleasurable emotional states and/or relieve negative emotional states, but the specific 
subjective effects differ by drug type.  For example, alcohol, opiates, and cannabinoids 
produce disinhibition, analgesia, relaxation, and feelings of euphoria in addition to motor 
and memory impairments (National Institute on Drug Abuse, 2010a; 2011). On the other 
hand, stimulants such as cocaine and amphetamines are associated with euphoria, 
increased energy, wakefulness, increased activity, and decreased appetite (National 
Institute on Drug Abuse, 2006; 2010b). Nicotine produces mild stimulant effects, without 
euphoria, and can also enhance cognitive processes (Rusted et al., 2009; Holmes et al., 
2008; Lawrence et al., 2002; Green et al., 2005). 
Rodent Models  
  Addiction has a variety of detrimental health, social, and economic 
consequences, therefore, it is important to understand the neural underpinnings of the 
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relationship between ELS and the increased vulnerability towards addiction of the 
victims. Elucidating the neural mechanisms of this relationship is of great value in the 
pursuit of possible treatment and intervention. One way to achieve this is investigations 
using animal models. In the rat, it is well known that ELS has profound impacts because 
of plastic neurological development during the first two weeks of life. As a part of normal 
development, rat pups undergo a stress hypo-responsive period (SHRP) during the first 
two weeks of life, whereby the HPA axis is relatively unresponsive (Levine, 1994).  
There may be a similar hyposensitive period in human infants (Gunnar & Donzella, 
2002). Preclinical studies show that when maternal care is disrupted for long periods, 
stress hormones are abnormally elevated in infants during the SHRP. Exposing the 
developing brain to stress and stress hormones during the SHRP period causes a 
multitude of neurobiological changes. For example, rats exposed to stress during the 
SHRP demonstrate alterations in monoaminergic systems, the primary excitatory and 
inhibitory neurotransmitter systems, as well as the neuroendocrine stress responses in 
adulthood (Meaney, 2001). Therefore, rodent paradigms that model both ELS and 
addiction like behaviors have been developed to further study these phenomena. Below, 
we will briefly discuss prominent rodent paradigms that model both ELS and addiction.   
     Early Life Stress. 
 There is an abundant amount of literature investigating the lasting neurobiological 
and behavioral effects of ELS in rodents. Within this body of literature, multiple 
paradigms exist including maternal separation, maternal deprivation, naturally occurring 
low levels of maternal behavior, and brief exposure to an abusive female. Within the 
body of literature investigating the effects of ELS and vulnerability towards addiction, 
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there are two primary rodent models of ELS. First,  in the maternal separation/deprivation 
paradigms (in which pups are removed from maternal care during the first 1-2 weeks of 
life) modeled after Plotsky and Meaney’s (1993) original paradigm, there is an 
unfortunate amount of variability in various parameters, ranging from manipulation of 
litter composition, cross-fostering, number of days of separation, time and length of 
separation, separation environment, day of weaning, and housing conditions during 
adolescence. Furthermore, the appropriate use of a control group has also received 
considerable debate (Matthews et al., 2001; Matthews et al., 1999). In general, the adult 
phenotype of pups exposed to ELS consists of a hyperactive HPA axis, increased anxiety-
like and depressive behaviors, increased drug intake, a compromised immune system, and 
alterations in monoaminergic systems (Ladd et al., 2000; Lippmann et al., 2007; Meaney, 
2001).  
 Second, Meany and colleagues postulated that the change in adult offspring 
phenotype after maternal separation was due to a change in maternal behavior rather than 
the actual physical separation (Liu et al., 1997). This spurred an investigation into the 
natural variations in maternal care, which ultimately led to the development of another 
paradigm to investigate the effects of early life experiences. In this paradigm, pups are 
not physically separated from their mothers, but instead maternal care is coded daily in 
order to define which litters receive high maternal care in the form of licking, grooming, 
and arch back nursing (designated “H-LG” for high licking and grooming) or low 
maternal care (designated “L-LG” for low licking and grooming) (Liu et al., 1997). Adult 
offspring who received L-LG maternal behavior develop similar phenotypes as pups 
exposed to separation/deprivation procedures. The consistent manipulation across these 
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paradigms is the disruption of maternal care during the SHRP, followed by the evaluation 
of effects in adulthood. For descriptions of other less frequently used ELS rodent 
paradigms, see Lutz and Turecki (2013) for a review.  
     Addiction. 
 While human research can elucidate many factors that contribute to the 
characteristics and cycle of addiction, animal research is necessary to fully examine the 
neurobiological consequences of repeated drug use. Additionally, animal models aid in 
the investigation of neuropharmacological actions of drugs of abuse and efficacy of 
pharmacological treatments for addiction.  Furthermore, utilizing animal models of 
addiction allows researchers to investigate the addictive potential of drugs without 
administering them to humans. Common examples of the most frequently used animal 
models of addiction include intracranial self-stimulation (ICSS), conditioned place 
preference (CPP), behavioral sensitization, and self-administration (SA) paradigms with 
subsequent extinction training and reinstatement (Balster, 1991). Here we will briefly 
review the basic design, benefits, and limitations of CPP, SA, extinction training, and 
reinstatement procedures.  
 CPP is based on principles of classical (associative) conditioning that assert that if 
a drug has rewarding or reinforcing properties, then an animal will prefer a context with 
which the drug has been repeatedly paired. Researchers use a two- or three-chambered 
apparatus which differs from one side to the other on many variables such as color, 
texture, and lighting. The animals are then repeatedly conditioned with saline on one side 
and a drug on the other over a period of 1-2 weeks. After conditioning, the animal is 
allowed to freely explore either side of the apparatus. CPP is considered to have occurred 
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if the animal spends more time in the drug-paired context as compared to the saline-
paired context. Multiple drugs of abuse can induce a CPP including opiates, nicotine, 
cocaine, and METH (Feltenstein & See, 2008; Hensleigh & Pritchard, 2014). CPP is a 
useful paradigm as it is a relatively fast and inexpensive procedure, requires no animal 
surgery, and little behavioral training. Some limitations, however, include variations in 
how the drug is introduced to the animal (i.e., intraperitoneal vs. subcutaneous injections, 
neither of which are voluntarily administered by the experimental subject), number of 
conditioning sessions, and the lack of established drug dependence.  Additionally, dose-
effects curves are difficult to assess (Feltenstein & See, 2008).   
 Arguably the best rodent model of addiction to date is the SA paradigm. In this 
paradigm, rodents are trained to complete an operant response, such as a lever press or a 
nose-poke into a specified aperture, in order to receive a drug reinforcer.  For over half a 
century, researchers have found that rodents will self-administer opiates, cannabinoids, 
alcohol, nicotine, amphetamine, METH, and cocaine to a similar extent as humans, 
although some drugs are more readily self-administered than others (Feltenstein & See, 
2008). SA paradigms can differ by the route of administration. For example, rodents and 
primates can be trained to self-administer drugs orally, intracranially, or intravenously by 
a surgically implanted catheter. This paradigm also offers the advantage of providing 
evidence for the abuse potential of novel drugs. Additionally, subjecting the animal to 
extinction training (i.e., withholding the drug reinforcer) provides a model for drug 
seeking behavior and drug-related inhibitory learning in humans. Furthermore, 
reinstatement after extinction can be induced by three primary modalities: acute drug 
exposure (drug prime), stress, or exposure to drug associated cues, all of which model 
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relapse behavior in humans. Though, theoretical limitations of the reinstatement 
paradigm exist, such that no drug is obtained from the seeking behavior, therefore the rat 
does not actually experience relapse.  
Early Life Stress and Adult Vulnerability Towards Addiction-Like Behaviors   
 The maternal separation (MS) paradigm is commonly used to investigate the 
influences of early life events on addictive behaviors. Many neural systems implicated in 
drug addiction are influenced by MS, such as the HPA axis (Plotsky & Meaney, 1993), 
endocannabinoid system (Romano-López et al.,  2012), monoaminergic systems 
(Dimatelis et al., 2012a; Matthews et al., 2001; Ploj et al., 2003), and neurotrophic factors 
such as brain derived neurotrophic factor (BDNF) (Bolaños & Nestler, 2004; Lippmann 
et al., 2007). In general, adult pups previously exposed to MS for several hours per day 
exhibit depression-like symptoms, anxiety-like behavior,  and an exaggerated 
neuroendocrine responses to stress (Huot et al., 2001). MS has been reported to also alter 
the reinforcing effects of cocaine, ethanol, amphetamine, and morphine (Der-Avakian & 
Markou, 2010; Huot et al., 2001; Moffett et al., 2006; Vazquez et al., 2005). However, 
only a few reports have been published on the effects of MS on adult METH 
vulnerability. In one study, MS failed to produce a significant increase in METH CPP in 
adolescent rodents (Faure et al., 2009; Hensleigh & Pritchard, 2014), while another study 
demonstrated that MS attenuated METH CPP in adolescent rats (Dimatelis et al., 2012a). 
MS has also been shown to produce a sex- and dose-dependent increase in locomotor and 
stereotypy responses to METH in adolescent rats (Pritchard et al., 2012). Recently, we 
published the first report on the effect of MS on adult intravenous METH self-
administration (SA), extinction, and reinstatement (see Chapter 2 and Lewis et al., 2013). 
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In order to understand the need for continued research concerning the interactions 
between ELS and METH addiction, we will briefly discuss this highly addictive 
substance in more detail.   
Methamphetamine 
 METH is an extremely potent and highly addictive neurotoxic drug in the 
phenylethylamine class of psychostimulants (Vearrier et al., 2012; Xie & Miller, 2009). 
METH has a range of potential medical uses from attention deficit hyperactivity disorder 
treatment to narcolepsy, asthma, and obesity treatments (Marshall & O’Dell, 2012). 
METH is an N-methylated form of amphetamine, which increases lipid solubility thus 
allowing for a more rapid crossing of the blood-brain barrier. METH exerts its central 
nervous system effects through interactions with plasma membrane monoamine reuptake 
transporters and intracellular vesicular monoamine transporters (VMAT) located in 
presynaptic terminals, acting as a pseudo-substrate for DA, NE and 5-HT transporters 
(Sulzer, 2011). METH is transported into the presynaptic terminal where it also is 
transported into synaptic vesicles by VMATs, where it causes a redistribution of 
vesicular monoamines to the cytoplasm. This results is a reversal of the directionality of 
plasma membrane transporters and a subsequent flow of monoamines out of the 
presynaptic terminal into the extracellular space (Ciccarone, 2011). While METH 
increases NE and 5-HT levels in the NAc, increases in extracellular DA plays a more 
prominent role in at least the initial rewarding and reinforcing properties of METH 
(Sulzer, 2011).  
 METH abuse has many detrimental consequences for the individual and for 
society as a whole. For the individual, chronic abuse has negative neuropsychological and 
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psychiatric effects, as well as modifying the healthy brain’s functional and structural 
reward and learning neurocircuitry (Bernacer et al., 2013; Darke et al., 2008; Taylor et 
al., 2013). METH abuse has been identified as both a strong risk-factor for violence and 
high-risk sexual behaviors. In one study of a population between the ages of 18 and 25, 
34.9% of respondents self-reported violent behavior while under the influence of METH, 
such as domestic violence, gang-related violence, and random acts of violence (Sommers 
et al., 2006). Individuals on METH often engage in unprotected vaginal and anal sex and 
also have unprotected sex with multiple partners (Springer et al., 2007). Acute METH use 
has many effects such as dilated pupils, dry mouth, sweating, numbness, and increased 
heart rate, blood pressure, and body temperature. Chronic METH use has a wide range of 
potential negative health consequences such as damage to oral health, behavioral 
disturbances, increased risk of stroke and heart attack, and liver and kidney damage. It is 
apparent that chronic METH use has a multitude of deleterious effects on the users, 
which in turn has a negative outcome on society.  
Epigenetic Mechanisms 
 Exposure to childhood abuse and household dysfunction has been related to an 
earlier onset of METH use in both men and women (Messina et al., 2008), and while 
preclinical work demonstrates that the deleterious effects of ELS on neurodevelopment 
are abundant, many relevant questions have gone unanswered for decades. How does an 
experience early in life effectively change the development of a complex system such as 
the brain? Why do some but not all people who experience ELS develop psychiatric 
illnesses in adulthood? Recent evidence has suggested epigenetics as a possible 
mechanism to answer these and many other questions. One of the leaders of the field, 
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David Sweatt (2013), reviewed the striking increase in epigenetics research over the last 
15 years. Within this influx of research is an impressive body of literature demonstrating 
that DNA methylation and histone modifications in neuronal cells are modulated by 
experiences, both in early life and adulthood.  This new field, referred to as 
‘neuroepigenetics’ (Sweatt, 2013) or ‘neurobehavioral epigenetics (Lutz & Turecki, 
2013), indicates that a myriad of external factors including nutritional status, education 
and socioeconomic status (SES), exposure to environmental toxins and drugs of abuse, 
withdrawal from chronic drug intake, and stress can all influence epigenetic regulators of 
gene expression. Gene expression in turn influences behavior, phenotypes, and 
vulnerability to various psychiatric illnesses. The concept that our adult genetic profile is 
shaped partially based on our earliest experiences is an innovative paradigm shift from 
traditional views of neurodevelopment (Sweatt, 2013). It also addresses the long-standing 
debate of nature versus nurture in the field of psychology; it is no longer nature versus 
nurture, but now it is undeniably nature and nurture that determine the sum of the 
complex individual. 
 The word “epigenetics” comes from the Greek root ‘epi’ meaning ‘above’, ‘over’, 
or ‘in addition to’. This refers to the regulation of gene expression outside of genomic 
information in the DNA nucleotide sequence (Biliński et al., 2012).  In 1942, the 
developmental biologist Conrad H. Waddington introduced this term and the ‘epigenetic 
landscape’ to explain the process by which multicellular organisms develop different 
phenotypes independent of their identical genome (Waddington, 1942). Through 
activation and repression of specific genes, cells differentiate into distinct phenotypes 
such that a liver cell is distinct from a muscle cell and so forth. The epigenetic cellular 
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profile is then inherited by the daughter cells and is maintained through cellular division, 
thus liver cells remain liver cells and muscle cells remain muscle cells for the lifespan of 
the organism. This traditional definition of epigenetics included ‘heritability’ as a 
qualifier. In more recent decades it has become apparent that post-mitotic cells, such as 
neurons, go through rapid dynamic processes that modulate gene expression (Narayan & 
Dragunow, 2010; Renthal & Nestler, 2008; Roth, 2012; Tsankova et al., 2007). Hence, 
the term ‘epigenetics’ and the debate over its accurate definition spans many disciplines 
(Ho & Burggren, 2010). 
There are numerous epigenetic mechanisms, but the most commonly studied are 
post-translational modifications to histones and DNA methylation. Other mechanisms 
such as non-coding RNAs (e.g., microRNAs and others), prion proteins, and histone 
remodeling, though emerging as relevant processes, are beyond the scope of this review. 
Briefly described here are the mechanisms underlying post-translational histone 
modifications and DNA methylation in regulating gene expression. For readings on other 
epigenetic mechanisms please see other reviews (Bannister & Kouzarides, 2011; Cohen 
et al., 2011; Strahl & Allis, 2000; Sweatt, 2013; Zheng & Hayes, 2003).  
     Histone modifications.  
 Eukaryotic DNA is packaged into chromatin that consists of units known as 
nucleosomes, which is comprised of the DNA double helix wrapping around a protein 
complex made of eight histone protein subunits. Chromatin can exist in the form of 
heterochromatin or euchromatin (Tamaru, 2010). In the heterochromatin state, the DNA 
is tightly packaged which blocks transcriptional machinery and silences gene expression. 
In contrast, euchromatin is more loosely packaged and permissive of gene transcription.  
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Histone complexes are protein octamers with 2 copies each of histone H3, H4, H2A, and 
H2B. Histone variants such as H2A.Z and H3.3 have been associated with replacement of 
the typical histone proteins during transcription and chromatin structural remodeling 
(Henikoff et al., 2004). The double-stranded DNA helix is wrapped around the histone 
octamer ~1.5 times, equivalent to ~147 base pairs, and histone H1 serves as a connector 
histone between nucleosomes (Thoma et al., 1979).  Histones have protruding N- and C-
terminal tails in which specific amino acids undergo covalent post-translational 
modifications, of which the most commonly studied are methylation, acetylation, and 
phosphorylation (Bode & Dong, 2005; Kouzarides, 2007; Morales et al., 2001). 
 Histone modifications regulate chromatin structure in various ways, including the 
recruitment of remodeling enzymes and altering the overall charge of the histone protein 
complex. Histone phosphorylation state is regulated by kinases and phosphatases that add 
or remove phosphate groups, respectively, significantly altering the overall charge of the 
histone which in turn influences chromatin structure. Histone phosphorylation is 
associated with both transcriptional repression and activation. Histone methylation and 
acetylation are by far the most studied modifications of these proteins. Histone 
acetylation is regulated by histone acetyltransferases (HATs) and histone deacetylases 
(HDACs). Histone acetylation at lysine (K) residues is generally associated with 
euchromatin and is permissive of gene expression (Bode & Dong, 2005; Kouzarides, 
2007; Morales et al., 2001).  
Histone methylation was traditionally thought to be a static process, but it is now 
widely accepted as being dynamic (Bannister & Kouzarides, 2005; Bannister et al., 
2002). Histone methyltransferases (HMTs) regulate the complexity of histone 
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methylation; lysine (K) residues can be mono-, di-, or tri-methylated and arginine (R) 
residues can be mono- and di-methylated (either symmetrically or asymmetrically). 
Methylation is different from acetylation and phosphorylation since it does not change 
the overall charge of the nucleosome. Unlike acetylation, methylation is associated with 
both transcriptional activation and repression, which are dependent on various factors 
including the specific histone subunit, residue, and methylation state. Furthermore, the 
overall ‘histone code’ or histone ‘crosstalk’ between modifications and DNA methylation 
makes for an almost infinite level of possible gene expression regulatory processes (Ben-
Porath & Cedar, 2001; Kondo, 2009).  
     DNA methylation. 
Most eukaryotic cells contain methylated DNA that is distributed across the 
genome, referred to as global methylation (Bird, 2002). In mammals, DNA 
methyltransferases (DNMTs) mostly target a 5’ cytosine (C) adjacent to guanine (G) on 
the same strand (i.e., not complementary C-G base pairing), which is also referred to as a 
CpG dinucleotide site, although there are exceptions. Regions of DNA with greater than 
~55% CpG site content are referred to as CpG islands and tend to appear around 
promoter regions of genes, with ~40% of genes having CpG islands in their promoter 
sequences (Miranda & Jones, 2007). It is estimated that the human genome has ~29,000 
CpG islands (Bird, 2002). Methylation of CpG sites is associated with gene silencing in 
cell fate determination, genomic imprinting, and X chromosome inactivation, although 
many genes with unmethylated CpG sites can also be silenced. DNA methylation is 
stable and inherited by daughter cells after division even when histone modifications are 
not, thus maintaining the same gene expression patterns that lead to cell type 
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determination and perpetuation. DNA methylation represses gene transcription on a 
multitude of levels: by inhibiting transcription factor access; by attracting 
methylcytosine-binding proteins (MBDs), one of the most commonly studied being 
methyl-CpG-binding protein 2 (MeCP2); and by recruiting protein complexes that 
contain other repressors and chromatin remodelers such as HDACs and HMTs (Jones et 
al., 1998). DNA methylation may also influence nucleosome occupancy over promoter 
sites and prevent gene activation (Miranda & Jones, 2007). The notion that DNA 
methylation patterns in the central nervous system and germ cells are highly dynamic is 
now widely accepted (Bohacek et al., 2013; Ho & Burggren, 2010; Jiang et al., 2008; 
Kovalchuk, 2012; Miller & Sweatt, 2007;Roth et al., 2009). Methylation patterns may be 
“rapid and reversible” by various mechanisms, allowing for previously methylated CpG 
sites to become de-methylated and vice versa. Several mechanisms of active DNA 
demethylation have been proposed (Klengel et al., 2014; Ooi & Bestor, 2008). Recently, 
a large body of evidence has accumulated showing that the epigenetic mechanisms 
discussed above are involved in drug-induced maladaptive neural plasticity. Below we 
will briefly summarize the literature concerning psychostimulants and MeCP2.  
Addiction and MeCP2 
Although drugs of abuse may have different sites of action and affect various 
neurotransmitter and receptor systems (Taylor et al., 2013), their chronic use leads to 
specific alterations in gene expression. These changes in gene expression are thought to 
lead to the changes in behavior, brain structure, and neuronal function that underlie 
impaired cognition and maladaptive behaviors that are characteristic of addiction 
(McClung & Nestler, 2008). Rodent and human research has established that multiple 
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mechanisms of epigenetic regulation are directly affected by drugs of abuse (Biliński et 
al., 2012; Cadet, 2014). These epigenetic changes may be the primary process by which 
drugs induce highly stable changes in the expression of genes in multiple brain regions 
that mediate the transition for casual intermittent drug use to compulsive habitual drug 
use in addiction. While there are a myriad of known epigenetic changes produced by 
drugs of abuse, we will primarily focus on MeCP2. 
MeCP2 is a methylated DNA binding protein that attracts histone deacetylases 
(HDACs) and is generally associated with repression of transcription (Jones et al., 1998). 
It may also act to mediate transcription on a genome wide manner as well (Skene et al., 
2010). However, recent studies have shown that MeCP2 can also facilitate transcription 
in a phosphorylation state-dependent manner (Chahrour et al., 2008; Cohen et al., 2011; 
Tao et al., 2009). Interestingly, drug exposure mediates levels of MeCP2 in various brain 
regions and manipulating MeCP2 levels prior to drug exposure can affect the rewarding 
properties of some psychostimulants (Cassel et al., 2004; Deng et al., 2010; Im et al., 
2010). Cocaine self-administration in rats increases MeCP2 mRNA in the anterior 
cingulate cortex, DS, and NAc (Host et al., 2011). Consistent with this, repeated daily 
exposure of mice to cocaine injections increased MeCP2 expression in the dentate gyrus, 
frontal cortex, and DS (Cassel et al., 2006). Im et al. (2010) showed that a lentiviral 
knockdown of MeCP2 in the DS decreased cocaine intake under extended access 
conditions. Deng et al. (2010) demonstrated that viral knockdown of MeCP2 in the NAc 
of mice enhanced amphetamine-induced CPP, whereas overexpression of MeCP2 in the 
NAc reduced amphetamine CPP. More recently, it has been demonstrated in mice that 
ethanol exposure modulates MeCP2 expression and inversely that MeCP2 expression is 
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involved in both ethanol sensitivity and intake behavior (Repunte-Canonigo et al., 2013).  
Furthermore, ethanol induced changes in MeCP2 expression is a potential molecular 
mechanism for Fetal Alcohol Spectrum Disorders as continuous ethanol exposure in vitro 
upregulates MeCP2 expression while ethanol withdrawal down-regulates expression 
(Liyanage et al., 2015). Hou et al. (2015) conducted a study in which they demonstrated 
that chronic pain maintains morphine-seeking behavior after morphine withdrawal and 
these animals had a reduction of MeCP2 at the promoter region of gria1, encoding 
GluA1. Viral overexpression of MeCP2 in the central AMG of these animals eliminated 
morphine seeking behavior after morphine withdrawal. Additionally, the aforementioned 
investigations demonstrated that MeCP2 in the NAc is highly related to neuroplasticity as 
it plays a role in dendritic spine density, GABAergic synapses, and bdnf expression 
regulation (Deng et al., 2010; Im et al., 2010).  
Cleary, this collection of studies suggests that that MeCP2 plays a role in drug 
reward and reinforcement. While some studies yielded seemingly conflicting reports,  
such that virally-mediated reductions in MeCP2 expression in the nucleus accumbens  
increases the conditioned rewarding effects of amphetamines (Deng et al., 2010), and 
MeCP2 knockdown in the DS actually reduced cocaine self-administration (Im et al., 
2010). This collection of studies suggests that not only is MeCP2 expression regulated by 
various drugs of abuse, but that MeCP2 expression regulates the sensitivity of an 
organism, and the reinforcing, and rewarding properties of drugs of abuse. Meaning, that 
one’s individual epigenetic landscape may mediate their physiological and behavioral 
response to drugs of abuse, therefore altering their predisposition to developing a SUD. 
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Next, we will briefly review the literature investigating if ELS may be epigenetically 
enhancing vulnerability toward various psychiatric disorders.  
Early Life Stress and Epigenetic Effects 
Animal models allow the experimental control and design that are often 
impractical, impossible, or immoral when using human participants. While peripheral and 
post-mortem brain samples have been utilized to investigate epigenetic mechanism in 
humans, animal models allow for the investigation of specific neuronal tissues and 
circuitries. A recent collection of work, reviewed below, has demonstrated that ELS can 
in fact modulate multiple brain systems epigenetically. These studies serve as models for 
the mechanisms by which ELS may be modulating neural systems, such as the reward 
circuitry, to increase addiction vulnerability. Since much of this literature focuses on the 
effects of ELS on the hypothalamic-pituitary-axis (HPA) stress response, we will briefly 
review the neurobiology of this system.  
The HPA axis is initiated by either a real or perceived stressful stimulus activating 
the cells in the paraventricular nucleus (PVN) of the hypothalamus that project to various 
limbic brain regions. The parvocellular projections of the PVN secrete corticotrophin-
releasing factor (CRF, or sometime CRH for corticotrophin-releasing hormone) and 
arginine vasopressin (AVP) via the median eminence into the anterior pituitary. CRF and 
AVP in the anterior pituitary stimulate the synthesis and release of adrenocorticotropic 
hormone (ACTH) into circulation. ACTH in the blood stream acts on the adrenal cortex 
to initiate the synthesis and release of glucocorticoids (GC) (primarily cortisol in humans 
and corticosterone in rodents, collectively referred to as CORT) into circulation. GCs in 
the systemic circulation then act upon cytosolic and plasma membrane receptors, most 
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notably glucocorticoid and mineralocorticoid receptors (the latter also known as 
aldosterone receptors). GCs regulate the termination of the stress response via a negative 
feedback loop both directly and indirectly in the central nervous system.  
     Glucocorticoid receptor (Nr3c1). 
The most extensively studied effect of ELS and epigenetics is of the GC receptor 
gene (nuclear receptor subfamily 3, group C, member 1, or Nr3c1). In the 
groundbreaking study by Weaver et al., (2004) it was shown that variation in maternal 
care altered methylation of exon 17  of the GC receptor (GR) promoter in hippocampal 
neurons. More specifically, maternal care was associated with variations in methylation 
of a specific CpG site in which the immediate early gene nerve-growth factor inducible 
protein A (NGFI-A) binds DNA as a transcription factor, altering GR expression levels in 
the hippocampus. A change in GR expression then influences HPA axis function and the 
negative feedback loop that plays a role in terminating the stress response. This initial 
research was highly influential, as it demonstrated for the first time a relationship 
between ELS-altering epigenetic markers regulating protein expression that directly 
affects neurophysiological systems implicated in psychiatric disorders. Multiple 
laboratories have continued research investigating the effects of ELS on epigenetic 
regulation of the Nr3c1 gene. This avenue of research continues to be promising, 
although some have failed to replicate Weaver’s initial findings (Daniels et al., 2009; 
Kember et al., 2012). This could be due to different ELS paradigms, or different rodent 
strains utilized. As others have demonstrated, the effects of ELS on epigenetic regulation 
of the GR gene is complex and dependent on multiple factors including the genetic 
background, litter composition, sex, cell type, and brain region of interest (Kember et al., 
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2012; Kosten et al., 2013; Kundakovic et al., 2013; Liberman et al., 2012; McGowan et 
al., 2011). Interestingly, acute and chronic stress in adult rats does not mimic the change 
in methylation patterns of the Nr3c1 gene as observed after ELS, demonstrating the 
importance of the developmental window in this phenomenon (Witzmann et al., 2012).  
 The similar adult phenotypes observed in rodents and humans with a history of 
ELS has long suggested that the underlying mechanisms may be conserved across 
species. Accordingly, McGowan and colleagues were the first to investigate a 
relationship between ELS and epigenetic regulation of the GR gene in humans, assessing 
methylation of Nr3c1 exon 1F (the human homolog of rat exon 17) (McGowan et al., 
2009). These investigators found increased DNA methylation at specific CpG sites in 
exon 1F of the Nr3c1 promoter in postmortem hippocampal tissue of suicide victims with 
a history of ELS compared to controls and suicide victims without a history of abuse. The 
increased DNA methylation was related to decreased rates of GR expression. Other 
groups have extended this work by demonstrating a relationship between ELS and 
methylation status of the Nr3c1 gene with both increased and decreased methylation 
states for different GR transcripts (Labonté et al., 2012; Perroud et al., 2011; Steiger et 
al., 2013; Suderman et al., 2012; Tyrka et al., 2012). The functional impact on the HPA 
axis and adult behaviors of these epigenetic alterations begs further investigation. While 
the previous data concerning ELS epigenetically modulating the GR gene is intriguing, 
McGowan et al. (2011) argued the importance for broadening the investigative scope of 
this work, as ELS affects numerous systems and behaviors into adulthood. In this latter 
study, a ~7 million base pair locus around the GR gene in the rat hippocampus was 
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examined, and findings revealed that maternal care influenced DNA methylation in non-
promoter regions in non-random, gene-specific, and bi-directional manners.   
    Arginine vasopressin. 
Arginine vasopressin (AVP) is a hormone involved with HPA regulation, and is 
also involved in depression (Londen et al., 1997). Murgatroyd et al. (2009) found that 
mice exposed to ELS had decreased methylation of the Avp enhancer and increased AVP 
expression in the PVN as adults. It is likely that the decrease in methylation in adulthood 
was due to reduced MeCP2 occupancy at the Avp enhancer during ELS. ELS activates 
HPA circuits which trigger phosphorylation of MeCP2 and its release from methylated 
DNA. This leads to life-long hypo-methylation and overexpression of AVP in the PVN. 
This functional consequence of epigenetic regulation was associated with a hyperactive 
stress response as it was partially reversed by treatment with an AVP V1b receptor 
antagonist. Additionally, ELS modulates methylation patterns of the Avp gene in the 
hippocampus (Kember et al., 2012) and DNA methylation of other HPA regulatory 
genes. For example, increased mRNA expression of the pituitary pro-opiomelanocortin 
(Pomc) gene after ELS was associated with a decrease in DNA methylation (Wu et al., 
2014). Clearly, the interaction between ELS and epigenetic markers is exceedingly 
complex, dynamically modulating the HPA axis via multiple avenues in multiple brain 
regions throughout development.  
     Brain derived neurotrophic factor. 
Brain derived neurotrophic factor (BDNF) is a protein belonging to the 
neurotrophin family of growth factors, and its gene bdnf is another affected by ELS. Roth 
et al., (2009) used a novel paradigm targeting the effects of abuse during postnatal days 1 
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– 7. Rat pups were exposed to a stressed female that displayed multiple abuse behaviors 
including rough physical contact and active avoidance. In adulthood, these rats showed 
increased DNA methylation of bdnf in the PFC and decreased BDNF expression. The 
DNA methylation status and expression levels of BDNF in the PFC were rescued by 
chronic intracerebroventricular treatment with a DNMT inhibitor. BDNF has emerged as 
having somewhat of a ubiquitous role in brain functioning, and is implicated in various 
diseases including depression, stroke, Alzheimer’s, and addictive disorders (Biliński et 
al., 2012; Nagahara & Tuszynski, 2011). Thus, evidence that ELS can trigger BDNF 
expression changes in adulthood has immense implications concerning vulnerability 
towards the development of these disorders.  
     5-HT transporter (Slc6a4). 
 The serotonin system is highly involved with emotion regulation and various 
psychiatric illnesses such as major depression, autism, and addictive disorders (Uaswani 
et al., 2003). Variation in the serotonin transporter (5-HTT) gene (solute carrier family 6, 
subfamily a, member 4, Slc6a4) moderates individual reactions to stress, a potential risk 
factor for development of psychiatric illness (Caspi et al., 2003; Kendler et al., 2005), and 
determines clinical responsiveness to certain antidepressants (Kim et al., 2000). ELS 
influences the development of the serotonergic system, and this regulation may be 
epigenetically determined (Beach et al., 2010; Vijayendran et al., 2012). In non-human 
primates, higher levels of methylation of the Slc6a4 gene has been associated with higher 
stress reactivity in females exposed to ELS but not controls (Kinnally et al., 2011). 
Another study conducted in adopted humans demonstrated that DNA methylation levels 
and the specific 5HTT allele (long or short) interact to influence psychological coping 
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with loss and trauma (Van IJzendoorn et al., 2010).  These data highlight the complex 
interaction of genetics, epigenetics, and ELS in shaping individual phenotypes.    
     GABA and glutamate. 
ELS also affects the major excitatory and inhibitory neurotransmitter systems, 
glutamate and GABA, respectively (Bagot et al., 2009; Meaney, 2001) in part via 
epigenetic mechanisms. Low maternal care was associated with an increase in DNA 
methylation of the promoter region of the GAD1 gene in the hippocampus of adult rats 
(Zhang et al., 2010). The GAD1 gene codes for glutamic acid decarboxylase (67 kDa 
isoform), the rate limiting enzyme of GABA synthesis. Methylation status of the GAD1 
promoter in postmortem tissue samples has been associated with schizophrenia (Zhang et 
al., 2010), implicating a potential mechanism by which ELS may confer vulnerability to 
this disease. These findings, along with those showing that ELS induced long-term 
alterations of the GABAA and central benzodiazepine (CBZ) receptor subunit profiles in 
the hippocampus (Meaney, 2001), paint an intriguing picture as to the wide scope in 
which ELS can modify brain systems. Furthermore, ELS epigenetically affects 
hippocampal long-term-potentiation and depression, two forms of neural plasticity 
intimately related to glutamatergic transmission. High maternal care was associated with 
decreased DNA methylation and changes in histone modifications of the gene coding for 
the type 1 metabotropic glutamate (mGluR1) receptor (Grm1) in the hippocampus of 
adult offspring (Bagot et al., 2012). Accordingly, these animals displayed an increase in 
both mRNA and protein levels of the mGluR1 receptor (Bagot et al., 2012). Collectively, 
these data implicate epigenetic regulation as a mechanism by which ELS can have long 
lasting effects on excitatory and inhibitory amino acid neurotransmission. Given the 
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ubiquitous distribution of GABA and glutamate systems across the brain, the ability of 
ELS to epigenetically modulate their development and function has profound and long 
reaching implications for resulting adult phenotypes.  
     Epigenetic machinery.  
 ELS can alter the expression of epigenetic machinery as well. For example ELS 
was shown to decrease mRNA levels for multiple HDACs in the cortex (Levine et al., 
2012). This decrease in HDAC expression was accompanied by increased acetylation of 
H4, altered emotional phenotypes, and responsivity to an antidepressant. Other 
investigators have demonstrated a relationship between ELS and HDAC expression as 
well (Tesone-Coelho et al., 2013). Additionally, ELS decreased nucleus accumbens 
DNMT expression rates which were associated with hyper-methylation of neuronal 
plasticity genes (Anier et al., 2013). It is thus apparent that ELS modulates the epigenome 
by numerous mechanisms. These alterations can persist into adulthood and regulate gene 
expression via bi-directional changes in histone acetylation, DNA methylation, and gene 
expression in both promoter and non-promoter regions (McGowan et al., 2011). 
Summary  
 Thus far, we have reviewed the current literature investigating the long term 
epigenetically mediated consequences of ELS exposure. Early experience-driven 
epigenetic markers have the capacity to modulate neuronal gene transcription. 
Consequent changes in gene expression have been demonstrated to functionally alter 
multiple neuroendocrine and neurotransmitter systems. In turn, these alterations influence 
behavior, future responses to various environments, and vulnerability towards multiple 
psychiatric illnesses, such as addiction. We also discussed the notion that drug induced 
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epigenetic alterations may be crucial to the process by which casual intermittent drug use 
transitions to compulsive habitual drug use in addiction (Nielsen et al., 2012; Schmidt et 
al., 2013; Taylor et al., 2013), while others have shown that the epigenetic landscape 
prior to drug exposure may play a role in addiction vulnerability (Deng et al., 2010; Im et 
al., 2010; Tesone-Coelho et al., 2013). There is thus an interesting and circular 
relationship here, in which the epigenome prior to drug use may predispose the individual 
to higher addiction vulnerability or resiliency, and the epigenetic response to drugs of 
abuse further modulates risk and progression towards addiction. Interestingly, despite the 
established link between ELS and addictive disorders, investigation of ELS induced 
epigenetic alterations that predispose an individual to a high risk for addiction is still very 
much in its infancy (Anier et al., 2013; Lewis et al., 2013; Romano-López et al., 2012; 
Tesone-Coelho et al., 2013). Furthermore, there are contradicting results concerning NAc 
MeCP2 expression after ELS (Romano-López et al., 2012; Tesone-Coelho et al., 2013). 
Thus, one possible way by which ELS may be modulating addiction vulnerability is 
through lasting epigenetic changes in the reward circuitry. Therefore, more research on 
ELS effects on NAc MeCP2 expression and the role of MeCP2 on the rewarding and 
reinforcing effects drugs of abuse is warranted.  
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CHAPTER 2 
THE EFFECTS OF MATERNAL SEPARATION ON METHAMPHETAMINE SELF-
ADMINISTRATION, EXTINCTION, AND CUE INDUCED REINSTATEMENT 
 METH is an extremely potent and highly addictive psychostimulant and 
neurotoxic drug (Xie & Miller, 2009). METH abuse has many detrimental consequences 
for the individual and for society as a whole. For the individual, chronic abuse has 
negative neuropsychological and psychiatric effects, and modifies functional and 
structural reward and learning neurocircuitry in the healthy brain (Taylor et al., 2013). 
METH abuse has been identified as both a strong risk-factor for violence and high-risk 
sexual behaviors. In one study of a population between the ages of 18 and 25, 34.9% self-
reported violent behavior while under the influence of METH, such as domestic violence, 
gang-related violence, and random acts of violence (Baskin-Sommers & Sommers, 
2006). Individuals on METH often engage in unprotected vaginal and anal sex and also 
have sex with multiple partners (Springer, et al, 2007). It is apparent that chronic METH 
use has a multitude of deleterious effects on the users that in turn have a negative 
outcome on society.  
 Since METH use has been associated with a variety of detrimental health and 
social consequences, it is important to identify risk-factors associated with its abuse. 
Clinical research has shown ELS, particularly childhood abuse and neglect, is a reliable 
risk factor that influences adult drug abuse (Anda et al., 2006; Messina et al., 2008). 
Childhood abuse or neglect is highly prevalent with ~1.5 million cases reported in a 2010 
survey (Child Maltreatment 2010, US Department of Health and Human Services) and 
exposure to childhood abuse and household dysfunction has been related to an earlier 
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onset of METH use in both men and women (Messina et al., 2008).There is substantial 
evidence that ELS produces long-lasting changes in the brain, including regions that 
mediate reward-seeking and executive control, which may ultimately predispose the 
individual to increased propensity toward illicit drug use and addiction (Matthews et al., 
2001; Meaney et al., 2002). Stressors during adulthood have also been implicated in 
affecting drug and alcohol intake behaviors (Piazza et al., 1990; Breese et al., 2011).  
 The rodent maternal separation model of ELS is a commonly used paradigm to 
investigate the influences of early life events on addictive behaviors. In this paradigm, 
rodents undergo daily separation from maternal care during critical postnatal 
development and are assessed for propensity towards addiction-like behaviors in 
adulthood. For example, pups undergoing maternal separation for several hours exhibit 
depression-like symptoms, high anxiety-like behavior, exaggerated 
neuroendocrinological responses to stress, and have a high preference for ethanol (Huot 
et al, 2001). MS has been reported to also alter the reinforcing effects of cocaine, 
amphetamine, and morphine (Der-Avakian & Markou, 2010; Moffett et al., 2006; 
Vazquez et al., 2005). However, only a few reports have been published on the effects of 
maternal separation on adult METH vulnerability. In one study, maternal separation 
failed to produce a significant increase in adolescent METH CPP (Faure et al., 2009), 
while another study demonstrated that maternal separation attenuated METH CPP in 
adolescents (Dimatelis et al., 2012b). Maternal separation has also been shown to 
produce a sex- and dose-dependent increase in locomotor and stereotypy responses to 
METH in adolescent rats (Pritchard et al., 2012). To our knowledge, however, there are 
no reports to date on the effect of maternal separation on adult intravenous METH SA, 
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extinction, and reinstatement. Given the negative impact of METH abuse and the 
relationship observed between maternal separation and other drugs of abuse, more 
research in this area is warranted. 
 Emerging evidence suggests a strong role of epigenetics in regulating gene 
transcription based on early experiences that in turn modulate brain systems and behavior 
into adulthood. Many neural systems implicated in drug addiction are influenced by MS, 
such as the HPA axis (Plotsky and Meaney, 1993), endocannabinoid system (Romano-
Lopez et al., 2012), monoaminergic systems (Matthews et al., 2001, Ploj et al., 2003; 
Dimatelis et al., 2012), and growth factors such as BDNF (Bolaños & Nestler, 2004, 
Lippmann et al., 2007). Recent studies implicate epigenetic modifications as a 
mechanism behind these changes in rodents, non-human primates, and humans 
(McGowan et al., 2009; Murgatroyd et al., 2009; Kinnally et al., 2011). For example, 
Murgatroyd (2009) showed that maternal separation induced hypomethylation of the 
AVP enhancer, subsequently causing upregulation of Avp expression and a hyper-
responsive HPA axis. Additionally, maternal care has been implicated in DNA 
methylation and corresponding changes in glucocorticoid receptor (GR) expression levels 
in the hippocampus (Weaver et al., 2004). Furthermore, adult rats exposed to ELS have 
demonstrated reduced BDNF in the PFC correlated with hypermethylation of the BDNF 
IV promoter region (Roth et al., 2009). Indeed, these studies suggest that early life 
experiences are influencing epigenetic markers that modulate multiple brain systems 
implicated in drug vulnerability.  
 Interestingly, epigenetic factors are also altered by drug exposure and can 
influence drug intake, behavioral, and neural responses (Lewis & Olive, 2013; Biliński et 
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al., 2012; Cadet, 2014; Renthal & Nestler, 2009). For example, trimethylation of histone 
H3 lysine 4 (H3K4) at the promoter region of a chemokine receptor type 2 (CCR2), a 
gene implicated in locomotor sensitization, has been associated with METH-induced 
hyperlocomotion in mice (Ikegami et al., 2010). Additionally, cocaine increases MeCP2 
expression in multiple brain regions of the rat (Cassel et al., 2006) and MeCP2 has been 
implicated in cocaine and amphetamine reward and reinforcement (Im et al., 2010; Deng 
et al., 2010). Specifically, Deng et al (2010) found that virally-mediated ablation of 
MeCP2 expression in the NAc increased the conditioned rewarding effects of 
amphetamines, whereas overexpression of MeCP2 in the NAc decreased amphetamine 
reward. Furthermore, Im et al (2010) showed that cocaine intake was reduced after 
knockdown of MeCP2 expression in the DS. Hence, recent studies suggest that the 
predisposition of one’s epigenetic phenotype may influence their behavioral response to 
drugs of abuse while exposure to drugs of abuse also modulates their epigenetic 
phenotype.   
 Although maternal separation and psychostimulants have been shown to 
individually affect epigenetic factors such as MeCP2,  and MeCP2 has been implicated in 
drug seeking behavior, it is yet to be determined if maternal separation and, specifically, 
METH also interact to affect epigenetic factors. Therefore, the goal of the present study 
was to investigate the relationship between ELS, METH SA, extinction and 
reinstatement, and MeCP2 expression in the NAc. We hypothesized that MS would 
increase susceptibility to the acquisition of METH SA, impair extinction learning, and 
increase cue-induced reinstatement. We also predicted that MeCP2 expression in the NAc 
would be negatively correlated with levels of METH SA. 
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Abbreviated Methods 
Animals 
 Pregnant dams were purchased from Charles River Laboratories and arrived on 
gestational day 12. Litters were randomly assigned to 1 of 2 conditions: maternal 
separation for 180 min per day (MS180) or the handled control group, 15 min per day 
(MS15). Separation procedures were carried out from PND2-14. During PND15-20 litters 
were left undisturbed, weaned on PND21 into same sex group housing, and pair housed 
with a sibling on PND45. Females were not used for the remainder of the study. Male rats 
were implanted with intravenous catheters into the jugular vein on PND60 (± 1).  
Behavioral Testing 
 Beginning on PND67 male rats underwent 2 hr daily SA sessions whereby presses 
on one of the levers (designated the active lever) resulted in delivery of METH (0.05 
mg/kg per infusion, delivered in a volume of 0.06 ml over a 2 sec period) on an fixed 
ratio 1 (FR1) schedule of reinforcement. Each METH infusion delivery was followed by 
a 20-sec timeout period, during which additional active lever presses were recorded but 
produced no drug infusions. Each infusion was accompanied by concurrent illumination 
of a stimulus light located directly above the active lever, and presentation of an auditory 
stimulus for 2 sec. SA sessions were conducted 7 days per week for 15 consecutive days. 
Next, all animals were subjected to 2 hr extinction training sessions for 15 consecutive 
days, whereby presses on the active lever no longer produced any programmed 
consequences. On the day immediately following the last extinction session, all rats 
underwent cue-induced reinstatement, whereby presses on the active lever produced the 
tone and light cue previously presented during METH infusion, but did not deliver any 
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drug solution. Presses on the inactive lever did not produce any programmed 
consequences throughout the experiment. 
Tissue Preparation, Immunohistochemistry, and Analysis 
 Fluorescent immunochemistry procedures for labeling MeCP2 were carried out 
according to standard procedures. A total of three bilateral slices of the NAc core were 
counted for each subject (i.e., 1 sample area/2 hemispheres/3 sections). The counts from 
all six sample areas from the NAc core were averaged to provide a mean number of 
immunoreactive cells per animal to be used as an n = 1 for statistical analysis.  
Results 
Litter Effects  
 A repeated-measures ANCOVA conducted by litters, controlling for rearing 
condition, revealed no significant pre-existing differences between litters  on the number 
of METH infusions per session over 15 days  (p = 0.23).    
METH Self-Administration  
 Repeated-measures ANOVA revealed a significant main effect of rearing 
condition on the number of METH infusions per session, F(1, 24) = 9.83, p = 0.004 
(Figures 1 and 2), as well as the number of total active lever presses per session, F(1, 24) 
= 13.79, p = 0.001 (data not shown), with MS180 having more active lever presses and 
receiving more infusions than MS15. No group differences in the total number of inactive 
lever presses were observed, F(1, 17) = 38.76, p = 0.425. However, in both rearing 
conditions we noted a time-dependent increase in inactive lever pressing across self-
administration sessions (see Table 1), and we attribute this to be a result of non-specific 
motor activity that resulted from increasing level of METH SA. 
 
  
39 
 
Extinction 
 For both groups, extinction training produced a significant reduction in the 
number of active lever presses when comparing the average of the final 2 days of 
extinction to the average of the final 2 days of SA (n = 51), t(50) = 5.10, p < 0.0001. 
Repeated measures ANOVA revealed no significant group differences (MS15: n = 9, 
MS180: n = 17) in rate of extinction of active lever pressing, F(1, 20)= 0.94, p = 0.34 
(Figure 3). However, a significant group difference in the number of inactive lever 
presses during extinction training F(1, 24) = 5.47, p = 0.028, was observed, with rats in 
the MS15 group emitting more inactive lever presses over the 15 day extinction period 
compared to the  MS180 group (see Table 1).  
Cue-Induced Reinstatement  
 Cue induced reinstatement was observed in all animals as assessed by the number 
of active lever presses (averaged across the final 2 days of Ext) compared to active lever 
presses during the reinstatement session, t(50) = -4.46, p < 0.0001. However, there was 
no significant difference between the groups for the number of active lever presses during 
reinstatement testing, F(1,24) 1.134, p = 0.298 (Figure 4).  
MeCP2 Immunoreactivity  
 A total of 6 pups from 5 different litters (3 per rearing condition) were used in the 
analysis of the MeCP2 data. We found a significant difference in MeCP2 
immunoreactivity between MS15 rats and MS180 rats in the NAc core, p < 0.001, with 
MS15 expressing more labeled profiles than did MS180 (Figure 5). There was also a 
negative correlation between MeCP2 immunoreactivity and number of total active lever 
presses during 15 days of SA, r = -0.839, p = .003 (n = 5 per rearing condition), (Figure 
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6). Rats emitting fewer lever presses expressed higher numbers of labeled profiles in the 
NAc core (Figure 7).  
Discussion 
 Early life maternal care is known to influence a multitude of neurological, 
endocrine, epigenetic, and behavioral outcomes in adulthood (Roth, 2012; Francis et al., 
1999). Our findings contribute to the literature by suggesting that MS causes alterations 
that influence vulnerability to drug abuse (Moffett et al., 2007), in this case METH SA. 
For the first time, our study suggests that either repeated and prolonged maternal 
separation leads to increased vulnerability to METH intake or that minimal maternal 
separation protects against adult METH SA vulnerability. This is evidenced by our 
findings that MS180 rats showed higher levels of METH SA over 15 daily sessions 
compared to MS15. These findings are in agreement with previous studies examining 
effects of maternal separation on intake of cocaine, morphine, amphetamine, and ethanol 
(Moffet et al., 2006; Der-Avakian et al., 2010; Vazquez et al., 2006; Huot et al, 2000). 
Additionally, we noted that MS15 rats demonstrated a preference for the inactive lever 
over the active lever during SA. While the reason for this is currently unknown, a 
possible explanation for this counterintuitive observation is different non-specific 
behavioral response to METH SA or enhanced operant sensation seeking in the MS15 
group.  
 Since our data set does not include a non-handled control it is difficult to 
distinguish whether the SA behavior is reflective of increased vulnerability in the MS180, 
protective effects in MS15, or both. We chose MS15 as the ideal control group since it 
controls for handling effects, while other commonly used control groups do not. 
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Furthermore, the use of control groups (including MS0, non-handled, and Animal Facility 
Reared) is highly variable. The issues concerning different control groups and variations 
in procedures have previously been discussed by others (Matthews et al., 2001; Matthews 
et al., 1999). Jaworski et al. (2005) provides a well laid out table comparing different 
experimental and control groups commonly used. Recently, a trend towards comparing 
only two groups has emerged. For example, Matthews (2001) used a MS2 and MS360, 
Ploj (2003) only used MS15 and MS360, and Murgatroyd (2009) used non-disturbed and 
MS180 with mice. Our current paradigm met the goal of optimizing the differences 
between conditions and is consistent with the type of two group design that is currently 
gaining momentum in this field. The current literature on maternal separation and drug 
reward, reinforcement, and SA demonstrates that MS180 and MS15 tend to be the most 
divergent groups when compared to the various controls. For this reason, in the present 
study, we did not include a non-separated control group in order to increase validity and 
reliability in our data and improve interpretation in comparison with other studies. 
Additionally, there are large inconsistencies across laboratories with regards to 
procedures for breeding, culling, fostering, litter sex ratios, separation duration and days, 
the order in which dams and pups are returned to the home cage, controlled temperature 
settings outside of the home-cage, PND of weaning, and post-weaning housing 
conditions prior to and during manipulations. 
The effects of brief and prolonged maternal separation we found on METH SA 
fits the inverted U-shape typically found in drug abuse-related behaviors after maternal 
separation (Neisewander et al., 2012). It has been postulated that the protective effects 
seen in the MS15 group may be due to the increased maternal care post separation 
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(Francis & Kuhar, 2008; Marmendal et al., 2004). Many have argued that the MS15 
rearing condition is more ethologically relevant than the standard non-separated controls 
since food foraging and other activities would necessitate the dam to leave the litter for 
brief amounts of time. The possible protective or resilient effect in the MS15 group 
provides an interesting comparison. MS15 adults have shown reduced responding for 
cocaine when compared to non-separated controls (Flagel et al., 2003; Moffett et al., 
2006).  
 For almost a decade, it has been known that maternal care during early 
neurological development influences DNA methylation that is directly responsible for 
HPA reactivity to stress throughout the lifespan. Weaver et al. (2004), showed that 
offspring of low licking/grooming  and arch-back nursing (LG-ABN) mothers had higher 
levels of GR DNA methylation, decreased expression of the GR gene, a heightened HPA 
stress response, and displayed more fear-like behavior. Since this pioneering study, many 
laboratories have demonstrated various alterations in DNA methylation in adulthood 
following ELS. For example, ELS has been associated with increased global methylation, 
as well as increased methylation at the regulatory region of serotonin transporter (5-
HTT), and higher behavioral stress responses in female macaques (Kinnally et al., 2011). 
ELS has also been found to induce hypomethylation of the AVP enhancer in male mice 
with a subsequent increased HPA reactivity (Murgatroyd et al., 2009). Although the brain 
region, gene, and direction in which DNA methylation is altered by ELS is diverse, the 
outcome tends to remain constant, with a hyperactive HPA stress response and/or 
increased behavioral stress reactivity in adulthood. Since an overactive HPA axis and 
ELS are strongly associated with a higher risk for drug addiction, additional research is 
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needed to investigate if ELS mediates epigenetic factors influencing the reward network 
that may predispose the animal to a higher propensity towards drug intake.  
 MeCP2 is a methylated DNA binding protein that attracts HDACs and is 
commonly associated with specific gene silencing and repression of transcription (Jones 
et al., 1998), although it may also act to mediate transcription on a genome wide manner 
as well (Skene et al., 2010). Interestingly, drug exposure mediates levels of MeCP2 in 
various brain regions and manipulating MeCP2 levels prior to drug exposure can affect 
the drugs rewarding properties (Cassel et al., 2004; Im et al., 2010; Deng et al., 2010). 
Therefore we investigated the MeCP2 levels in the NAc core, a brain region associated 
with the initial rewarding effects of drugs of abuse (Taylor et al., 2013). We observed 
group differences in MeCP2 immunoreactivity in the NAc core, such that MS15 rats 
expressed significantly higher levels of MeCP2 compared to MS180 rats.  
 Our results suggest a difference in DNA methylation in the NAc; however, the 
precise genes where methylation has occurred and that is bound by MeCP2 was not 
determined. Previous studies have suggested that MS rats may have altered DA, NE, and 
5-HT function and GABA and glutamate levels in the NAc (Matthews et al., 
2001;Romaro-Lopez et al., 2012). It has also been demonstrated that nucleus accumbens 
protein expression is extensively changed after both MS and METH exposure (Dimatelis 
et al., 2012). Therefore, the difference in methylated DNA may be associated with any 
number of genes involved in these systems in the NAc, and identification of methylated 
genes is worthy of further investigation. It is important to note that Romaro-Lopez (2012) 
did not find a difference in MeCP2 levels in the NAc between their separated and non-
separated pups using immunoblotting techniques. Thus, quantification by 
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immunohistochemistry may not reveal the same results as by immunoblotting. 
Additionally, the differences in separation procedures and drug exposure potentially 
played a role in these contrary results. 
 The negative correlation between active lever presses and MeCP2 
immunoreactivity in the NAc core aligns well with Deng et al. (2010) in which MeCP2 in 
the NAc had an inverse relationship with amphetamine CPP. This data warrants future 
investigations in order to explicate this relationship. For example, additional studies are 
needed to determine the influence of rearing condition on MeCP2 levels in the NAc in 
drug-naïve animals as well as the influence of varying levels of METH exposure. Also 
worthy of future studies is the possibility that an enriched environment during 
adolescence could reverse the detrimental effects of maternal separation on METH SA in 
adulthood and also mediate MeCP2 expression in the NAc. Enriched environment during 
an abstinence phase of cocaine showed protective effects to cue-induced reinstatement 
(Thiel et al., 2009) and reduced CPP to cocaine (Solinas et al., 2008). More recently, it 
was demonstrated that an enriched environment during different developmental time 
points can protect against METH SA acquisition and cue-induced reinstatement (Lü et 
al., 2012).  
 Few studies have investigated the effect of maternal separation on drug relapse 
paradigms yet, there some data that suggests ELS may increase relapse vulnerability 
(Neisewander et al., 2012). Contrary to existing literature and our predictions that 
maternal separation would influence extinction rates and cue-induced reinstatement, we 
failed to detect an effect. It is possible that we may have detected an extinction or 
reinstatement effect if the rats were trained on a progressive ratio or a higher FR of 
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reinforcement since these schedules produce higher response rates. On the other hand, 
failing to find an effect may be indicative that rearing condition only influenced the initial 
rewarding or reinforcing effects of METH as opposed to the subsequent course of 
addiction, abstinence, and relapse. Also, we only tested for cue-induced reinstatement, 
future research is necessary to determine group differences in stress and drug induced 
reinstatement.  
 In summary, we observed that ELS in the form of extended maternal separation 
produced an increased vulnerability to adult METH SA in adult male rats. Increases in 
METH intake were paralleled by decreased MeCP2 immunoreactivity in the NAc core. 
Surprisingly, extinction and cue-induced reinstatement were unaffected by maternal 
separation. These results suggest the possibility that ELS may contribute to vulnerability 
towards METH intake. Further studies are needed to establish a contributory role for 
changes in MeCP2 levels in the NAc core or other brain regions in these behavioral 
effects. 
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CHAPTER 3 
EARLY LIFE STRESS INFLUENCES METHAMPHETAMINE INTAKE BEHAVIOR 
THROUGH MODIFICATION OF MECP2 EXPRESSION IN THE  
NUCLEUS ACCUMBENS CORE 
MeCP2 is a multifunctional epigenetic protein well known for binding to 
methylated CpG islands. DNA bound MeCP2 recruits transcriptional repressor 
complexes such as Sin3a, HDAC1 and 2 (Jones et al., 1998), creating a barrier to 
transcriptional machinery and silencing downstream genes. Although, MeCP2 interacts 
with DNA on multiple complex levels. For instance, MeCP2 also has binding sites for 
both un-methylated DNA and chromatin. Interactions at these sites can lead to DNA 
bridging and looping, chromatin condensation, and nucleosomal clustering (Hansen et al., 
2010; Nikitina et al., 2007), all which regulate transcription. Additionally, MeCP2 can 
bind to multiple cytosine variants, such as a methyl group attached to the carbon 5 
position of cytosine to produce 5-methylcytosine (5-mC) and to the oxidized 5-
methylcytosine into 5-hydroxymethylcytosine (5-hmC) with similar high affinities in the 
brain (Mellén et al., 2012). While bound to 5hmC, MeCP2 may act as a transcription 
facilitator. The interactions between MeCP2 and DNA are diverse, leading to various 
functional outcomes, making it a viable protein to study for various disease states.  
The role dynamic epigenetic architecture plays in vulnerability and development 
of psychiatric disease has received an increasing amount of attention over the last couple 
decades. In 1999, a report pinpointed 6 mutations in the gene coding for MeCP2 as the 
cause for Rett Syndrome, an X-linked neurological disorder causing intellectual 
disability. Mutations in the gene coding for MeCP2 have also been implicated in other 
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disorders such as MeCP2 Duplication Disorder, Angelman Syndrome, X-linked 
Intellectual Disability, and Severe Neonatal Encephalopathy (see Ezeonwuka & Rastegar, 
2014 for review). MeCP2 plays a role in the neurodegenerative disorder Huntington ’s 
disease through interaction with huntingtin protein to regulate transcription of BDNF 
(McFarland et al., 2014). Animal models have also demonstrated that MeCP2 is involved 
in the molecular, cellular, and behavioral responses to drugs of abuse. 
Drug addiction, or SUD, is a product of chronic exposure to drugs of abuse that 
modulate gene expression, ultimately altering brain reward circuitry. Therefore, drug 
induced changes in the epigenome, such as MeCP2 expression, of neuron populations in 
brain reward regions has been postulated as a mechanism in the development of these 
disorders. 5-HT modulating drugs such as fluoxetine and cocaine were shown to increase 
MeCP2 expression in multiple brain regions of the rat after 10 days of investigator-
delivery (Cassel et al., 2006) and after 4 days of intravenous cocaine SA (Host et al., 
2011). In 2010, two seminal papers implicated striatal MeCP2 in the reinforcing and 
rewarding effects of amphetamine and cocaine through CPP and SA paradigms (Deng et 
al., 2010; Im et al., 2010). Additionally, MeCP2 regulated dendritic spine density, the 
number of GABAergic synapses, and the expression of bdnf via homeostatic interactions 
with microRNA-212 (Deng et al., 2010; Im et al., 2010), suggesting that MeCP2 may be 
intimately involved in the maladaptive plasticity implicated in the transition from casual 
to compulsive drug use. More recently, it has been demonstrated in mice that ethanol 
exposure modulates MeCP2 expression and inversely that MeCP2 expression is involved 
in both ethanol sensitivity and intake behavior (Repunte-Canonigo et al., 2013). 
Furthermore, ethanol induced changes in MeCP2 expression is a potential molecular 
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mechanism for Fetal Alcohol Spectrum Disorders as continuous ethanol exposure in vitro 
upregulates MeCP2 expression while ethanol withdrawal down-regulates expression 
(Liyanage et al., 2015). Hou et al. (2015) recently conducted a study in which they 
demonstrated that chronic pain maintains morphine-seeking behavior after morphine 
withdrawal and these animals had a reduction of MeCP2 at the promoter region of gria1, 
encoding the GluA1 receptor subunit. Viral overexpression of MeCP2 in the central 
AMG of these animals eliminated morphine seeking behavior after morphine withdrawal. 
This collection of studies suggests that not only is MeCP2 expression regulated by 
various drugs of abuse, but that MeCP2 expression regulates the sensitivity of an 
organism, and the reinforcing and rewarding properties of drugs of abuse. Meaning, that 
one’s individual epigenetic landscape may mediate their physiological and behavioral 
response to drugs of abuse, therefore altering their predisposition to developing a SUD.  
 The link between ELS and psychopathology, including SUDs, is well 
documented.  Exposure to ELS alters neurobiological development by programming 
various systems such as the neuroendocrine stress response, the sympathetic nervous 
system, monoamines, oxytocin, and the immune system to name a few (De Bellis & Zisk, 
2014). While the last century has produced this impressive body of knowledge, the 
mechanism by which experiences early in life modulate complex neurobiological systems 
and behavior throughout adulthood remained elusive until the last decade. Weaver et al. 
(2004) demonstrated that maternal care during early life in the rat led to persistent DNA 
methylation changes along with altered behavioral and neuroendocrine phenotypes in 
adulthood. Specifically, they showed that high maternal care, defined as 
licking/grooming and arch-back nursing (LG-ABN), led to increased GR expression in 
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the hippocampus when compared with pups reared by low LG-ABN dams. The higher 
GR mRNA expression was associated with lower DNA methylation in the promoter 
region of the GR gene, thereby facilitating the binding of the transcription factor nerve 
growth factor-induced protein A (NGFI-A). Interestingly, since this seminal paper, 
MeCP2 has been shown to contribute to ELS-dependent epigenetic programming of HPA 
regulatory genes (CRH, AVP, and Pomc) in stress circuitry brain regions (Murgratroyd et 
al., 2009; Wang et al., 2014; Wu et al., 2014). Clearly, ELS is epigenetically designing 
adult stress circuitry resulting in altered physiological and behavioral phenotypes.   
 While this literature demonstrates that ELS is epigenetically programing stress 
circuits, few studies have investigated if ELS is epigenetically programming reward 
circuitry implicated in the development of SUDs. Recent studies found contradicting 
results concerning NAc MeCP2 expression after ELS (Romano-Lopez et al., 2012; 
Tesone-Coelho et al., 2013). In our previous study (Lewis et al., 2013), we found that 
ELS increased METH intake behavior compared to handled control animals. A history of 
ELS and high METH intake was related to less NAc core MeCP2 expression in these 
animals. From this study, we were unable to determine what was modulate striatal 
MeCP2 expression in these animals. Therefore, we set out to determine if ELS and 
METH SA, independently, and/or interact to modulate MeCP2 expression in various 
brain reward regions. It has previously been shown that virally mediated knockdown of 
DS MeCP2 decreases cocaine intake behavior (Im et al., 2010) and knockdown of NAc 
MeCP2 increases amphetamine CPP (Deng et al., 2010). However, since the progression 
of initial drug use to compulsive drug abuse entails a transition from the NAc to the DS, 
we investigated if virally mediated knockdown of MeCP2 in the NAc core influenced 
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METH intake behavior. We also investigated if this manipulation would affect intake 
behavior for a non-drug reinforcer, saccharin (sacc). Specifically, we predicted that both 
ELS, in the form of prolonged maternal separation, and METH SA would increase 
MeCP2 in brain reward regions. Furthermore, we predicted that exogenously reducing 
MeCP2 expression in the NAc core would decrease METH intake, motivation, and 
seeking behavior.  
Abbreviated Methods 
Study 1 
This study was designed to investigate the influence of ELS, in the form of 
prolonged maternal separation, and METH SA on MeCP2 in various brain regions. One 
to two pups per litter were used for statistical analysis.  
Animals  
Pregnant dams were purchased from Charles River Laboratories and arrived on 
gestational day 12. Litters were randomly assigned to one of two conditions: maternal 
separation for 180 min per day (MS180) or the handled control group, 15 min per day 
(MS15). Separation procedures were carried out from PND2-14. During PND15-20 litters 
were left undisturbed, weaned on PND21 into same sex group housing, and pair housed 
with a sibling on PND45. Females were not used for the remainder of the study. Male rats 
were implanted with intravenous catheters into the jugular vein on PND60 (± 1).  
Behavioral Testing 
Beginning on PND67 male rats underwent 2 hr daily SA sessions whereby an 
active nose poke operant response resulted in delivery of METH (0.05 mg/kg per 
infusion, delivered in a volume of 0.06 ml over a 2 sec period) on a FR1 schedule of 
 
  
51 
 
reinforcement. Each METH infusion delivery was followed by a 20-sec timeout period, 
during which additional active responses were recorded but produced no drug infusions. 
Each infusion was accompanied by concurrent illumination of a stimulus light located 
directly above the active nose poke, and presentation of an auditory stimulus for 2-sec.  
See Appendix General Methods for methods concerning transcardial perfusion and 
immunohistochemistry.  
Study 2 
 This study was designed investigate the influence of NAc core MeCP2 expression 
on METH and sacc intake, motivation, and reinstatement. 
Animals 
Male Long Evans rats were purchased from Charles River Laboratories and 
arrived on PND45. Rats were allowed to acclimate to the new environment for 5-7 days 
before viral infusion surgeries. An adeno-associated virus (AAV) expressing a short 
hairpin loop RNA (shRNA) against rat MeCP2 mRNA (mecp2-sh) or an empty control 
virus (mecp2-ctrl) were synthesized by Virovek Inc (Hayward, CA) was infused in a 
volume of 2 μl per side (2.25x1013 particles/ml) (See Appendix).  Animals were left 
undisturbed for 8 days before receiving jugular vein catheter implantations (See 
Appendix). Animals were allowed 5 days of recovery before beginning SA procedures at 
approximately PND65.  
Behavioral Testing 
 Male rats underwent 6 hr daily SA sessions whereby an active nosepoke operant 
response resulted in delivery of METH (0.05 mg/kg per infusion, delivered in a volume 
of 0.06 ml over a 2 sec period) on a FR1 schedule of reinforcement. After earning 10 or 
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more infusions in two consecutive days, rats progressed to FR3 and then FR5 schedules 
of reinforcement. Each METH infusion delivery was followed by a 20-sec timeout 
period, during which additional active responses were recorded but produced no drug 
infusions. Each infusion was accompanied by concurrent illumination of a stimulus light 
located directly above the active nose poke, and presentation of an auditory stimulus for 2 
sec. After self-administration, animals underwent 2 days of progressive ratio testing, in 
which the number of lever presses required to obtain an infusion of METH increased 
exponentially (Richardson and Roberts, 1996). Next, lever responding was re-established 
by two days METH SA sessions on an FR1 schedule. Following reestablishment, rats 
underwent extinction training for 8 days, where all operant responses produced no 
programmed consequences. Following extinction, METH rats were administered a 1 
mg/kg intraperitoneal (i.p.) priming injection of METH 30 min prior to placement into 
the operant chamber. Sacc trained rats were placed into the operant chamber and 
underwent cue-induced reinstatement. 
See Appendix B, I, and L for methods on Rotarat testing, virus design, bilateral virus 
injection surgeries (Figure 8), and virus validation via immunoblot analysis.  
Results 
Study 1 
     Self-administration.  
Repeated-measures ANOVA revealed a significant main effect of rearing 
condition on the number of METH infusions per session, F(1, 16) = 10.88 , p = .005 
(Figure 9), but no within-effect of days, F(1, 16) = .17 , p  = .69. Repeated-measures 
ANOVA revealed a significant main effect of rearing condition on the active responses 
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per session, F(1, 16) = 9.59 , p = .007 (see Figure 10), but no within-effect of days, F(1, 
16) = .93 , p  = .35. The Early Life Stress (ELS) group exhibited more active responses 
and received more infusions than the Handled Control (HC) group. Repeated-measures 
ANOVA revealed no significant difference in inactive responses between groups, F(1, 
16) = .43 , p = .52.  
     Immuno-labeling MeCP2 analysis. 
A 2x2 multi-analysis of variance (MANOVA) was used to investigate the effects 
of ELS (HC Saline vs ELS Saline) and METH SA (HC METH vs HC Saline) on MeCP2 
immunoreactive labeling in the: nucleus accumbens core, NAc core F(3, 23) = 4.89, p  = 
0.01, LSD post hoc analysis HC METH vs HC Saline, p = 0.001, ELS METH vs ELS 
Saline p = .8, HC Saline vs ELS Saline, p = 0.01 (Figure 11 and Figure 12); NAc shell, 
NAc shell F(3, 23) = 3.98, p  = 0.02, LSD post hoc analysis HC METH vs HC Saline, p = 
0.01, ELS METH vs ELS Saline p = 0.9, HC Saline vs ELS Saline, p = 0.15 (Figure 13); 
the medial dorsal striatum, F(3, 23) = 5.86, p  = 0.005, LSD post hoc analysis HC METH 
vs HC Saline, p = 0.005, ELS METH vs ELS Saline p = 0.01, HC Saline vs ELS Saline, p 
= 0.56 (Figure 14); and the lateral dorsal striatum,  F(3, 23) = 3.29, p  = 0.04, LSD post 
hoc analysis HC METH vs HC Saline, p = 0.02, ELS METH vs ELS Saline p = 0.11, HC 
Saline vs ELS Saline, p = 0.11 (Figure 15). The n’s per group were as follows, HC 
Saline: n = 5, HC METH: n = 5, ELS Saline: n = 6, and ELS METH: n = 7. 
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Study 2  
     METH. 
     Self-administration.  
 Repeated-measures ANOVA revealed a significant main effect of sh-MeCP2 on 
the number of METH infusions per session, F(1, 15) = 16.77 , p = 0.001 (Figure 16), and 
a significant within-effect of days, F(1, 15) = 6.32 , p  = 0.02. The sh-Control group 
received more infusions than the MeCP2 KD group. Repeated-measures ANOVA 
revealed no significant difference in inactive responses between groups, F(1, 12) = 1.57 , 
p = 0.23.  
     Progressive ratio. 
The sh-MeCP2 group demonstrated reduced motivation for METH in the 
progressive ratio paradigm for active lever presses compared to sh-Control, t(13) = 3.56, 
p = 0.003 and for reinforcements t(13) = 4.49, p = 0.001 (Figures 17 and 18).  
     Extinction and drug-primed reinstatement. 
For both sh-Control and sh-MeCP2 groups, extinction training produced a 
significant reduction in the number of active responses as assessed on the final two days 
of extinction as compared to the final two days of SA (p’s <0.05) (Figure 19). For both 
groups, METH-priming produced reinstatement, as evidenced by a significant increase in 
the number of active responses following METH administration versus the average of the 
last 2 days of Ext (p’s < 0.05) (Figure 19). The groups did not differ in their reinstatement 
magnitude (calculated by a ratio of reinstatement to SA active responses), t(13) = 1.12, p 
= .14.    
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     Saccharin  
     Self-administration.  
 Repeated-measures ANOVA revealed a significant main effect of sh-MeCP2 on 
the number of Sacc reinforcers per session, F(1, 8) = 6.52 , p = 0.034 (Figure 20), and a 
significant within-subjects effect of days, F(1, 8) = 22.49 , p  = 0.001. The Control group 
received more Sacc reinforcers than the MeCP2 KD group. Repeated-measures ANOVA 
revealed no significant difference in inactive responses between groups, F(1, 8) = 1.61 , p 
= 0.24, nor over time, F(1, 8) = 0.18 , p = 0.68. 
     Progressive ratio. 
The sh-Control and sh-MeCP2 groups did not differ in motivation for sacc in the 
progressive ratio paradigm for active lever presses (p = 0.9) or reinforcements (p = 0.7) 
(Figures 21 and 22). 
     Extinction and cue-primed reinstatement. 
For both sh-Control and sh-MeCP2 groups, extinction training produced a 
significant reduction in the number of active responses as assessed on the final two days 
of extinction as compared to the final two days of SA (p = .01 and p = .023 respectively) 
(Figure 23). For both groups, cue-priming produced reinstatement, as evidenced by a 
significant increase in the number of active responses following cue priming versus the 
average of the last two days of extinction (p = .031 and p = .002 respectively) (Figure 
23). The groups did not differ in their reinstatement magnitude (calculated by 
reinstatement/SA active responses), t(8) = 0.29, p = .35.    
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     Rotational motor activity. 
 We failed to find a difference between sh-Control and sh-MeCP2 (n = 12, 6/group) on 
rotational motor activity measured in 360, 90, and 2 turns (all p’s > .5) (Figure 24, A). 
Additionally, we failed to find a difference between sh-Control and sh-MeCP2 (n = 15, 
sh-Control: n = 6, sh-MeCP2: n = 9) on METH primed rotational motor activity 
measured in 360, 90, and 2 turns (all p’s > .5) (Figure 24, B).   
      Immunoblot analysis. 
 Differences in MeCP2 levels across groups were present in the NAc core. Animals who 
received bi-lateral injection of sh-MeCP2 had significantly decreased MeCP2 levels 
compared to animals who received bi-lateral injection of sh-Control (ns = 4/group), p = 
.001. There was no group differences in levels of the loading control, GAPHD (Figure 
25). 
Discussion 
In this study, we show molecular and behavioral evidence that ELS increases 
METH intake behavior in male rats through modulation of NAc core MeCP2 expression. 
Our results suggest that the experience of ELS has long-lasting effects on MeCP2 
expression in NAc core and expression in this region plays a role in METH intake 
behavior. We show METH self-administration increases MeCP2 expression throughout 
the striatum in an ELS dependent manner. Furthermore, we demonstrate that virally 
mediated knockdown of NAc core MeCP2 expression drastically decreases METH intake 
behavior, suggesting that NAc core MeCP2 expression may be necessary for escalating 
METH intake. This highlights a possible epigenetic mechanism by which ELS influences 
vulnerability towards increasing METH intake. During the past decade, a large body of 
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evidence demonstrating that ELS epigenetically alters the HPA axis has emerged; here 
we present evidence of ELS affecting brain reward circuitry via altered NAc core MeCP2 
expression.   
 MeCP2 is an epigenetic transcriptional regulator and multifunctional protein that 
can activate or repress transcription of downstream genes (Chahrour et al., 2008). 
Interestingly, genes regulated by MeCP2 are involved in drug reward and reinforcement 
(Deng et al., 2010; Deng et al., 2014; Hou et al., 2015; Im et al., 2010; Jayanthi et al., 
2014; Zhang et al., 2014;). For example, MeCP2 is implicated in opioid seeking behavior 
in rats after persistent pain through regulating GluA1 proteins in the central amygdala. 
Additionally, MeCP2 represses the histone dimethyltransferase G9a in the central 
amygdala, leading to an increase in BDNF expression that increases morphine 
conditioned reward (Zhang et al., 2014). These same investigators found that knock down 
of MeCP2 in the DS reduced cocaine intake and identified MeCP2 as an indirect 
regulator of BDNF through interactions with microRNA-212 (Im et al, 2010). Chronic 
METH exposure induced a reduction of AMPA receptors in striatal neurons is in part 
mediated by MeCP2 recruitment (Jayanthi et al., 2014). Furthermore, psychostimulant 
induced phosphorylation of MeCP2 regulates behavioral responses to both amphetamine 
and cocaine (Deng et al., 2010; Deng et al., 2014). In line with these studies, the present 
study demonstrates that ELS increases MeCP2 expression in the NAc core, a brain region 
implicated in drug reward and reinforcement. Importantly, we also show that viral 
knockdown of MeCP2 in this region decreases METH intake and motivation behavior in 
male rats.  
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 In this study, we replicated our previous findings (Lewis et al., 2013; Chapter 2) 
that ELS, in the form of prolonged maternal separation, increases METH intake behavior 
compared to handled controls in male Long-Evans rats.  Here, we also demonstrate that 
ELS increases MeCP2 expression in the NAc core but not the NAc shell or the DS. 
Additionally, we show that METH SA increases MeCP2 expression throughout the 
ventral and DS in an ELS experience-dependent fashion. Such that METH SA increases 
NAc core, shell, and lateral DS MeCP2 expression in non-ELS rats but not in rats with a 
history ELS. Whereas, METH SA increased MeCP2 expression in the medial DS 
regardless of ELS experience. The transition from casual drug use to habitual drug abuse 
entails a gradual progression from initial NAc-dependent mechanisms to later DS-
dependent mechanisms (Everitt & Robbins, 2013).  Our observed interactions between 
ELS and METH SA on MeCP2 expression in these regions suggest that genetic 
regulation from MeCP2 may differentially influence stages of addiction development and 
maintenance.   
 Our findings are in agreement with the existing literature that exposure to 
psychostimulants increases MeCP2 expression throughout the striatum (Cassel et al., 
2004; Im et al., 2010; Host et al., 2011), while providing new insights suggesting that the 
reward circuitry may have differing molecular responses to psychostimulants dependent 
on early life experiences. We previously reported that our ELS group self-administered 
more METH than the control handled group and had less MeCP2 expression in the NAc 
core (Lewis et al., 2013). It is possible that the decrease in MeCP2 expression was due to 
METH withdrawal, as brain tissue was collected more than two weeks following the last 
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METH exposure. This interpretation is in agreement with other findings that METH 
withdrawal produces a change in a multitude of transcription factors (Cadet et al., 2014).  
 The present study provides evidence that virally mediated MeCP2 knockdown in 
the NAc core influences both METH and sacc intake behavior. Interestingly, we found 
that while intake behavior for METH was affected immediately, group divergence in sacc 
SA did not take place until nine days after initiation. Additionally, while MeCP2 
knockdown decreased motivation for METH in the progressive ratio paradigm it did not 
affect motivation for sacc. This suggests that NAc core MeCP2 expression mediates gene 
expression involved in motivation towards METH but not the non-drug reward sacc. 
MeCP2 knockdown did not affect either METH-primed drug seeking behavior or cue-
induced drug seeking behavior for sacc. These results suggest that MeCP2 genetic 
regulation in the NAc core, while affecting METH and sacc intake, does not affect 
reinforcement seeking behavior, as measured by reinstatement. Interestingly, this mirrors 
our previous findings (Chapter 2; Lewis et al., 2013) that ELS influences METH SA but 
not cue-induced reinstatement. These results highlight that NAc core MeCP2 expression 
differentially mediates METH intake behavior, motivation, and drug-primed seeking in 
male rats. Importantly, our data also demonstrates that NAc core MeCP2 affects the 
reinforcing properties of METH and a non-drug reward differently.  
 Future research is needed to expand on these findings, such as investigation into 
the genes regulated by MeCP2 in brain reward regions after ELS and METH SA. 
Additionally, our findings did not elucidate specific cell types involved in these 
processes. This is an important distinction as both the NAc and DS have heterogeneous 
cell populations that contribute to different aspects of learning, motor control, and 
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reinforcement (Crittenden & Graybiel, 2011). Distinct cellular populations differ in 
genetic profiles, afferent and efferent projections, and contributions to various disorders 
(Crittenden & Graybiel, 2011). Therefore future research is required to determine if ELS 
and METH SA regulate MeCP2 expression in different populations such as the striosome 
and matrix departments and D1 and D2 receptor containing striatal neurons. Moreover, it 
remains to be determined if MeCP2 expression is regulating METH reinforcement 
through D1 and/or D2 containing NAc neurons. This specificity is important, as distinct 
and opposing roles for these neuronal subpopulations has been demonstrated in drug 
reward through interactions with BDNF (Lobo et al., 2010).  
            ELS has a well-established role in the etiology of many psychiatric conditions. 
Specifically, ELS alters the HPA stress response and dysregulation of this 
neuroendocrine system is implicated in disorders such as schizophrenia, post-traumatic 
stress disorder, major depression, and SUDs. An abundant amount of rodent research 
over the last decade demonstrated that ELS programs the adult HPA stress response 
through epigenetic regulation of various HPA genes including the genes coding for the 
GR, Avp, and POMC (Murgratroyd et al., 2009; Wang et al. 2014; Weaver et al., 2004). 
Additionally, post-mortem studies evaluating human brain tissue has also found a 
relationship between ELS and GR gene methylation and expression (Labonte et al., 2012; 
McGowan et al., 2009). Interestingly, the relationship between ELS and gene methylation 
status can also be evaluated in human peripheral tissue samples such as blood and buccal 
cells  (Essex et al., 2013; Labonte et al., 2012; C Murgatroyd et al., 2015; Ouellet-Morin 
et al., 2012; Romens et al., 2014). While HPA dysregulation is involved in drug 
reinforcement and reward (Kosten & Ambrosio, 2002), an intriguing question remains - 
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can ELS also prime addiction vulnerability through epigenetic regulation in brain reward 
circuitry? Tesone-Coelho et al. (2013) demonstrated that ELS produced long lasting 
increases in MeCP2 expression throughout the striatum that may be responsible for 
greater opiate vulnerability in adulthood. Our data are in agreement with these findings, 
we also found ELS induced increases in MeCP2 expression in the NAc core and this 
epigenetic regulator may be responsible for increased vulnerability towards METH 
addictive behaviors. These findings implicate MeCP2 expression in the NAc core as a 
possible neuroepigenetic mechanism by which ELS may predispose individuals to 
respond differently to drugs of abuse. Our results highlight that experiences early in life 
can have long lasting effects on epigenetic regulation in reward circuitry that may shape 
vulnerability to METH abuse in adulthood.  
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CHAPTER 4 
EARLY LIFE STRESS AND CHRONIC VARIABLE STRESS IN 
ADULTHOOD INTERACT TO INFLUENCE METHAMPHETAMINE SELF-
ADMINISTRATION IN MALE RATS 
 Chronic METH abuse has dire effects on both society and users’ health. METH is 
a highly addictive psychostimulant with worldwide abuse rates comparable to both heroin 
and cocaine combined (United Nations Office on Drugs and Crime, 2007). Therefore, 
identifying risk factors that contribute to the development of METH addiction is critical. 
ELS is implicated in long-term alterations in numerous behavioral and neurobiological 
systems that contribute to addiction vulnerability. The MS paradigm is a rodent model of 
ELS that has been shown to increase the rewarding and reinforcing properties of various 
drugs of abuse in adulthood (Moffett et al., 2007). While interactions between early life 
and adult stress differently modulate various neural systems and vulnerability to 
psychiatric illnesses such as schizophrenia and post-traumatic stress disorder (Choy et al., 
2009; Yehuda et al., 2010), investigations into the effects of ELS in conjunction with 
adult stress on vulnerability to addiction-related behaviors has largely been unexplored.  
 The majority of research investigating the effects of ELS on addiction-like 
behaviors typically includes a single developmental insult. While this design allows for 
the detailed examination of effects of adverse early life events alone, it does not take into 
account the fact that many individuals with a history of ELS are also exposed to repeated 
or chronic stress later in adulthood. The purpose of the present study was to evaluate the 
effects of ELS, adult chronic variable stress, and their potential interactions on 
vulnerability towards METH addiction-related behaviors. Therefore, we utilized an 
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established paradigm of ELS (the MS paradigm) in conjunction with adult stress in the 
form of chronic variable stress. We hypothesized the combination of two developmental 
stressors would increase METH self-administration, delay extinction, and increase the 
magnitude of cue induced reinstatement compared to rats that either experienced only 
early life or adult chronic variable stress, or rats with no history of prior stress exposure.  
Abbreviated Methods 
 Pregnant Long-Evans dams (Charles River Laboratory, Kingston, NY, USA) 
arrived on gestational day 12. On the day of birth (PND0), litters were assigned to one of 
two rearing conditions: maternal separation for 180 min/day (ELS) or 15 min/day (No 
Stress). The MS180 separation was chosen as a commonly utilized early life stressor, and 
the 15 min/day separation was chosen as control for handling that does not produce 
neurophysiological stress responses in the pups (Kuhn and Schanberg, 1998), and has 
previously been utilized for comparison to effects of prolonged separation (Ploj et al., 
2003). Separation procedures were conducted on PND2-14. During PND15-20, litters 
were left undisturbed with the exception of once weekly cage cleaning. Litters were 
weaned on PND21, and female offspring were then removed from the study. Male 
offspring were sibling group housed until PND45 after which they were pair housed. On 
PND55, half the rats were exposed to a 10 day chronic variable stress paradigm 
(ELS+Adult Stress and Adult Stress groups). For 10 consecutive days, rats in the chronic 
variable stress condition received either two daily stressors or one daytime stressor and 
an overnight stressor (see Table 2 for details).  
After chronic variable stress procedures concluded, all rats were implanted with 
intravenous catheters into the jugular vein using standard procedures as described 
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elsewhere (See Appendix). Rats were allowed five days of recovery prior to 
commencement of SA procedures. Rats were allowed to spontaneously acquire METH 
SA (0.05 mg/kg/infusion, delivered in a volume of 0.06 ml over a 2-sec period) by 
pressing a designated active lever in standard operant conditioning chambers (ENV-008; 
Med Associates, St. Albans, VT). An FR1 schedule of reinforcement was used in 2-hr 
daily sessions for 15 consecutive days. Each infusion was paired with a 2-sec auditory 
stimulus (~65 dB, 2900 Hz) and illumination of a stimulus light located above each 
response lever. Each drug infusion was followed by a 20-sec timeout period during which 
additional active lever presses were recorded but produced no programmed 
consequences. Next, all animals were subjected to extinction training, whereby presses on 
the active lever no longer produced any programmed consequences. Extinction training 
sessions were 2-hr in length and were conducted for eight consecutive days. On the day 
immediately following the last extinction session, all rats underwent cue-induced 
reinstatement testing (2-hr duration), whereby presses on the active lever resulted in the 
presentation of the tone and light previously presented during METH infusions, but did 
not result in drug infusion. One to two pups per litter were used for statistical analysis.  
Results 
Repeated measures ANOVA revealed a significant effect of time (p = .003) and a 
main effect of Early Life Stress on the number of METH infusions obtained per session, 
F(1,23) = 13.00, p = 0.001 (Figure 26), as well as the number of active lever presses per 
session, F(1,23) = 14.73, p = 0.001 (Figure 27). There was no main effect of Adult Stress 
on either the number of METH infusions or active lever presses, but there was a 
significant interaction between Adult Stress and Early Life Stress with regards to the 
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number of METH infusions obtained, F(1,23) = 4.38, p = 0.04, and active lever presses, 
F(1,23) = 3.99, p = 0.04. The effect of Adult Stress was dependent on Early Life Stress 
history, such that Adult Stress reduced responding for METH in the Early Life Stress 
group. No group differences in the number of inactive lever presses during self-
administration were observed (p > 0.05, data not shown), nor were there any group 
differences in extinction rates or the number of active (Figure 28), or active lever presses 
during reinstatement testing (all p’s >0.05, Figure 29). 
Discussion  
 The current study replicates our previous findings that ELS, induced by prolonged 
MS, increases adult METH intake compared to handled control rats (Chapter 2, 3; Lewis 
et al., 2013). Additionally, the current results also revealed that chronic variable stress in 
adulthood attenuates METH SA in rats with a history of ELS. However, adult chronic 
variable stress had no effect on METH SA in animals without a history of ELS. Contrary 
to our hypothesis, we found that animals exposed to both stressors self-administer less 
METH compared to animals exposed to ELS only. While the mechanism behind this 
behavioral difference is unclear, it is possible that these animals are more sensitive to 
METH and therefore self-administer less to obtain the same desired effect. Future studies 
assessing dose response curves are necessary to evaluate this possibility. Furthermore, it 
is possible that animals exposed to both early life and adult stress may enter a state of 
anhedonia, in which METH fails to produce reinforcing effects.  It should be noted, 
however, that while inactive lever presses did not differ across treatment groups, 
additional studies are needed to confirm that reductions in general motor function did not 
influence these findings. Additional studies are needed to assess potential stressor 
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interaction in females, as well as in animals with no history of MS to assess potential 
effects of handling.  
There are several possible mechanisms underlying the apparent protective effect 
of chronic variable stress against METH SA in male rats with a history of ELS. For 
example, the acute neuroendocrine stress response is considered a predictor for 
acquisition of psychostimulant self-administration, and adult chronic variable stress 
decreases the neuroendocrine stress response in rats with a history of ELS (Ladd et al., 
2005; Renard et al., 2007). Adult CORT treatment following ELS desensitizes dopamine 
receptors without changing the receptor density in the NAc, a brain region associated 
with drug reinforcement (Choy et al., 2009). Additionally, chronic social defeat stress in 
adulthood increases thresholds for brain stimulation reward in rats with a history of ELS 
(Der-Avakian & Markou, 2010). Thus, our findings are in agreement with the extant 
literature suggesting that mild chronic adult stress can potentially reverse detrimental 
effects of ELS and modulate the reinforcing properties of psychostimulants. Overall, our 
results suggest that chronic variable stress alters the reinforcing effects of METH in 
animals with a history of ELS but does not alter extinction or cue-induced reinstatement 
of METH-seeking.  
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CHAPTER 5 
THE EFFECT OF LITTER SEPARATION ON DAMS’  
CONDITIONED PLACE PREFERENCE TO METH 
METH abuse continues to be a worldwide problem with use rates equivalent to 
heroin and cocaine combined (United Nations Office on Drugs and Crime, 2007). 
Intravenous METH use was first reported in 1959 and illicit production in California 
became rampant through the 1960’s (Vearrier et al., 2012). As popularity and abuse rates 
grew the Comprehensive Drug Abuse Prevention and Control Act of 1970 placed 
amphetamines as Schedule II substances. Despite this, the drug remained popular and 
was associated with biker gangs throughout the 1970’s and 1980’s. During the 1980’s 
and through the 1990’s METH use spread throughout the West Coast and into the 
Midwest. For multiple decades METH use was predominated by Caucasian males in 
blue-collar careers (Vearrier et al., 2012). However, METH use among women has 
undergone a sharp increase the last few decades (Drug and Alcohol Services Information 
System [DASIS], 2008; Venios & Kelly, 2010).  
 The upward trend for METH abuse among women is concerning. METH usage is 
associated with increased energy, weight-loss, and intensifying sexual pleasure, all 
making it an alluring drug of choice for many women (Obert, 2005). Additionally, 
women have reported that METH induces a sense of power related to their sexual 
behavior that is rewarding (Lorvick et al., 2012). A recent review found that women are 
more susceptible to METH dependency and have earlier initiation to METH use than 
men (Dluzen and Lui, 2008). Women are now admitting themselves to rehabilitation with 
METH as their primary abused substance more than other abused substances. Whereas 
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men make up a larger proportion of abusers of heroin and cocaine, METH use is 
relatively equal among men and women (UCLA Integrated Substance Abuse Programs 
[UCLA ISAP], 2009). 
 The repercussions of drug abuse are paramount in female populations due to 
many factors. Indeed, SUDs in women have overlapping and unique characteristics in 
manifestation, attributes, and risks compared to men and the concerns are often more far-
reaching (Brentari et al., 2011; Stocco et al., 2012). Inherently, women’s drug use during 
pregnancy has negative implications for the infant. Prenatal exposure to METH leads to 
small for-gestational-age incidences and low birth weight, which are associated with 
negative health consequences including childhood mortality, morbidity, type 2 diabetes, 
and developmental delays (Smith et al., 2006). This is concerning as admissions for 
pregnant women using METH had a three-fold increase from 1994 to 2006 (Terplan et 
al., 2009). Additionally, women who used METH while pregnant were 12% more likely 
to develop a SUD than their non-pregnant METH using comparisons (Derauf et al., 
2007). In a study done among mothers who use METH in the United States and New 
Zealand it was found that they had lower SES, delayed prenatal care, and increased rates 
of single parenting (Wouldes et al., 2013). SUDs typically impede parenting and mothers 
often struggle in recognizing and satisfying their children’s needs (Barnard & 
McKeganey, 2004). Furthermore, mothers abusing drugs typically provide an at-risk 
environment for their children and the drug use has negative influences on the mother-
child bond (Barnard & McKeganey, 2004; Stocco et al., 2012). Women with a SUD may 
struggle with feelings of guilt and failure pertaining to motherhood and their drug use, 
which leads to a feedback mechanism as increased drug use is used as a coping 
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mechanism. Unfortunately, these unique factors may contribute to women avoiding 
treatment.  
 Societal roles and support systems specific to women play a role in the 
development and recovery of SUDs (Tracy et al., 2010). For example, finding adequate 
childcare while in treatment may serve as a specific barrier to women. In 2013, less than 
16% of the funds for Substance Abuse and Mental Health Services Administration were 
dedicated to women’s specific needs. Furthermore, female representation is sorely 
lacking in biomedical research, and studies utilizing rodent models of addiction are not 
exempt from this criticism. In 2009, neuroscience research ranked last compared to other 
disciplines with 5.5 articles using only male subjects for every 1 article investigating 
females (Beery & Zucker, 2011). While there are practical reasons to investigate males 
alone, such as the 4-day estrous cycle affecting some experimental outcomes, it does not 
condone the lack of female specific testing. This bias in research results in findings, 
theories, ideas, and eventually treatments that are generalized to all, yet, only founded in 
data derived from male subjects. Understanding SUDs as they manifest differently in 
both sexes is necessary to develop effective treatments for SUDs. This is especially 
relevant given the established notions that all major classes of abused drugs interact with 
gonadal steroid hormones, and although males are more likely to use drugs of abuse, 
females tend to be more sensitive to them (Wood, 2010).  
 Sex differences in psychostimulant-induced behavioral effects in rats are well 
established. Specifically, female rats often display enhanced drug induced motor activity 
compared to males with cocaine and METH (Cailhol & Mormede 1999; Schindler et al., 
2002). Additionally, a greater percentage of female rats acquire cocaine, heroin, and 
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METH SA (Carroll et al., 2001; Lynch & Carroll 1999; Roth & Carroll, 2004), and at a 
faster rate than male rats (Lynch & Carroll 1999). While work in female rodents utilizing 
models of addiction is of utmost necessity and merit, these studies are typically carried 
out in virgins or females who have never undergone pregnancy nor been exposed to pups. 
This distinction is of importance as pregnancy, lactation, and pup exposure affects 
monoamine, oxytocin, and GABAergic systems in various brain regions of the female rat 
brain (Lonstein et al., 2003; Lonstein et al., 2014; Macbeth et al., 2008; Rutherford et al., 
2011), indicating the possibility that the rewarding and reinforcing properties of drugs 
may be altered during or after these experiences. Additionally, pup rearing behavior is 
regulated by brain structures overlapping with the reward network (hypothalamus, PFC, 
VTA, and NAc) (Rutherford et al., 2011), thus, these regions may respond to drugs 
differently after pup exposure. Therefore, to better model the population of women 
METH users who are post-childbirth, we investigated CPP to METH in dams 
immediately after their pups were weaned and virgin females. To model a stressful 
environment common to women with an SUD raising children, we separated the dams 
from their litters for 3 hours daily or 15 min daily during the first two weeks postpartum, 
an established stressor paradigm for postpartum rats (Banky et al., 1994; Boccia et al., 
2007; Eklund et al., 2009; von Poser Toigo et al., 2012). We hypothesized that both 
postpartum groups would show greater CPP to METH compared to virgins. Additionally, 
we predicted dams separated from their litters for prolonged periods would show greater 
CPP to METH and greater CORT response to stress, than dams separated for short 
periods.  
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Abbreviated Methods 
Animals, Litter Separation, and Stress Procedures  
 Pregnant dams and virgin females were purchased from Charles River 
Laboratories and arrived on gestational day 12 or ~PND85 (to correspond to the age of 
dams during CPP testing). Dams and virgins were housed individually in standard 
polycarbonate cages in a temperature and humidity controlled room with food and water 
available ad libitum. Litters were culled to a maximum size of 12 immediately upon 
discovery. Day of birth was considered postnatal day 0 (PND0). Dams were randomly 
assigned to one of two conditions: litter separation for 180 min per day (LS180) or 15 
min per day (LS15). The separation procedure was conducted from PND2-14. At 8:00 am 
(reverse light cycle, lights off at 7:00 am) the dam was removed from the home cage and 
placed into a new cage with fresh bedding. The litters were then removed and placed into 
a separation cage kept in an isolated room. After the corresponding separation period, 
pups were returned to the home cage immediately prior to the dams return. During 
PND15-20 dams and litters were left undisturbed with the exception of once a week cage 
cleaning. Litters were weaned on PND21 the following day, dams received one 30 min 
restraint stress session. Immediately after the restraint session a blood sample was 
collected by tail bleed to assay blood stress hormone levels stress reactivity.  
Methamphetamine Conditioned Place Preference  
 The day following restraint stress and blood sample collection, the dams 
underwent CPP procedures for METH. Rats received one 30-min habituation session 
prior to pre-conditioning preference testing. After individual preferences were 
determined, rats began five days of conditioning (30 min per session). Each animal 
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received METH (0.5 mg/kg i.p.) 15-min prior to placement in the initially non-preferred 
compartment, or saline (i.p.) 15-min prior to placement in the initially preferred 
compartment. Following five sequential conditioning days, animals were tested for place 
preference by allowing free access to both conditioning compartments for 30-min (See 
Appendix D). CPP score was calculated by subtracting time spent (measured in seconds) 
in the METH-paired chamber pre-conditioning from time spent (measured in seconds) in 
the METH-paired chamber post-conditioning.  
Corticosterone Assay 
 Plasma CORT levels were determined by a standard enzyme-linked 
immunosorbent assay (ELISA) kit (Catalog# ADI-900-97 Enzo Corticosterone ELISA) 
following manufacturer’s protocol. Briefly, 10µl of 1:100 steroid displacement reagent 
(SDR) was added to 10µl of each sample. Samples were then vortexed and diluted with 
380µl EIA assay buffer. 
Results 
Estrous Cycle 
  A subset of rats received vaginal smears in order to assess if the estrous cycle 
affected the conditioned reward of METH. To verify phase, vaginal smears were taken 
prior to behavioral testing and divided into either estrous or di-estrous phase based on 
microscope visual analysis of cells (Goldman et al., 2007; Mennenga et al., 2015). No 
group differences were found in neither percent time spent in METH chamber (p > 0.05) 
nor CPP score (p > 0.05).  
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CPP Score 
CPP score was calculated by subtracting the number of seconds spent in the 
METH-paired chamber pre-conditioning from the number of seconds spent in the 
METH-paired chamber post-conditioning. A one-way ANOVA revealed a main effect of 
litter separation, LS15 displayed a larger METH CPP score compared to LS180 and 
Virgins, (LS15: n = 8, LS180: n = 10, and Virgins: n = 7), F(2, 24) = 4.29, p = .027. LSD 
post-hoc comparisons LS15 vs LS180 p = .013, LS15 vs Virgins p = .028, LS180 vs 
Virgins p = ns (Figure 30). The groups did not differ in Saline CPP score, F(2, 24) = .48, 
p = .625 (Figure 31). 
Locomotor Activity  
Groups did not differ in either Saline or METH primed locomotor activity (p’s 
>.05). All groups increased locomotor activity in response to METH compared to saline 
(LS15 p = .01, LS180 p = .01, Virgins p <.000) (Figure 32). There were no group 
differences in locomotor activity change score (Meth-Saline) (p’s >.05). No groups 
changed in saline primed locomotor activity over time, F(2,15) = 1.91, p = 0.19 (Figure 
31). All groups changed in METH primed locomotor activity over time, F(2,15) = 15.68, 
p = 0.001, though not different from each other, F(1,15) = 0.66, p = 0.53 (Figure 31). 
Plasma Corticosterone Levels  
 We performed ELISA for CORT levels in serum collected immediately following 
30-min of acute restraint stress. One rat per group was removed from the analysis as an 
outlier (>±1.5 SD from the mean). A one-way ANOVA demonstrated that difference in 
serum CORT concentration between groups, (LS15: n = 8, LS180: n = 7, and Virgins: n = 
7) F(3, 19) = 3.32, p = .05 (Table 3). LSD post-hoc analyses revealed a significant CORT 
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elevation in LS15 rats compared to Virgins, p = .02, a trend-level difference between 
LS180 and Virgins, p = .08, and no significant difference between LS15 and LS180, p = 
.52 (Table 3).  
Discussion  
 The rise of METH use among women is concerning. While animal research 
demonstrates that female rats may have higher vulnerability towards METH abuse (Roth 
& Carroll, 2004), it is important to evaluate female responses to drugs of abuse across the 
lifespan. The brain undergoes vast alterations in response to pregnancy, lactation, and 
pup rearing that may influence the behavioral and physiological response to drugs 
(Frankfurt et al., 2011; Seip et al., 2008). Additionally, we argue the importance of 
investigating maternal stress during the postpartum experience as this is likely most 
translationally relevant for women struggling with an SUD. In this study, we present 
evidence that dams exposed to short separations from their litters display higher levels of 
conditioned reward to METH, and trend towards higher stress induced CORT levels, 
compared to dams exposed to long separation and virgins. While we predicted 
postpartum females would be more sensitive to the rewarding properties METH 
compared to virgins, we also predicted that this effect would be exacerbated in the long 
litter separation group. Contrary to our prediction, our data suggests that the stress of the 
long separation negated the increased conditioned drug reward seen in postpartum 
females (Seip et al., 2008). While the mechanism behind the reduction in METH 
conditioned reward is unclear, it is possible that dams exposed to long litter separations 
have altered sensitivity to METH. If more sensitive, the METH dose may have produced 
aversive effects whereas, or if less sensitive, this dose may not have been sufficient to 
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produce CPP.  Future studies assessing dose response curves are necessary to evaluate 
METH sensitivity in animals with this history of stressors. Furthermore, it is possible that 
dams exposed to long litter separations are in a state of anhedonia, in which METH does 
not produce rewarding effects.  
 Due to the established and robust relationship between ELS and adult psychiatric 
vulnerability, the vast majority of litter separation research has focused on the 
development of the offspring. However, litter separation also serves as a form of stress 
for the dam (Banky et al., 1994; Boccia et al., 2007; Eklund et al., 2009; von Poser Toigo 
et al., 2012). In humans, mothers separated from their children are more likely to have a 
SUD (Zlotnick et al., 2003). Therefore, animal models should be utilized to also 
investigate the effects of separation on the vulnerability to drug abuse in mothers. Moffett 
et al. (2006) did not find a difference in cocaine SA between dams exposed to litter 
separation and those not separated. Additionally, Kalinichev et al. (2000) found 
prolonged litter separations reduced the dam’s sensitivity to morphine. To our knowledge 
we are the first to report on conditioned reward to METH in dams exposed to litter 
separation. 
Recently, litter separation and has been shown to influence both anxiety and 
depressive-like behavioral phenotypes long after litter weaning (Boccia et al., 2007; 
Kalinichev et al., 2000; Maniam & Morris, 2010). Specifically, many have reported that 
long litter separation is associated with increased immobility behavior in the forced swim 
test, suggesting an increased depressive-like phenotype in the dam (Boccia et al., 2007; 
Maniam & Morris, 2010; Sung et al., 2010). The effects of long litter separation on 
behavior in the elevated plus maze is less consistent, some have reported increased 
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anxiety like behavior (Maniam & Morris, 2010), while others report less (Kalinichev et 
al., 2000). While we did not find a difference between groups in baseline locomotor 
activity or METH induced locomotor activity, we did not take any additional measures of 
anxiety or depressive like behaviors. It is apparent from these studies that litter separation 
has long lasting effects on anxiety and depressive-like behavior of the dam post-weaning 
and more investigations are warranted to further explore this relationship.  
Litter separation not only influences dam behavior but also modulates various 
neurophysiological systems that may influence the rewarding and reinforcing properties 
of drugs of abuse. For example, long litter separation influences the dam’s 
neuroendocrine system as it has been shown to increase plasma CORT levels, increase 
hypothalamic CRH mRNA, and decrease mRNA for glucocorticoid receptors in the 
hippocampus (Maniam & Morris, 2010). Here, we present data demonstrating all post-
partum dams, exposed to either long or short forced litter separations, trended towards an 
increased CORT response to acute restraint stress. This is noteworthy as much research 
supports a link between the HPA axis and behavioral sensitivity to psychoactive drugs 
(Kosten & Ambrosio, 2002). Furthermore, serotonergic dysregulation has been 
implicated in addiction vulnerability and dams separated from their pups showed a 
decrease in expression of both serotonin and the rate limiting enzyme, tryptophan 
hydroxylase, in the dorsal raphe (Kirby et al., 2011; Sung et al., 2010). The GABAergic 
system plays a major role in the development of drug dependence and addiction 
(Addolorato et al., 2012) and during the postpartum experience the maternal brain goes 
through major alterations of this system (Lonstein et al., 2014). Interestingly, one 
prolonged litter separation has been shown to decrease GABA receptor expression, 
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highlighting the importance of investigating drug response in females after a stressful 
postpartum experience. Lastly, neurophysiological responses to catecholamines and an 
amphetamine-like drug can be measured by Na
+
/K
+
-ATPase activity (Rezin et al., 2013; 
Hernandez, 1992), and both long and short litter separation reduced Na
+
/K
+
-ATPase 
activity in various regions of the dam brain (von Poser Toigo et al., 2012). Clearly, stress 
in the form of forced litter separation alters various neurobiological systems that may 
influence the dam’s response to drugs of abuse and thus, susceptibility towards addiction-
like behaviors.    
We demonstrate here that forced short separations from litters led to increased 
conditioned reward to METH and increased acute restraint induced CORT, at a trend 
level, in postpartum dams. In order to design adequate treatment strategies for women 
suffering from an SUD during the postpartum period, we must first understand the risk at 
a pre-clinical level. Therefore, there is a need to further this line of research, evaluating 
the effects of litter separation on the vulnerability to drug abuse in dams. 
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CHAPTER 6 
GENERAL DISCUSSION  
The collection of studies in this dissertation used three distinct paradigms in the 
rat to characterize how stress and epigenetics influence METH addiction-like behaviors. 
Our findings highlight that this relationship is not simple, but rather highly complex. We 
show that various types of stress exposure throughout development, and in both sexes, 
have multifaceted effects on METH intake, motivation, conditioned reward, and 
reinstatement. Moreover, for clinical translation, this work suggests that various events 
and experiences throughout the lifespan can influence behavioral response to drugs as 
well as the motivation to obtain them. We especially emphasize the robust influence of 
ELS on METH intake behavior, a relationship reflected in the clinical population.  
Early Life Stress, MeCP2 Expression, and METH Addictive-Like Behavior 
 This series of experiments was the first to test the effects of ELS, in the form of 
prolonged maternal separation, on METH intake in male rats. ELS has known effects on 
the rewarding and reinforcing properties of other drugs of abuse including cocaine, 
amphetamine, and opiates (Moffet et al., 2006; Der-Avakian et al., 2010; Vazquez et al., 
2005). In Chapter 2, we show that exposure to ELS has a robust effect on METH intake 
behavior in adult male rats. Furthermore, we found that ELS exposure and METH intake 
patterns were related to MeCP2 expression patterns in the NAc core. Next, in Chapter 3, 
we investigated the possible long-term effects of ELS and/or interactions with subsequent 
METH SA on MeCP2 expression in multiple reward-related brain regions. We found that 
ELS and METH SA have unique and interactive effects on MeCP2 expression throughout 
these brain reward regions. Specifically, ELS leads to a long lasting increase in MeCP2 
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expression in the NAc core and METH, self-administration increases MeCP2 expression 
in the striatum in an ELS dependent fashion. Further, we provide evidence that virally 
mediated reduction of MeCP2 expression in the NAc core decreases METH intake 
behavior. The current findings are in agreement with the literature demonstrating that 
ELS can lead to long lasting effects on the epigenome (Weaver et al., 2004; Tesone-
Coelho et al., 2013), psychostimulant exposure increases MeCP2 expression (Cassel et 
al., 2004; Im et al., 2010; Host et al., 2011), and that striatal MeCP2 expression impacts 
the reinforcing and rewarding properties of psychostimulants (Deng et al., 2010; Im et al., 
2010). Taken together, this collection of studies demonstrates that ELS may 
epigenetically prime individuals to be at greater risk for a SUD via lasting changes in the 
brain reward circuitry.  
Early Life Stress, Adult Chronic Stress, and METH Intake Behavior 
 Interactions between ELS and adult stress differently modulate various neural 
systems and vulnerability to psychiatric illnesses such as schizophrenia and post-
traumatic stress disorder (Choy et al., 2009; Ozer et al., 2008). Therefore, in Chapter 4, 
we investigated the combined impact of ELS and chronic variable stress in early 
adulthood on METH intake behavior. Firstly, we replicated our previous findings, as 
described in Chapter 2 and 3, that ELS induced by prolonged MS increases adult METH 
intake compared to handled control rats. Additionally, our data revealed that chronic 
variable stress in adulthood actually attenuates METH SA in rats with a history of ELS. 
However, adult chronic variable stress had no effect on METH self-administration in 
animals without a history of ELS. These findings were unexpected, since instead of 
demonstrating that the two types of stressors produced additive effects of increasing 
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METH SA, it appears that chronic variable stress in adulthood confers resiliency towards 
reduced METH intake. Our findings are in agreement with the extant literature 
suggesting that mild adult stress can potentially reverse detrimental effects of ELS and 
modulate the reinforcing properties of psychostimulants (Ladd et al., 2005; Renard et al., 
2007; Choy et al., 2009; Der-Avakian & Markou, 2010). This study highlights the 
complex interplay between experiences throughout the lifespan and how they may 
interact to modulate the neurophysiological response to drugs and subsequent SUD 
vulnerability.  
Postpartum Stress and Conditioned Reward to METH  
 The prevalence of METH abuse among women is on the rise and women who 
have their children taken from them are more likely to have an SUD. In Chapter 5, we 
argue for the need to evaluate this relation by utilizing the common maternal separation 
paradigm. While much research has investigated the effects of maternal separation on the 
adult offspring, few reports evaluate the effects on the dams, and even fewer on the 
dam’s addiction vulnerability. Our study is the first to report on the effects of stress 
during the postpartum experience on post-weaning conditioned reward to METH in 
dams. In this study, we present evidence that dams exposed to short separations from 
their litters display higher levels of conditioned reward to METH compared to dams 
exposed to long separation and virgins. While we predicted postpartum females would be 
more sensitive to the rewarding properties METH compared to virgins, we also predicted 
that this effect would be exacerbated in the long litter separation group. Contrary to our 
prediction, our data suggest that the stress of the prolonged litter separation negated the 
increased reward often seen in postpartum females (Seip et al., 2008). Again, these data 
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demonstrate that the relationship between stress and METH reward and reinstatement is 
highly complex. Evidence shows that females have a different addiction like phenotype 
compared to males (Roth & Carroll, 2004) and that this phenotype can change throughout 
the postpartum experience compared to virgins (Seip et al., 2008).Additionally, 
accumulating evidence demonstrates that stress during the postpartum experience leads to 
alterations in the postpartum brain and behavior (Banky et al., 1994; Boccia et al., 2007; 
Eklund et al., 2009; von Poser Toigo et al., 2012). Therefore, more translationally 
relevant research is needed to model this unique period of vulnerability in women.  
Final Conclusions  
In summary, METH use disorder is a chronic neuropsychiatric illness 
characterized by complex clinical symptoms. It is important to note that human METH 
addiction manifests differently in the clinical population, with different intake patterns, 
amount of drug intake, and comorbidities such as depression, suicidal ideations, and 
psychotic symptoms (Cadet, 2014). Therefore, to accurately study the neural, 
(epi)genetic, and psychopharmacological aspects of addiction, we must employ a 
diversity of animal paradigms (Cadet, 2014). Large strides have been made during the 
last 50 years in our understanding of the actions of abused drugs in the brain. Yet, this 
information should not be confused as having a better understanding of addiction 
etiology. One of the most important questions in addiction research today, is why the vast 
majority of individuals are exposed to drugs of abuse in their life time yet only a small 
percentage develops a SUD (Le Moal, 2009).  
The current prevailing notion is that SUDs develop as a consequence of chronic 
exposure to drugs. These drugs act on brain structures evolved for motivation, learning, 
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and reward. Thus, abused drugs mimic the effects of natural rewards and reinforcers to 
cause an artificial pleasure state and intense and uncontrolled drug craving (Vrecko, 
2010), essentially ‘hijacking’ the reward circuitry (Leshner and Koob, 1999). Caution is 
warranted against the conceptualization and reduction of SUDs as primarily genetic, 
neurological, or biological disorders. This reasoning denies the importance of social 
context, such as developmental factors, in the initiation, use and misuse, cessation, 
abstinence, and relapse behaviors concerning drugs (Galea et al., 2004). The collection of 
studies described in this dissertation use three different rodent paradigms to model the 
complex interaction between social stressors and the reinforcing and rewarding effects of 
METH. The reported results underscore the importance of evaluating the past and current 
social environments in the etiology of SUDs and subsequent treatment plan for each 
individual patient. Furthermore, to staunchly promote addiction vulnerability as primarily 
biological allows the general public and policy makers to all but ignore the massive 
amount of evidence suggesting SES and other social factors play a major role in all stages 
of SUDs (Galea et al., 2004). As addiction researchers, we must recognize the inherent 
dilemma in our current drug policy. The National Institute of Health’s division of Drug 
Abuse is the primary funding agency for research yet, the “War on Drugs” and 
criminalizing of addicts is still prevalent. Finally, SUDs are a substantial socioeconomic 
and psychiatric concern for modern society, therefore, it is necessary to re-examine our 
failing controlled substance policies. For example, as opposed to treating drug use as a 
criminal act, there are potential beneficial effects for decriminalization of drug use in 
order for addicts to receive medical care through individualized treatment plans. Finally, 
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re-examining our controlled substance policies may open for the door for research into 
novel addiction treatments, such as psychedelic assisted cognitive behavioral therapy.  
Research in the 21
st
 century has thus far demonstrated that exogenous and 
endogenous factors contributing to behavior and psychiatric vulnerability are intimately 
linked. For example, gene by environment studies demonstrate an interaction in which 
our environment shapes us and we shape our environment. The field of neuroepigenetics 
shows that our environment influences genetic expression that determines behavior. As 
discussed by Dr. Nancy Eisenberg, in a presidential column of the Association for 
Psychological Science journal, the modern field of psychology is at risk of jeopardizing 
our understanding of human functioning through reductionist thinking (Eisenberg, 2014). 
Therefore, while modern neuroscience techniques evolve and allow us to answer novel 
and important molecular questions; we must not lose sight of the human condition as 
dynamic, with various levels of complexity that cannot be fully measured at any single 
level.   
 
 
 
 
 
 
 
 
 
 
  
84 
 
 REFERENCES  
Addolorato, G., Leggio, L., Hopf, F. W., Diana, M., & Bonci, A. (2012). Novel 
therapeutic strategies for alcohol and drug addiction: Focus on GABA, ion 
channels and transcranial magnetic stimulation. Neuropsychopharmacology, 
37(1), 163–177.  
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental 
disorders, (DSM-5®). American Psychiatric Association, Washington, DC. 
Anda, R. F., Felitti, V. J., Bremner, J. D., Walker, J. D., Whitfield, C., Perry, B. D., … 
Giles, W. H. (2006). The enduring effects of abuse and related adverse 
experiences in childhood. A convergence of evidence from neurobiology and 
epidemiology. European Archives of Psychiatry and Clinical Neuroscience, 
256(3), 174–86.  
Anier, K., Malinovskaja, K., Pruus, K., Aonurm-Helm, A., Zharkovsky, A., & Kalda, 
A. (2013). Maternal separation is associated with DNA methylation and 
behavioural changes in adult rats. European Neuropsychopharmacology, 24(3), 
459-468.  
Bagot, R. C., van Hasselt, F. N., Champagne, D. L., Meaney, M. J., Krugers, H. J., & 
Joëls, M. (2009). Maternal care determines rapid effects of stress mediators on 
synaptic plasticity in adult rat hippocampal dentate gyrus. Neurobiology of 
Learning and Memory, 92(3), 292–300.  
Bagot, R. C., Zhang, T. Y., Wen, X., Nguyen, T. T. T., Nguyen, H. B., Diorio, J., ... & 
Meaney, M. J. (2012). Variations in postnatal maternal care and the epigenetic 
regulation of metabotropic glutamate receptor 1 expression and hippocampal 
function in the rat. Proceedings of the National Academy of Sciences, 109(2), 
17200-17207.  
Balster, R. L. (1991). Drug abuse potential evaluation in animals. British Journal of 
Addiction, 86(12), 1549–1558. 
Banky, Z., Nagy, G. M., & Halasz, B. (1994). Effect of various partial separations of 
the litters from their mother on plasma prolactin levels of lactating rats.pdf. Acta 
Biologica Hungarica, 45, 169–178. 
Bannister, A. J., & Kouzarides, T. (2005). Reversing histone methylation. Nature, 
436(7054), 1103–6.  
 
  
85 
 
Bannister, A. J., & Kouzarides, T. (2011). Regulation of chromatin by histone 
modifications. Cell Research, 21(3), 381–95.  
Bannister, A. J., Schneider, R., & Kouzarides, T. (2002). Histone methylation: Dynamic 
or static? Cell, 109(7), 801–6. 
Barnard, M., & McKeganey, N. (2004). The impact of parental problem drug use on 
children: What is the problem and what can be done to help? Addiction, 99(5), 
552–559.  
Bassareo V, Di Chiara G. (1999). Differential responsiveness of dopamine transmission 
to food-stimuli in nucleus accumbens shell/core compartments. Neuroscience, 
89, 637-41. 
Beach, S. R. H., Brody, G. H., Todorov, A. A, Gunter, T. D., & Philibert, R. a. (2010). 
Methylation at SLC6A4 is linked to family history of child abuse: an 
examination of the Iowa Adoptee sample. American Journal of Medical 
Genetics. Part B, Neuropsychiatric Genetics , 153(2), 710–3.  
Beery, A. K., & Zucker, I. (2011). Sex bias in neuroscience and biomedical research. 
Neuroscience and Biobehavioral Reviews, 35(3), 565–72.  
Ben-Porath, I., & Cedar, H. (2001). Epigenetic crosstalk. Molecular Cell, 8(5), 933–5. 
Bernacer, J., Corlett, P. R., Ramachandra, P., McFarlane, B., Turner, D. C., Clark, L., 
… Murray, G. K. (2013). Methamphetamine-induced disruption of frontostriatal 
reward learning signals: relation to psychotic symptoms. American Journal of 
Psychiatry, 170, 1326-1334.  
Berridge KC, Robinson TE. (1995). The mind of an addicted brain: Neural sensitization 
of wanting versus liking. Current Directions in Psychological Science, 4,71-6. 
Biliński, P., Wojtyła, A., Kapka-Skrzypczak, L., Chwedorowicz, R., Cyranka, M., & 
Studziński, T. (2012). Epigenetic regulation in drug addiction. Annals of 
Agricultural and Environmental Medicine, 19(3), 491–6. 
Bird, A. (2002). DNA methylation patterns and epigenetic memory. Genes & 
Development, 16(1), 6–21.  
Blasi G, Goldberg TE, Weickert T, et al. (2006). Brain regions underlying response 
inhibition and interference monitoring and suppression. European Journal of 
Neuroscience, 23, 1658-64. 
 
  
86 
 
Boccia, M. L., Razzoli, M., Vadlamudi, S. P., Trumbull, W., Caleffie, C., & Pedersen, 
C. a. (2007). Repeated long separations from pups produce depression-like 
behavior in rat mothers. Psychoneuroendocrinology, 32(1), 65–71.  
Bode, A. M., & Dong, Z. (2005). Inducible covalent posttranslational modification of 
histone H3. Science’s STKE : Signal Transduction Knowledge Environment, 
2005(281), re4.  
Bohacek, J., Gapp, K., Saab, B. J., & Mansuy, I. M. (2013). Transgenerational 
epigenetic effects on brain functions. Biological Psychiatry, 73(4), 313–20.  
Bolaños, C. A, & Nestler, E. J. (2004). Neurotrophic mechanisms in drug addiction. 
Neuromolecular Medicine, 5(1), 69–83.  
Brake W. G., Flores G., Francis D., Meaney M. J., Srivastava L. K., Gratton A. (2000). 
Enhanced nucleus accumbens dopamine and plasma corticosterone stress 
responses in adult rats with neonatal excitotoxic lesions to the medial prefrontal 
cortex. Neuroscience, 96, 687-95. 
Breese, G. R., Sinha, R., Heilig, M.. (2011). Chronic alcohol neuroadaptation and stress 
contribute to susceptibility for alcohol craving and relapse. Pharmacology and 
Therapeutics, 129(2), 149-71. 
Breiter, H. C., Gollub, R. L., Weisskoff, R. M., et al. (1997). Acute effects of cocaine 
on human brain activity and emotion. Neuron, 19, 591-611. 
Bremne, J. D., & Vermetten, E. (2001). Stress and development: behavioral and 
biological consequences. Development and Psychopathology, 13(3), 473–89. 
Brentari, C., Hernandez, B., & Tripodi, S. (2011). Attention to women drug users in 
Europe.  European Project ‘Democracy, Cities and Drugs II–2008–2010’. 
Thematic Platform. 
Cadet, J. L. (2014). Epigenetics of stress, addiction, and resilience: Therapeutic 
implications. Molecular Neurobiology, 1-16.  
Cadet, J. L., Brannock, C., Jayanthi, S., & Krasnova, I. N. (2014). Transcriptional and 
epigenetic substrates of methamphetamine addiction and withdrawal: Evidence 
from a long-access self-administration model in the rat. Molecular 
Neurobiology, 51(2), 696–717.  
 
  
87 
 
Cailhol, S., Mormede, P. (1999) Strain and sex differences in the locomotor response 
and behavioral sensitization to cocaine in hyperactive rats. Brain Research, 842, 
200–205. 
Cardinal, R. N., Parkinson, J. A., Hall, J., Everitt, B. J. (2002). Emotion and motivation: 
The role of the amygdala, ventral striatum, and prefrontal cortex. Neuroscience 
and Biobehavioral Reviews, 26, 321-52. 
Carroll, M. E., Campbell, U. C., & Heideman, P. (2001) Ketoconazole suppresses food 
restriction-induced increases in heroin selfadministration in rats: Sex 
differences. Experimental and Clinical Psychopharmacology, 9, 307–316. 
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., … 
Poulton, R. (2003). Influence of life stress on depression: Moderation by a 
polymorphism in the 5-HTT gene. Science, 301(5631), 386–9.  
Cassel, S., Carouge, D., Gensburger, C., Anglard, P., Burgun, C., Dietrich, J., … 
Zwiller, J. (2006). Fluoxetine and cocaine induce the epigenetic factors MeCP2 
and MBD1 in adult rat brain. Molecular Pharmacology, 70(2), 487–492.  
Cassel, S., Revel, M.-O., Kelche, C., & Zwiller, J. (2004). Expression of the methyl-
CpG-binding protein MeCP2 in rat brain. An ontogenetic study. Neurobiology of 
Disease, 15(2), 206–11.  
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. 
(2008). MeCP2, a key contributor to neurological disease, activates and 
represses transcription. Science , 320(5880), 1224–9.  
Choy, K. H. C., de Visser, Y. P., & van den Buuse, M. (2009). The effect of “two hit” 
neonatal and young-adult stress on dopaminergic modulation of prepulse 
inhibition and dopamine receptor density. British Journal of Pharmacology, 
156(2), 388–96.  
Choy, K. H. C., & van den Buuse, M. (2008). Attenuated disruption of prepulse 
inhibition by dopaminergic stimulation after maternal deprivation and 
adolescent corticosterone treatment in rats. European 
Neuropsychopharmacology , 18(1), 1–13.  
Ciccarone, D. (2011). Stimulant abuse: Pharmacology, cocaine, methamphetamine, 
treatment, attempts at pharmacotherapy. Primary Care - Clinics in Office 
Practice, 38(1), 41-58. 
 
  
88 
 
Cohen, S., Gabel, H. W., Hemberg, M., Hutchinson, A. N., Sadacca, L. A., Ebert, D. H., 
… Greenberg, M. E. (2011). Genome-wide activity-dependent MeCP2 
phosphorylation regulates nervous system development and function. Neuron, 
72(1), 72–85.  
Crittenden, J. R., & Graybiel, A. M. (2011). Basal ganglia disorders associated with 
imbalances in the striatal striosome and matrix compartments. Frontiers in 
Neuroanatomy, 5, 59.  
Daniels, W. M. U., Fairbairn, L. R., van Tilburg, G., McEvoy, C. R. E., Zigmond, M. J., 
Russell, V. a, & Stein, D. J. (2009). Maternal separation alters nerve growth 
factor and corticosterone levels but not the DNA methylation status of the exon 
1(7) glucocorticoid receptor promoter region. Metabolic Brain Disease, 24(4), 
615–27.  
Darke, S., Kaye, S., McKetin, R., & Duflou, J. (2008). Major physical and 
psychological harms of methamphetamine use. Drug and Alcohol Review, 27(3), 
253–62.  
De Bellis, M. D. (2002). Developmental traumatology: A contributory mechanism for 
alcohol and substance use disorders. Psychoneuroendocrinology, 27, 155–70. 
De Bellis, M. D., & Zisk, A. (2014). The biological effects of childhood trauma. Child 
and Adolescent Psychiatric Clinics of North America, 23(2), 185-222. 
Deng, J. V, Rodriguiz, R. M., Hutchinson, A. N., Kim, I.-H., Wetsel, W. C., & West, A. 
E. (2010). MeCP2 in the nucleus accumbens contributes to neural and 
behavioral responses to psychostimulants. Nature Neuroscience, 13(9), 1128–
36.  
Deng, J. V., Wan, Y., Wang, X., Cohen, S., Wetsel, W. C., Greenberg, M. E., … West, 
A. E. (2014). MeCP2 phosphorylation limits psychostimulant-induced 
behavioral and neuronal plasticity. Journal of Neuroscience, 34(13), 4519–4527. 
  
Derauf, C., LaGasse, L. L., Smith, L. M., Grant, P., Shah, R., Arria, A., … Lester, B. M. 
(2007). Demographic and psychosocial characteristics of mothers using 
methamphetamine during pregnancy: preliminary results of the infant 
development, environment, and lifestyle study (IDEAL). American Journal of 
Drug and Alcohol Abuse, 33(2), 281–289.  
 
  
89 
 
Der-Avakian, A., & Markou, A. (2010). Neonatal maternal separation exacerbates the 
reward-enhancing effect of acute amphetamine administration and the anhedonic 
effect of repeated social defeat in adult rats. Neuroscience, 170(4), 1189–98.  
Dimatelis, J. J., Russell, V. A., Stein, D. J., & Daniels, W. M. (2012a). Effects of 
maternal separation and methamphetamine exposure on protein expression in 
the nucleus accumbens shell and core. Metabolic Brain Disease, 27(3), 363–75. 
Dimatelis, J. J., Russell, V. A, Stein, D. J., & Daniels, W. M. (2012b). The effects of 
lobeline and naltrexone on methamphetamine-induced place preference and 
striatal dopamine and serotonin levels in adolescent rats with a history of 
maternal separation. Metabolic Brain Disease, 27(3), 351–61.  
Dluzen, D.E. & Liu, B. (2008). Gender differences in methamphetamine use and 
responses: A review. Gender Medicine, 5(1), 24–35. 
Doherty MD, Gratton A. (1997). NMDA receptors in nucleus accumbens modulate 
stress-induced dopamine release in nucleus accumbens and ventral tegmental 
area. Synapse, 26, 225-34. 
Eisenberg, N. (2014). Is Our Focus Becoming Overly Narrow? Retrieved June 1, 2015, 
from 
http://www.psychologicalscience.org/index.php/publications/observer/2014/sept
ember-14/is-our-focus-becoming-overly-narrow.html 
Eklund, M. B., Johansson, L. M., Uvnäs-Moberg, K., & Arborelius, L. (2009). 
Differential effects of repeated long and brief maternal separation on behaviour 
and neuroendocrine parameters in Wistar dams. Behavioural Brain Research, 
203(1), 69–75.  
Essex, M. J., Thomas, B. W., Hertzman, C., Lam, L. L., Armstrong, J. M., Neumann, S. 
M., & Kobor, M. S. (2013). Epigenetic vestiges of early developmental 
adversity: Childhood stress exposure and DNA methylation in adolescence. 
Child Development, 84(1), 58–75.  
Everitt, B. J., Morris, K. A., O'Brien, A., Robbins, T.W. (1991). The basolateral 
amygdala-ventral striatal system and conditioned place preference: Further 
evidence of limbic-striatal interactions underlying reward-related processes. 
Neuroscience, 42, 1-18. 
Everitt, B. J. & Robbins, T. W. (2005). Neural systems of reinforcement for drug 
addiction: From actions to habits to compulsion. Nature Neuroscience, 8, 1481-
9. 
 
  
90 
 
Everitt, B. J., & Robbins, T. W. (2013). From the ventral to the dorsal striatum: 
Devolving views of their roles in drug addiction. Neuroscience & Biobehavioral 
Reviews, 37(9), 1946-1954. 
Everitt, B. J., Wolf, M. E. (2002). Psychomotor stimulant addiction: A neural systems 
perspective. Journal of Neuroscience, 22, 3312-20. 
Everitt, B. J., Belin, D., Economidou, D., Pelloux, Y., Dalley, J. W., & Robbins, T. W. 
(2008). Neural mechanisms underlying the vulnerability to develop compulsive 
drug-seeking habits and addiction. Philosophical Transactions of the Royal 
Society of London, 363(1507), 3125–35.  
Ezeonwuka, C., & Rastegar, M. (2014). MeCP2-related diseases and animal models. 
Diseases, 2(1), 45–70.  
Faure, J., Stein, D. J., & Daniels, W. (2009). Maternal separation fails to render animals 
more susceptible to methamphetamine-induced conditioned place preference. 
Metabolic Brain Disease, 24(4), 541–559. 
Feil, J., Sheppard, D., Fitzgerald, P. B., Yucel, M., Lubman, D. I., Bradshaw, J. L. 
(2010). Addiction, compulsive drug seeking, and the role of frontostriatal 
mechanisms in regulating inhibitory control. Neuroscience and Biobehavioral 
reviews, 35, 248-75. 
Feltenstein, M. W., & See, R. E. (2008). The neurocircuitry of addiction: an overview. 
British Journal of Pharmacology, 154(2), 261–74.  
Flagel, S. B., Vázquez, D. M., & Robinson, T. E. (2003). Manipulations during the 
second, but not the first, week of life increase susceptibility to cocaine self-
administration in female rats. Neuropsychopharmacology, 28(10), 1741–51.  
Francis, D. D., & Kuhar, M. J. (2008). Frequency of maternal licking and grooming 
correlates negatively with vulnerability to cocaine and alcohol use in rats. 
Pharmacolology Biochemistry and Behavior, 90(3), 497–500.  
Frankfurt, M., Salas-Ramirez, K., Friedman, E., & Luine, V. (2011). Cocaine alters 
dendritic spine density in cortical and subcortical brain regions of the 
postpartum and virgin female rat. Synapse, 65(9), 955–961.  
Gaffan, D., Murray, E. A. (1990). Amygdalar interaction with the mediodorsal nucleus 
of the thalamus and the ventromedial prefrontal cortex in stimulus-reward 
associative learning in the monkey. Journal of Neuroscience, 10, 3479-93. 
 
  
91 
 
Galea, S., Nandi, A., & Vlahov, D. (2004). The social epidemiology of substance use. 
Epidemiologic Reviews, 26, 36–52.  
Gluckman, P. D., Hanson, M. A., Cooper, C., & Thornburg, K. L. (2008). Effect of in 
utero and early-life conditions on adult health and disease. New England Journal 
of Medicine, 359(1), 61–73.  
Gardner, K. L., Hale, M. W., Lightman, S. L., Plotsky, P. M., & Lowry, C. A. (2009). 
Adverse early life experience and social stress during adulthood interact to 
increase serotonin transporter mRNA expression. Brain Research, 1305, 47–63.  
Gates, E. “Life a Property of Matter.” Suggestion (Chicago: August, 1904), pp. 70-73. 
Gunnar, M. R., & Donzella, B. (2002). Social regulation of the cortisol levels in early 
human development. Psychoneuroendocrinology, 27(1-2), 199–220. 
Gluckman, P. D., Hanson, M. A., Cooper, C., & Thornburg, K. L. (2008). Effect of in 
utero and early-life conditions on adult health and disease. New England Journal 
of Medicine, 359(1), 61–73.  
Goldman, J., Murr, A., Cooper, R. (2007). The rodent estrous cycle: Characterization of 
vaginal cytology and its utility in toxicological studies. Birth Defects Research 
B: Developmental and Reproductive Toxicology, 80(2), 84-97. 
Green, A., Ellis, K. A., Ellis, J., et al. (2005). Muscarinic and nicotinic receptor 
modulation of object and spatial n-back working memory in humans. 
Pharmacology Biochemistry and Behavior, 81, 575-84. 
Gunnar, M. R., & Donzella, B. (2002). Social regulation of the cortisol levels in early 
human development. Psychoneuroendocrinology, 27(1-2), 199–220. 
Gunstad, J., Paul, R. H., Spitznagel, M. B., Cohen, R. A., Williams, L. M., Kohn, M., & 
Gordon, E. (2006). Exposure to early life trauma is associated with adult 
obesity. Psychiatry Research, 142(1), 31–7.  
Hall, F. S., Wilkinson, L. S., Humby, T., & Robbins, T. W. (1999). Maternal 
deprivation of neonatal rats produces enduring changes in dopamine function. 
Synapse, 32(1), 37–43. 
Hansen, J. C., Ghosh, R. P., & Woodcock, C. L. (2010). Binding of the Rett syndrome 
protein, MeCP2, to methylated and unmethylated DNA and chromatin. IUBMB 
Life, 62(10), 732–738.  
 
  
92 
 
Harlow, H. F., Dodsworth, R. O., Harlow, M. K. (1965). Total social isolation in 
monkeys. Proceeedings of the Nationtal Academy of Sciences USA 54, 90–7. 
Hebb, D. O. (1947). The effects of early experience on problem solving at 
maturity. American Psychologist, 2, 306-307. 
Henikoff, S., Furuyama, T., & Ahmad, K. (2004). Histone variants, nucleosome 
assembly and epigenetic inheritance. Trends in Genetics, 20(7), 320–6.  
Hensleigh, E., & Pritchard, L. M. (2014). Maternal separation increases 
methamphetamine-induced damage in the striatum in male, but not female rats. 
Behavioural Brain Research, 8–13.  
Hernández-R, J. (1992). Na+/K+-ATPase regulation by neurotransmitters. 
Neurochemistry International, 20(1), 1-10. 
Ho, D. H., & Burggren, W. W. (2010). Epigenetics and transgenerational transfer: a 
physiological perspective. Journal of Experimental Biology, 213(1), 3–16.  
Holmes, A. D., Chenery, H. J., Copland, D. A. (2008). Transdermal nicotine modulates 
strategy-based attentional semantic processing in non-smokers. International 
Journal of Neuropsychopharmacology, 11, 389-99. 
Host, L., Dietrich, J. B., Carouge, D., Aunis, D., & Zwiller, J. (2011). Cocaine self-
administration alters the expression of chromatin-remodelling proteins; 
modulation by histone deacetylase inhibition. Journal of Psychopharmacology, 
25(2), 222–9.  
Hou, Y.Y., Cai, Y.Q., & Pan, Z. Z. (2015). Persistent pain maintains morphine-seeking 
behavior after morphine withdrawal through reduced MeCP2 repression of 
glua1 in rat central amygdala. Journal of Neuroscience, 35(8), 3689–3700.  
Huang, L. T. (2014). Early-life stress impacts the developing hippocampus and primes 
seizure occurrence: Cellular, molecular, and epigenetic mechanisms. Frontiers 
in Molecular Neuroscience, 7, 8.  
Huot, R. L., Thrivikraman, K. V., Meaney, M. J., & Plotsky, P. M. (2001). 
Development of adult ethanol preference and anxiety as a consequence of 
neonatal maternal separation in Long Evans rats and reversal with antidepressant 
treatment. Psychopharmacology, 158(4), 366–73.  
 
  
93 
 
Hyman, S. E., Malenka, R. C. (2001). Addiction and the brain: the neurobiology of 
compulsion and its persistence. Nature Reviews Neuroscience, 1, 695-703. 
Hyman, S. E. (2005). Addiction: A disease of learning and memory. American Journal 
of psychiatry, 162, 1414-22. 
Ikegami, D., Narita, M., Imai, S., Miyashita, K., Tamura, R., Narita, M., … Suzuki, T. 
(2010). Epigenetic modulation at the CCR2 gene correlates with the 
maintenance of behavioral sensitization to methamphetamine. Addiction 
Biology, 15(3), 358–61.  
Im, H.I., Hollander, J. A., Bali, P., & Kenny, P. J. (2010). MeCP2 controls BDNF 
expression and cocaine intake through homeostatic interactions with microRNA-
212. Nature Neuroscience, 13(9), 1120–7.  
Ito, R., Dalley, J. W., Robbins, T. W., Everitt, B. J. (2002). Dopamine release in the 
dorsal striatum during cocaine-seeking behavior under the control of a drug-
associated cue. Journal of Neuroscience, 22, 6247-53. 
Ito, R., Robbins, T. W., Everitt, B. J. (2004). Differential control over cocaine-seeking 
behavior by nucleus accumbens core and shell. Nature Neuroscience, 7, 389-97. 
Jaworski, J. N., Francis, D. D., Brommer, C. L., Morgan, E. T., & Kuhar, M. J. (2005). 
Effects of early maternal separation on ethanol intake, GABA receptors and 
metabolizing enzymes in adult rats. Psychopharmacology, 181(1), 8–15.  
Jay, T. M. (2003). Dopamine: A potential substrate for synaptic plasticity and memory 
mechanisms. Progress in Neurobiology, 69, 375-90. 
Jiang, Y., Langley, B., Lubin, F. D., Renthal, W., Wood, M. A., Yasui, D. H., … 
Beckel-Mitchener, A. C. (2008). Epigenetics in the nervous system. Journal of 
Neuroscience, 28(46), 11753–9.  
Jones, P. L., Veenstra, G. J., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., 
… Wolffe, A. P. (1998). Methylated DNA and MeCP2 recruit histone 
deacetylase to repress transcription. Nature Genetics, 19(2), 187–91.  
Kalinichev, M., Easterling, K. W., & Holtzman, S. G. (2000). Periodic postpartum 
separation from the offspring results in long-lasting changes in anxiety-related 
behaviors and sensitivity to morphine in Long-Evans mother rats. 
Psychopharmacology, 152(4), 431–439.  
 
  
94 
 
Kalivas, P. W., Volkow ND. (2005). The neural basis of addiction: a pathology of 
motivation and choice. American Journal of Psychiatry, 162, 1403-13. 
Kalivas, P. W. (2009). The glutamate homeostasis hypothesis of addiction. Nature 
Reviews Neuroscience, 10, 561-72. 
Karreman, M., Moghaddam, B. (1996). The prefrontal cortex regulates the basal release 
of dopamine in the limbic striatum: An effect mediated by ventral tegmental 
area. Journal of Neurochemistry, 66, 589-98. 
Kelley, A. E. (2004). Ventral striatal control of appetitive motivation: Role in ingestive 
behavior and reward-related learning. Neuroscience and Biobehavioral Reviews, 
27, 765-76. 
Kember, R. L., Dempster, E. L., Lee, T. H., Schalkwyk, L. C., Mill, J., & Fernandes, C. 
(2012). Maternal separation is associated with strain-specific responses to stress 
and epigenetic alterations to Nr3c1, Avp, and Nr4a1 in mouse. Brain and 
Behavior, 2(4), 455–67.  
Kendler, K. S., Kuhn, J. W., Vittum, J., Prescott, C. A., & Riley, B. (2005). The 
interaction of stressful life events and a serotonin transporter polymorphism in 
the prediction of episodes of major depression: A replication. Archives of 
General Psychiatry, 62(5), 529–35.  
Kim, D. K., Lim, S. W., Lee, S., Sohn, S. E., Kim, S., Hahn, C. G., et al. (2000). 
Serotonin transporter gene polymorphism and antidepressant 
response. Neuroreport, 11, 215-219. 
Kinnally, E. L., Feinberg, C., Kim, D., Ferguson, K., Leibel, R., Coplan, J. D., & John 
Mann, J. (2011). DNA methylation as a risk factor in the effects of early life 
stress. Brain, Behavior, and Immunity, 25(8), 1548–53.  
Kirby, L. G., Zeeb, F. D., & Winstanley, C. A. (2011). Contributions of serotonin in 
addiction vulnerability. Neuropharmacology, 61(3), 421–432.  
Klengel, T., Pape, J., Binder, E. B., & Mehta, D. (2014). The role of DNA methylation 
in stress-related psychiatric disorders. Neuropharmacology, 80, 115-132. 
Kondo, Y. (2009). Epigenetic cross-talk between DNA methylation and histone 
modifications in human cancers. Yonsei Medical Journal, 50(4), 455–63.  
 
  
95 
 
Koob, G. F., Le Moal, M. (2008). Addiction and the brain antireward system. Annual 
Review of Psychology, 59, 29-53. 
Koob, G. F. & Le Moal, M. (1997). Drug abuse: Hedonic homeostatic dysregulation. 
Science, 278, 52-8. 
Koob, G. F. & Volkow, N. D. (2010). Neurocircuitry of addiction. 
Neuropsychopharmacology, 35, 217-38. 
Koob, G. F. (1992). Neural mechanisms of drug reinforcement. Annals of the New York 
Academy of Sciences, 654, 171-91. 
Koob, G. F. & Le Moal, M. (2008). Addiction and the brain antireward system. Annual 
Review of Psychology, 59, 29–53.  
Kopell, B. H. & Greenberg, B. D. (2008). Anatomy and physiology of the basal ganglia: 
Implications for DBS in psychiatry. Neuroscience and Biobehavioral Reviews, 
32, 408-22. 
Kosten, T. A., Huang, W., & Nielsen, D. A. (2013). Sex and litter effects on anxiety and 
DNA methylation levels of stress and neurotrophin genes in adolescent rats. 
Developmental Psychobiology, 56(3), 392-406. 
Kosten, T. A. & Ambrosio, E. (2002). HPA axis function and drug addictive behaviors: 
Insights from studies with Lewis and Fischer 344 inbred rats. 
Psychoneuroendocrinology, 27(1-2), 35–69.  
Kouzarides, T. (2007). Chromatin modifications and their function. Cell, 128(4), 693–
705.  
Kovalchuk, I. (2012). Transgenerational epigenetic inheritance in animals. Frontiers in 
Genetics, 3, 76.  
Kundakovic, M., Lim, S., Gudsnuk, K., & Champagne, F. A. (2013). Sex-specific and 
strain-dependent effects of early life adversity on behavioral and epigenetic 
outcomes. Frontiers in Psychiatry, 4, 78.  
Labonté, B., Suderman, M., Maussion, G., Navaro, L., Yerko, V., Mahar, I., … Turecki, 
G. (2012). Genome-wide epigenetic regulation by early-life trauma. Archives of 
General Psychiatry, 69(7), 722–31.  
 
  
96 
 
Labonte, B., Yerko, V., Gross, J., Mechawar, N., Meaney, M. J., Szyf, M., & Turecki, 
G. (2012). Differential glucocorticoid receptor exon 1(B), 1(C), and 1(H) 
expression and methylation in suicide completers with a history of childhood 
abuse. Biological Psychiatry, 72(1), 41–8.  
Ladd, C. O., Thrivikraman, K. V, Huot, R. L., & Plotsky, P. M. (2005). Differential 
neuroendocrine responses to chronic variable stress in adult Long Evans rats 
exposed to handling-maternal separation as neonates. 
Psychoneuroendocrinology, 30(6), 520–33.  
Ladd, C. O., Huot, R. L., Thrivikraman, K. V., Nemeroff, C. B., Meaney, M. J., & 
Plotsky, P. M. (1999). Long-term behavioral and neuroendocrine adaptations to 
adverse early experience. Progress in Brain Research, 122, 81-103.  
Lawrence, N. S., Ross T. J., Stein, E. A. (2002). Cognitive mechanisms of nicotine on 
visual attention. Neuron, 36, 539-48. 
Le Moal, M. (2009). Drug abuse: Vulnerability and transition to addiction.pdf. 
Pharmacopsychiatry, 42, 542–555. 
Leshner, A. I., & Koob, G. F. (1999). Drugs of abuse and the brain. Proceedings of the 
Association of American Physicians, 111(2), 99-108. 
Levine, S., Haltmeyer, G. C., Karas, G. G., Denenberg, V. H. (1967). Physiological and 
behavioral effects of infantile stimulation. Physiology & Behavior, 2, 55–59. 
Levine, A., Worrell, T. R., Zimnisky, R., & Schmauss, C. (2012). Early life stress 
triggers sustained changes in histone deacetylase expression and histone H4 
modifications that alter responsiveness to adolescent antidepressant treatment. 
Neurobiology of Disease, 45(1), 488–98.  
Levine, S. (1994). The ontogeny of the hypothalamic‐pituitary‐adrenal axis. The 
influence of maternal factorsa. Annals of the New York Academy of 
Sciences, 746(1), 275-288.  
Levine, S., Haltmeyer, G. C., Karas, G. G., Denenberg, V. H. (1967). Physiological and 
behavioral effects of infantile stimulation. Physiology & Behavior, 2, 55–59. 
Lewis, C. R., & Olive, M. F. (2014). Early-life stress interactions with the epigenome: 
Potential mechanisms driving vulnerability toward psychiatric illness. 
Behavioural Pharmacology, 25(5), 341-351. 
 
  
97 
 
Lewis, C. R., Staudinger, K., Scheck, L., & Olive, M. F. (2013). The effects of maternal 
separation on adult methamphetamine self-administration, extinction, 
reinstatement, and MeCP2 immunoreactivity in the nucleus accumbens. 
Frontiers in Psychiatry, 4(55), 1–9.  
Liberman, S. A., Mashoodh, R., Thompson, R. C., Dolinoy, D. C., & Champagne, F. A. 
(2012). Concordance in hippocampal and fecal Nr3c1 methylation is moderated 
by maternal behavior in the mouse. Ecology and Evolution, 2(12), 3123–31.  
Li, C. Y., Zhou, W. Z., Zhang, P. W., Johnson, C., Wei, L., & Uhl, G. R. (2011). Meta-
analysis and genome-wide interpretation of genetic susceptibility to drug 
addiction. BMC Genomics, 12(1), 508. 
Liberman, S. A., Mashoodh, R., Thompson, R. C., Dolinoy, D. C., & Champagne, F. A. 
(2012). Concordance in hippocampal and fecal Nr3c1 methylation is moderated 
by maternal behavior in the mouse. Ecology and Evolution, 2(12), 3123–31.  
Lippmann, M., Bress, A., Nemeroff, C. B., Plotsky, P. M., & Monteggia, L. M. (2007). 
Long-term behavioural and molecular alterations associated with maternal 
separation in rats. European Journal of Neuroscience, 25(10), 3091–8.  
Liu, D., Diorio, J., Tannenbaum, B., Caldji, C., Francis, D., Freedman, A., et al. (1997). 
Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-
pituitary-adrenal responses to stress. Science, 277(5332), 1659-1662.  
Liyanage, V. R. B., Zachariah, R. M., Davie, J. R., & Rastegar, M. (2015). Ethanol 
deregulates Mecp2/MeCP2 in differentiating neural stem cells via interplay 
between 5-methylcytosine and 5-hydroxymethylcytosine at the Mecp2 
regulatory elements. Experimental Neurology, 265, 102–117.  
Lobo, M. K., Covington, H. E., Chaudhury, D., Friedman, A. K., Sun, H., Damez-
Werno, D., et al. (2010). Cell type-specific loss of BDNF signaling mimics 
optogenetic control of cocaine reward. Science, 330(6002), 385–390.  
Londen, L. V., Goekoop, J. G., van Kempen G. M., Frankhuijzen-Sierevogel, A. C., 
Wiegant, V. M., van der Velde, E. A., et al. (1997). Plasma levels of arginine 
vasopressin elevated in patients with major depression. 
Neuropsychopharmacology, 17, 284-292. 
Lonstein, J. S., Dominguez, J. M., Putnam, S. K., De Vries, G. J., & Hull, E. M. (2003). 
Intracellular preoptic and striatal monoamines in pregnant and lactating rats: 
Possible role in maternal behavior. Brain Research, 970(1-2), 149–158.  
 
  
98 
 
Lonstein, J. S., Maguire, J., Meinlschmidt, G., & Neumann, I. D. (2014). Emotion and 
mood adaptations in the peripartum female: complementary contributions of 
GABA and oxytocin. Journal of Neuroendocrinology, 26(10), 649–664.  
Lorvick, J., Bourgois, P., Wenger, L. D., Arreola, S. G., Lutnick, A., Wechsberg, W. 
M., & Kral, A. H. (2012). Sexual pleasure and sexual risk among women who 
use methamphetamine: A mixed methods study. International Journal of Drug 
Policy, 23(5), 385–392.  
Lovallo, W. R., Farag, N. H., Sorocco, K. H., Acheson, A., Cohoon, A. J., & Vincent, 
A. S. (2012). Early life adversity contributes to impaired cognition and 
impulsive behavior: studies from the oklahoma family health patterns project. 
Alcoholism, Clinical and Experimental Research, 37(4), 616-623.   
Lü, X., Zhao, C., Zhang, L., Ma, B., Lou, Z., Sun, Y., … Liu, Y. (2012). The effects of 
rearing condition on methamphetamine self-administration and cue-induced 
drug seeking. Drug and Alcohol Dependence, 124(3), 288-298.  
Lutz, P. E., & Turecki, G. (2014). DNA methylation and childhood maltreatment: from 
animal models to human studies. Neuroscience, 264, 142-156.  
Lynch, W. J., Carroll, M. E. (1999). Sex differences in the acquisition of intravenously 
self-administered cocaine and heroin in rats. Psychopharmacology, 144, 77–82. 
Macbeth, A. H., Gautreaux, C., & Luine, V. N. (2008). Pregnant rats show enhanced 
spatial memory, decreased anxiety, and altered levels of monoaminergic 
neurotransmitters. Brain Research, 1241, 136–147.  
Maniam, J., & Morris, M. J. (2010). Long-term postpartum anxiety and depression-like 
behavior in mother rats subjected to maternal separation are ameliorated by 
palatable high fat diet. Behavioural Brain Research, 208(1), 72–79.  
Marmendal, M., Roman, E., Eriksson, C. J. P., Nylander, I., & Fahlke, C. (2004). 
Maternal separation alters maternal care, but has minor effects on behavior and 
brain opioid peptides in adult offspring. Developmental Psychobiology, 45(3), 
140–52.  
Marshall, J. F., & O’Dell, S. J. (2012). Methamphetamine influences on brain and 
behavior: Unsafe at any speed? Trends in Neurosciences, 35(9), 536–45.  
Matthews, K., Dalley, J. W., Matthews, C., Tsai, T. H., & Robbins, T. W. (2001). 
Periodic maternal separation of neonatal rats produces region- and gender-
 
  
99 
 
specific effects on biogenic amine content in postmortem adult brain. Synapse, 
40(1), 1–10.  
Matthews, K., Robbins, T. W., Everitt, B. J., & Caine, S. B. (1999). Repeated neonatal 
maternal separation alters intravenous cocaine self-administration in adult rats. 
Psychopharmacology, 141(2), 123–34. 
McClung, C. a, & Nestler, E. J. (2008). Neuroplasticity mediated by altered gene 
expression. Neuropsychopharmacology, 33(1), 3–17. 
McClure, S. M., Daw, N. D., Montague, P. R. (2003). A computational substrate for 
incentive salience. Trends in Neuroscience, 26, 423-8. 
McEwen, B. S. (2003). Early life influences on life-long patterns of behavior and 
health. Mental Retardation and Developmental Disabilities Research Reviews, 
9(3), 149–54.  
McFarland, K. N., Huizenga, M. N., Darnell, S. B., Sangrey, G. R., Berezovska, O., 
Cha, J. H. J., … Sadri-Vakili, G. (2014). MeCP2: A novel huntingtin interactor. 
Human Molecular Genetics, 23(4), 1036–1044.  
McGowan, P. O., Sasaki, A., D’Alessio, A. C., Dymov, S., Labonté, B., Szyf, M., … 
Meaney, M. J. (2009). Epigenetic regulation of the glucocorticoid receptor in 
human brain associates with childhood abuse. Nature Neuroscience, 12(3), 342–
8.  
McGowan, P. O., Suderman, M., Sasaki, A., Huang, T. C. T., Hallett, M., Meaney, M. 
J., & Szyf, M. (2011). Broad epigenetic signature of maternal care in the brain 
of adult rats. PloS One, 6(2), e14739.  
Meaney, M. J., Aitken, D. H., Bodnoff, S. R., Iny, L. J., & Sapolsky, R. M. (1985). The 
effects of postnatal handling on the development of the glucocorticoid receptor 
systems and stress recovery in the rat. Progress in Neuro-Psychopharmacology 
& Biological Psychiatry, 9(5-6), 731–4. 
Meaney, M. J. (2001). Maternal care, gene expression, and the transmission of 
individual differences in stress reactivity across generations. Annual Review of 
Neuroscience, 24(1), 1161-1192.  
Meaney, M. J., Aitken, D. H., Bodnoff, S. R., Iny, L. J., & Sapolsky, R. M. (1985). The 
effects of postnatal handling on the development of the glucocorticoid receptor 
 
  
100 
 
systems and stress recovery in the rat. Progress in Neuro-Psychopharmacology 
& Biological Psychiatry, 9(5-6), 731–4. 
Meaney, M. J., Brake, W., & Gratton, A. (2002). Environmental regulation of the 
development of mesolimbic dopamine systems: a neurobiological mechanism 
for vulnerability to drug abuse? Psychoneuroendocrinology, 27(1-2), 127–138. 
Meaney, M. J. (2001). Maternal care, gene expression, and the transmission of 
individual differences in stress reactivity across generations. Annual Review of 
Neuroscience, 24(1), 1161-1192.  
Kriaucionis, S. & Heintz, N. (2012). MeCP2 binds to 5hmC enriched within active 
genes and accessible chromatin in the nervous system. Cell, 151(7), 1417–1430.  
Mellén, M., Ayata, P., Dewell, S., Kriaucionis, S., & Heintz, N. (2012). MeCP2 binds 
to 5hmC enriched within active genes and accessible chromatin in the nervous 
system. Cell, 151(7), 1417–1430.  
Mennenga, S. E., Gerson, J. E., Koebele, S. V., Kingston, M. L., Tsang, C. W., Engler-
Chiurazzi, E. B., ... & Bimonte-Nelson, H. A. (2015). Understanding the 
cognitive impact of the contraceptive estrogen Ethinyl Estradiol: Tonic and 
cyclic administration impairs memory, and performance correlates with basal 
forebrain cholinergic system integrity. Psychoneuroendocrinology, 54, 1-13 
Mermelstein, P. G., Becker, J. B. (1995). Increased extracellular dopamine in the 
nucleus accumbens and striatum of the female rat during paced copulatory 
behavior. Behavioral Neuroscience, 109, 354-65. 
Messina, N., Marinelli-Casey, P., Hillhouse, M., Rawson, R., Hunter, J., & Ang, A. 
(2008). Childhood adverse events and methamphetamine use among men and 
women. Journal of Psychoactive Drugs, 40, 399–409. 
Miller, C. A. & Sweatt, J. D. (2007). Covalent modification of DNA regulates memory 
formation. Neuron, 53(6), 857–69.  
Miranda, T. B., & Jones, P. A. (2007). DNA methylation: the nuts and bolts of 
repression. Journal of Cellular Physiology, 213(2), 384-390.  
Mitchell, J. B., Gratton, A. (1991). Opioid modulation and sensitization of dopamine 
release elicited by sexually relevant stimuli: A high speed chronoamperometric 
study in freely behaving rats. Brain Research, 551, 20-7. 
 
  
101 
 
Moffett, M. C., Harley, J., Francis, D., Sanghani, S. P., Davis, W. I., & Kuhar, M. J. 
(2006). Maternal separation and handling affects cocaine self- administration in 
both the treated pups as adults and the dams. Journal of Pharmacology and 
Experimental Therapeutics, 317(3), 1210–1218.  
Moffett, M. C., Vicentic, a, Kozel, M., Plotsky, P., Francis, D. D., & Kuhar, M. J. 
(2007). Maternal separation alters drug intake patterns in adulthood in rats. 
Biochemical Pharmacology, 73(3), 321–30.  
Morales, V., Giamarchi, C., Chailleux, C., Moro, F., Marsaud, V., Le Ricousse, S., & 
Richard-Foy, H. (2001). Chromatin structure and dynamics: functional 
implications. Biochimie, 83(11-12), 1029–39. 
Murgatroyd, C., Patchev, A. V, Wu, Y., Micale, V., Bockmühl, Y., Fischer, D., … 
Spengler, D. (2009). Dynamic DNA methylation programs persistent adverse 
effects of early-life stress. Nature Neuroscience, 12(12), 1559–66.  
Murgatroyd, C., Quinn, J. P., Sharp, H. M., Pickles, a, & Hill, J. (2015). Effects of 
prenatal and postnatal depression, and maternal stroking, at the glucocorticoid 
receptor gene. Translational Psychiatry, 5(5), e560.   
Nagahara, A. H. & Tuszynski, M. H. (2011). Potential therapeutic uses of BDNF in 
neurological and psychiatric disorders. Nature Reviews Drug Discovery, 10(3), 
209–19.  
Narayan, P., & Dragunow, M. (2010). Pharmacology of epigenetics in brain disorders. 
British Journal of Pharmacology, 159(2), 285–303.  
Neisewander, J., Peartree, N., Pentkowski, N. (2012). Emotional valence and context of 
social influences on drug abuse-related behavior in animal models of social 
stress and prosocial interaction. Psychopharmacology, 224, 33-56. 
Nestler, E. J. (2005). Is there a common molecular pathway for addiction? Nature 
Neuroscience, 8(11), 1445–1449.  
NIDA. Cocaine: Abuse and Addiction: National Institutes of Health, U.S. Department 
of Health and Human Services; 2010b. Report No.: 10-4166. 
NIDA. Marijuana Abuse National Institutes of Health, U.S. Department of Health and 
Human Services; 2010a. Report No.: 10-3859. 
 
  
102 
 
NIDA. Methamphetamine Abuse and Addiction: National Institutes of Health, U.S. 
Department of Health and Human Services; 2006. Report No.: 06-4210. 
NIDA. Prescription Drugs: Abuse and Addiction: National Institutes of Health, U.S. 
Department of Health and Human Services; 2011. Report No.: 11-4881. 
Nielsen, D. A., Utrankar, A., Reyes, J. A., Simons, D. D., & Kosten, T. R. (2012). 
Epigenetics of drug abuse: Predisposition or response. Pharmacogenomics, 
13(10), 1149–60.  
Nikitina, T., Shi, X., Ghosh, R. P., Horowitz-Scherer, R. A., Hansen, J. C., & 
Woodcock, C. L. (2007). Multiple modes of interaction between the methylated 
DNA binding protein MeCP2 and chromatin. Molecular and Cellular Biology, 
27(3), 864–877.  
Obert, J. L. (2005). A clinician's guide to methamphetamine. Hazelden Publishing, 
Center City, MN. 
Ooi, S. K. T. & Bestor, T. H. (2008). The colorful history of active DNA demethylation. 
Cell, 133(7), 1145–8.  
Ouellet-Morin, I., Wong, C., Danese, A., Pariante, C. M., Papadopoulos, A. S., Mill, J., 
& Arseneault, L. (2012). Increased SERT DNA methylation is associated with 
bullying victimization and blunted cortisol response to stress in childhood: a 
longitudinal study of discordant MZ twins. European Journal of 
Psychotraumatology, 3, 1813–1823.  
Ozer, E. J., Best, S. R., Lipsey, T. L., & Weiss, D. S. (2008). Predictors of posttraumatic 
stress disorder and symptoms in adults: A meta-analysis. In Annual Meeting of 
the International Society for Traumatic Stress Studies, 14th, Nov, 1998, 
Washington, DC, US; This article is based on a paper presented at the 
aforementioned meeting. (No. 1, p. 3). Educational Publishing Foundation. 
Pechtel, P., & Pizzagalli, D. A. (2011). Effects of early life stress on cognitive and 
affective function: an integrated review of human literature. 
Psychopharmacology, 214(1), 55–70.  
Perroud, N., Paoloni-Giacobino, A., Prada, P., Olié, E., Salzmann, A., Nicastro, R., … 
Malafosse, A. (2011). Increased methylation of glucocorticoid receptor gene 
(NR3C1) in adults with a history of childhood maltreatment: A link with the 
severity and type of trauma. Translational Psychiatry, 1(12), e59.  
 
  
103 
 
Piazza, P. V, Deminiere, J. M., Le Moal, M., & Simon, H. (1990). Stress- and 
pharmacologically-induced behavioral sensitization increases vulnerability to 
acquisition of amphetamine self-administration. Brain Research, 514(1), 22–6. 
Ploj, K., Roman, E., & Nylander, I. (2003). Long-term effects of maternal separation on 
ethanol intake and brain opioid and dopamine receptors in male wistar rats. 
Neuroscience, 121(3), 787–799.  
Plotsky, P. M., & Meaney, M. J. (1993). Early, postnatal experience alters hypothalamic 
corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and 
stress-induced release in adult rats. Brain Research. Molecular Brain Research, 
18(3), 195–200. 
Pritchard, L. M., Hensleigh, E., & Lynch, S. (2012). Altered locomotor and stereotyped 
responses to acute methamphetamine in adolescent, maternally separated rats. 
Psychopharmacology, 223(1), 27–35.  
Renard, G. M., Rivarola, M. A., & Suárez, M. M. (2007). Sexual dimorphism in rats: 
effects of early maternal separation and variable chronic stress on pituitary-
adrenal axis and behavior. International Journal of Developmental 
Neuroscience, 25(6), 373–9.  
Renthal, W. & Nestler, E. J. (2008). Epigenetic mechanisms in drug addiction. Trends 
in Molecular Medicine, 14(8), 341–50.  
Renthal, W. & Nestler, E. J. (2009). Histone acetylation in drug addiction. Seminars in 
Cell & Developmental Biology, 20(4), 387–94.  
Repunte-Canonigo, V., Chen, J., Lefebvre, C., Kawamura, T., Kreifeldt, M., Basson, 
O., … Sanna, P. P. (2013). MeCP2 regulates ethanol sensitivity and intake. 
Addiction Biology, 19(5), 791–799.  
Rezin, G. T., Scaini, G., Gonçalves, C. L., Ferreira, G. K., Cardoso, M. R., Ferreira, A. 
G. K., … Streck, E. L. (2013). Evaluation of Na+, K+-ATPase activity in the 
brain of young rats after acute administration of fenproporex. Revista Brasileira 
de Psiquiatria, 36(2), 138–142.  
Robinson, T. E., Berridge, K. C. (1993). The neural basis of drug craving: An incentive-
sensitization theory of addiction. Brain Research Reviews, 18, 247-91. 
Romano-López, A., Méndez-Díaz, M., Ruiz-Contreras, A. E., Carrisoza, R., & 
Prospéro-García, O. (2012). Maternal separation and proclivity for ethanol 
 
  
104 
 
intake: A potential role of the endocannabinoid system in rats. Neuroscience, 
223, 296–304.  
Romens, S. E., McDonald, J., Svaren, J., & Pollak, S. D. (2014). Associations between 
early life stress and gene methylation in children. Child Development, 86(1), 
303-309. 
 Roth, M. E. & Carroll, M. E. (2004). Sex differences in the acquisition of IV 
methamphetamine self-administration and subsequent maintenance under a 
progressive ratio schedule in rats. Psychopharmacology, 172(4), 443–449.  
Roth, T. L. (2012). Epigenetics of neurobiology and behavior during development and 
adulthood. Developmental Psychobiology, 54(6), 590-597. 
Roth, T. L., Lubin, F. D., Funk, A. J., & Sweatt, J. D. (2009). Lasting epigenetic 
influence of early-life adversity on the BDNF gene. Biological Psychiatry, 
65(9), 760–9.  
Rusted, J., Sawyer, R., Jones, C., Trawley, S., Marchant, N. (2009). Positive effects of 
nicotine on cognition: The deployment of attention for prospective memory. 
Psychopharmacology, 202, 93-102. 
Rutherford, H. J. V, Williams, S. K., Moy, S., Mayes, L. C., & Johns, J. M. (2011). 
Disruption of maternal parenting circuitry by addictive process: Rewiring of 
reward and stress systems. Frontiers in Psychiatry, 2, 1–17.  
SAMHSA. Results from the 2010 National Survey on Drug Use and Health: Summary 
of national findings. In. Rockville, MD: Substance Abuse and Mental Health 
Services Administration; 2011:NSDUH Series H-41, HHS Publication No. 
(SMA) 11-4658. 
Schimmenti, A. & Bifulco, A. (2013). Linking lack of care in childhood to anxiety 
disorders in emerging adulthood: The role of attachment styles. Child and 
Adolescent Mental Health, 20, 41-48. 
Schindler, C. W., Bross, J. G., Thorndike, E. B. (2002). Gender differences in the 
behavioral effects of methamphetamine. Eur J Pharmacol, 442, 231–235. 
Schmidt, H. D., McGinty, J. F., West, A. E., & Sadri-Vakili, G. (2013). Epigenetics and 
psychostimulant addiction. Cold Spring Harbor Perspectives in Medicine, 3(3), 
a012047.   
 
  
105 
 
Seip, K. M., Pereira, M., Wansaw, M. P., Reiss, J. I., Dziopa, E. I., & Morrell, J. I. 
(2008). Incentive salience of cocaine across the postpartum period of the female 
rat. Psychopharmacology, 199(1), 119–130.  
Sellings, L. H. L., Clarke, P. B. S. (2003). Segregation of amphetamine reward and 
locomotor stimulation between nucleus accumbens medial shell and core. The 
Journal of Neuroscience, 23, 6295-303. 
Sesack, S. R., Carr, D. B., Omelchenko, N., Pinto, A. (2003). Anatomical substrates for 
glutamate-dopamine interactions: Evidence for specificity of connections and 
extrasynaptic actions. Annals of the New York Academy of Sciences, 100, 36-52. 
Sesack, S. R., Pickel, V. M. (1992). Prefrontal cortical efferents in the rat synapse on 
unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens 
septi and on dopamine neurons in the ventral tegmental area. Journal of 
Comparative Neurology, 320, 145-60. 
Shaham, Y., Shalev, U., Lu, L., De Wit, H., Stewart, J. (2003). The reinstatement model 
of drug relapse: history, methodology and major findings. Psychopharmacology, 
168, 3-20. 
Shalev, U., Grimm, J. W, Shaham, Y. (2002). Neurobiology of relapse to heroin and 
cocaine seeking: A review. Pharmacological Reviews, 54, 1-42. 
Sinha, R. (2008). Chronic stress, drug use, and vulnerability to addiction. Annals of the 
New York Academy of Sciences, 1141, 105-30. 
Skene, P. J., Illingworth, R. S., Webb, S., Kerr, A. R. W., James, K. D., Turner, D. J., 
… Bird, A. P. (2010). Neuronal MeCP2 is expressed at near histone-octamer 
levels and globally alters the chromatin state. Molecular Cell, 37(4), 457–68.  
Smith, L. M., LaGasse, L. L., Derauf, C., Grant, P., Shah, R., Arria, A., … Lester, B. M. 
(2006). The infant development, environment, and lifestyle study: Effects of 
prenatal methamphetamine exposure, polydrug exposure, and poverty on 
intrauterine growth. Pediatrics, 118(3), 1149–1156.  
Solinas, M., Chauvet, C., Thiriet, N., El Rawas, R., & Jaber, M. (2008). Reversal of 
cocaine addiction by environmental enrichment. Proceedings of the National 
Academy of Sciences USA, 105(44), 17145-17150. 
 
  
106 
 
Solinas, M., Thiriet, N., Chauvet, C., & Jaber, M. (2010). Prevention and treatment of 
drug addiction by environmental enrichment. Progress in Neurobiology, 92(4), 
572–92.  
Sommers, I., Baskin, D., & Baskin-Sommers, A. (2006). Methamphetamine use among 
young adults: health and social consequences. Addictive Behaviors, 31(8), 1469–
1476. 
Springer, A. E., Peters, R. J., Shegog, R., White, D. L., & Kelder, S. H. (2007). 
Methamphetamine use and sexual risk behaviors in U.S. high school students: 
Findings from a national risk behavior survey. Prevention Science, 8(2), 103–13.  
Steiger, H., Labonté, B., Groleau, P., Turecki, G., & Israel, M. (2013). Methylation of 
the glucocorticoid receptor gene promoter in bulimic women: Associations with 
borderline personality disorder, suicidality, and exposure to childhood abuse. 
The International Journal of Eating Disorders, 46(3), 246–55.  
Stocco, P., Simonelli, A., De Palo, F., & Capra, N. (2012). Research and intervention 
for drug-addicted mothers and their children: New perspectives. In: Addictions 
- From Pathophysiology to Treatment (D Belin, ed.), InTech Open Access. 
Stolerman, I. (1992). Drugs of abuse: Behavioural principles, methods and terms. 
Trends in Pharmacological Sciences, 13, 170-6. 
Strahl, B. D., & Allis, C. D. (2000). The language of covalent histone 
modifications. Nature, 403(6765), 41-45. 
Suderman, M., McGowan, P. O., Sasaki, A., Huang, T. C. T., Hallett, M. T., Meaney, 
M. J., … Szyf, M. (2012). Conserved epigenetic sensitivity to early life 
experience in the rat and human hippocampus. Proceedings of the National 
Academy of Sciences USA, 109, 17266–72.  
Sulzer, D. (2011). How addictive drugs disrupt presynaptic dopamine 
neurotransmission. Neuron, 69(4), 628-649. 
Sung, Y. H., Shin, M. S., Cho, S., Baik, H. H., Jin, B. K., Chang, H. K., … Kim, C. J. 
(2010). Depression-like state in maternal rats induced by repeated separation of 
pups is accompanied by a decrease of cell proliferation and an increase of 
apoptosis in the hippocampus. Neuroscience Letters, 470(1), 86–90.  
Sweatt, J. D. (2013). The emerging field of neuroepigenetics. Neuron, 80(3), 624–32.  
 
  
107 
 
Taber, M. T., Das, S., Fibiger, H. C. (1995). Cortical regulation of subcortical dopamine 
release: Mediation via the ventral tegmental area. Journal of Neurochemistry, 
65, 1407-10. 
Tamaru, H. (2010). Confining euchromatin/heterochromatin territory: Jumonji crosses 
the line. Genes & Development, 24(14), 1465–78.  
Tao, J., Hu, K., Chang, Q., Wu, H., Sherman, N. E., Martinowich, K., … Sun, Y. E. 
(2009). Phosphorylation of MeCP2 at Serine 80 regulates its chromatin 
association and neurological function. Proceedings of the National Academy of 
Sciences USA, 106(12), 4882–7.  
Taylor, S. B., Lewis, C. R., & Olive, M. F. (2013). The neurocircuitry of illicit 
psychostimulant addiction: Acute and chronic effects in humans. Substance 
Abuse and Rehabilatation, 4, 29-43. 
Teicher, M. H., Andersen, S. L., Polcari, A., Anderson, C. M., Navalta, C. P., & Kim, 
D. M. (2003). The neurobiological consequences of early stress and childhood 
maltreatment. Neuroscience & Biobehavioral Reviews, 27(1-2), 33–44.  
Terplan, M., Smith, E. J., Kozloski, M. J., & Pollack, H. A. (2009). Methamphetamine 
use among pregnant women. Obstetrics and Gynecology, 113(6), 1285–1291.  
Tesone‐Coelho, C., Morel, L. J., Bhatt, J., Estevez, L., Naudon, L., Giros, B., ... & 
Daugé, V. (2015). Vulnerability to opiate intake in maternally deprived rats: 
implication of MeCP2 and of histone acetylation. Addiction Biology, 20(1), 120-
131.  
Thiel, K. J., Sanabria, F., Pentkowski, N. S., & Neisewander, J. L. (2009). Anti-craving 
effects of environmental enrichment. International Journal of 
Neuropsychopharmacology, 12(9), 1151-6. 
Thoma, F., Koller, T., & Klug, A. (1979). Involvement of histone H1 in the 
organization of the nucleosome and of the salt-dependent superstructures of 
chromatin. Journal of Cell Biology, 83, 403–27. 
Tracy, E. M., Munson, M. R., Peterson, L. T., & Floersch, J. E. (2010). Social support: 
A mixed blessing for women in substance abuse treatment. Journal of Social 
Work Practice in the Addictions, 10(3), 257–282. 
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007). Epigenetic regulation in 
psychiatric disorders. Nature Reviews Neuroscience, 8(5), 355–67.  
 
  
108 
 
Tyrka, A. R., Price, L. H., Marsit, C., Walters, O. C., & Carpenter, L. L. (2012). 
Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid 
receptor: preliminary findings in healthy adults. PloS One, 7(1), e30148. 
U.S. Department of Health and Human Services. (2008, July). Treatment episode data 
set 1996–2006. Retrieved May 10, 2015, from 
http://wwwdasis.samhsa.gov/teds06/teds2k6aweb508.pdf. 
Uaswani, M., Linda, E. K., Ramesh, S. (2003). Role of selective serotonin reuptake 
inhibitors in psychiatric disorders: a comprehensive review. Progress in 
Neuropsychopharmacolology and Biological Psychiatry, 27, 85-102. 
UCLA Integrated Substance Abuse Programs. (2009). Methamphetamine special 
populations—women and meth. Retrieved May 10, 2015, from 
http://www.methamphetamine.org/html/special-pops-women.html. 
United Nations Office on Drugs and Crime (2007). World drug report. 
<http://www.unodc.org/pdf/research/wdr07/WDR_2007.pdf> Retrieved on May 
10, 2015. 
US Department of Health and Human Services. (2009). Administration for Children and 
Families, Administration on Children, Youth and Families, Children’s 
Bureau. Child maltreatment. 
Van IJzendoorn, M. H., Caspers, K., Bakermans-Kranenburg, M. J., Beach, S. R., 
Philibert, R. (2010). Methylation matters: interaction between methylation 
density and serotonin transporter genotype predicts unresolved loss or trauma. 
Biological Psychiatry, 68, 405-407. 
Van Londen, L., Goekoop, J. G., van Kempen, G. M., Frankhuijzen-Sierevogel, A. C., 
Wiegant, V. M., van der Velde, E. A., & De Wied, D. (1997). Plasma levels of 
arginine vasopressin elevated in patients with major depression. 
Neuropsychopharmacology, 17(4), 284-292. 
Vazquez, V., Penit-Soria, J., Durand, C., Besson, M. J., Giros, B., & Daugé, V. (2005). 
Maternal deprivation increases vulnerability to morphine dependence and 
disturbs the enkephalinergic system in adulthood. Journal of Neuroscience, 
25(18), 4453–62.  
Vearrier, D., Greenberg, M. I., Miller, S. N., Okaneku, J. T., & Haggerty, D. A. (2012). 
Methamphetamine: History, pathophysiology, adverse health effects, current 
trends, and hazards associated with the clandestine manufacture of 
methamphetamine. Disease-a-Month, 58(2), 38–89.  
 
  
109 
 
Venios, K. & Kelly, J. F. (2010). The rise, risks, and realities of methamphetamine use 
among women. Journal of Addictions Nursing, 21(1), 14–21.  
Vijayendran, M., Beach, S. R. H., Plume, J. M., Brody, G. H., & Philibert, R. A. (2012). 
Effects of genotype and child abuse on DNA methylation and gene expression at 
the serotonin transporter. Frontiers in Psychiatry, 3, 55. 
Volkow, N. D., Wang, G. J., Fowler, J. S., Tomasi, D., Telang, F. (2011). Addiction: 
Beyond dopamine reward circuitry. Proceedings of the National Academy of 
Sciences USA, 108, 15037-42. 
Von Poser Toigo, E., Diehl, L.A., Ferreira, A. G. K., Mackedanz, V., Mackendanz, V., 
Krolow, R., … Dalmaz, C. (2012). Maternal depression model: Long-lasting 
effects on the mother following separation from pups. Neurochemical Research, 
37(1), 126–33.  
Vrecko, S. (2010). Birth of a brain disease: science, the state and addiction 
neuropolitics. History of the Human Sciences, 23(4), 52–67.  
Waddington, C. H. (1942). The epigenotype. Endeavour, 1(1), 18–20.  
Wang, A., Nie, W., Li, H., Hou, Y., Yu, Z., Fan, Q., & Sun, R. (2014). Epigenetic 
upregulation of corticotrophin-releasing hormone mediates postnatal maternal 
separation-induced memory deficiency. PLoS One, 9(4), 1–12.  
Weaver, I. C. G., Diorio, J., Seckl, J. R., Szyf, M., & Meaney, M. J. (2004). Early 
environmental regulation of hippocampal glucocorticoid receptor gene 
expression: characterization of intracellular mediators and potential genomic 
target sites. Annals of the New York Academy of Sciences, 1024, 182–212.  
Wise, R. A. (1980). Action of drugs of abuse on brain reward systems. Pharmacology, 
Biochemistry, and Behavior, 13, 213-23. 
Witzmann, S. R., Turner, J. D., Mériaux, S. B., Meijer, O. C., & Muller, C. P. (2012). 
Epigenetic regulation of the glucocorticoid receptor promoter 1(7) in adult rats. 
Epigenetics, 7(11), 1290–301.  
Wood, R. I. (2010). The many facets of sex and drugs. Hormones and Behavior, 58(1), 
1.  
Wouldes, T. A., LaGasse, L. L., Derauf, C., Newman, E., Shah, R., Smith, L. M., … 
Lester, B. M. (2013). Co-morbidity of substance use disorder and 
 
  
110 
 
psychopathology in women who use methamphetamine during pregnancy in the 
US and New Zealand. Drug and Alcohol Dependence, 127(1-3), 101–107.  
Wu, Y., Patchev, A. V., Daniel, G., Almeida, O. F. X., & Spengler, D. (2014). Early-
life stress reduces DNA methylation of the POMC gene in male mice. 
Endocrinology, 155(5), 1751–1762.  
Xie, Z. & Miller, G. M. (2009). A receptor mechanism for methamphetamine action in 
dopamine transporter regulation in brain. Journal of Pharmacology and 
Experimental Therapeutics, 330(1), 316–325.  
Yin, H. H., Knowlton, B. J., Balleine, B. W. (2004). Lesions of dorsolateral striatum 
preserve outcome expectancy but disrupt habit formation in instrumental 
learning. European Journal of Neuroscience, 19, 181-9. 
Zhang, T.Y., Hellstrom, I. C., Bagot, R. C., Wen, X., Diorio, J., & Meaney, M. J. 
(2010). Maternal care and DNA methylation of a glutamic acid decarboxylase 1 
promoter in rat hippocampus. Journal of Neuroscience, 30(39), 13130–7.  
Zheng, C., & Hayes, J. J. (2003). Structures and interactions of the core histone tail 
domains. Biopolymers, 68(4), 539–46.  
Zlotnick, C., Najavits, L. M., Rohsenow, D. J., & Johnson, D. M. (2003). A cognitive-
behavioral treatment for incarcerated women with substance abuse disorder and 
posttraumatic stress disorder: Findings from a pilot study. Journal of Substance 
Abuse Treatment, 25(2), 99-105. 
 
 
 
 
 
 
 
 
 
  
111 
 
APPENDIX A 
ANIMALS AND MATERNAL SEPARATION PROCEDURES 
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 All experimental and surgical procedures were carried out in adherence to the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals 
(National Research Council, 1996) and approved by the Institutional Animal Care and 
Use Committee of Arizona State University.  
 Pregnant dams were purchased from Charles River Laboratories and arrived on 
gestational day 12. Dams were housed individually in standard polycarbonate cages in a 
temperature and humidity controlled room with food and water available ad libitum. 
Beginning on gestational day 20 (range of gestation 21-23 days) cages were checked for 
delivery of pups three times a day. Litters were culled to a maximum size of 12 
immediately after discovery. Litter sizes ranged from 10-12 with one litter at 8 due to pup 
attrition. The litter sex ratios were left natural. Day of birth was considered postnatal day 
0 (PND0).  
 Litters were randomly assigned to one of two conditions: MS for 180-min per day 
(MS180 or Early Life Stress) or the handled control group, 15-min per day (MS15, No 
Stress, or Handled Control). The separation procedure began on PND2. At 8:00 am 
(reverse light cycle, lights off at 7:00 am) the dam was removed from the home cage and 
placed into a new cage with fresh bedding. The pups were then removed and placed into 
a separation cage kept in an isolated room. Heat lamps were set over the separation cages 
and maintained at 30 ± 0.5 C to 32 ± 0.5C to prevent hypothermia. The pups were left 
unattended during the corresponding separation period then returned to the home cage 
immediately prior to the dams return.  
 After separation procedures, rats were left undisturbed with the exception of once 
a week cage cleaning performed by Department of Animal Care and Technologies 
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(DACT) employees. Pups were weaned on PND21 into same sex group housing, and pair 
housed with a sibling on PND40-45. Females were not used for the remainder of the any 
study.  
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APPENDIX B 
BILATERAL INTRACEREBRAL VIRUS INJECTION 
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Rats were anesthetized with isoflurane (2% v/v) vaporized in oxygen at a flow 
rate of 2 L/min. Rats were placed into a stereotaxic frame (Kopf Instruments, Tujunga, 
CA). The scalp was shaved and surgical area cleaned with ethanol and 1% iodine before a 
~2 cm incision was made to expose the skull. Guide cannulae (26G, Plastics One, 
Roanoke, VA) were aimed bilaterally into the NAc core. The following stereotaxic 
coordinates were used (in mm from bregma and skull surface): anterior +2.5, lateral ± 
1.5, from skull surface −6.0. An adeno-associated virus (AAV) expressing a short hairpin 
loop RNA (shRNA) against rat MeCP2 mRNA (sh-MeCP2), or an empty control virus 
(sh-Control), was synthesized by Virovek Inc (Hayward, CA) and bilaterally infused in a 
volume of 2 μl per side (2.25x1013 particles/ml).  Viruses were delivered over a 5 min 
period, after which the injector was left in place for an additional 10-min to allow for 
virus diffusion. Following withdrawal of the injector, skull holes were filled with bone 
wax, and the scalp sutured closed before treatment with topical antibiotic and analgesic 
ointments. Following surgery, animals remained single-housed in their home cage for 
two weeks prior to behavioral testing. 
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APPENDIX C 
CHRONIC VARIABLE STRESS EXPOSURE 
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 For data collected in Chapter 5, at PND55 half of the rats were exposed to 10 
consecutive days of chronic variable stress in which they either received two 
randomly assigned daily stressors or one daytime stressor and one overnight stressor. 
Day time stressors consisted of: 1) loud white noise (~100 dB) for 2-hr,-2) tail pinch 
with a clothespin during restraint for 10 min, 3) restraint in a Plexiglas rodent 
restrainer for 2-hr,-4) forced swim in a cylinder container (45 X 20 X 30 cm) in room 
temperature water for 10-min,-5) strobe light exposure for 2-hr,-6) placement of the 
cage on an orbital shaker for 2-hr, and -7) subcutaneous saline injections (1 ml/kg). 
Overnight stressors consisted of placing another rat’s dirty bedding in the home cage 
and overcrowding (maximum of 8 rats per cage).  
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APPENDIX D 
CONDITIONED PLACE PREFERENCE 
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An unbiased apparatus with two distinct conditioning compartments was used. 
Walls of each compartment were visually distinct. In addition, the floor texture was made 
different in each compartment, with a smooth floor on one side and wire mesh or 
material on the other side. Rats were habituated to the testing apparatus during a single 
30-min session with free access to both conditioning compartments. Animals were then 
subjected to a 30-min preconditioning test to determine any initial preference for one of 
the conditioning compartments. Each animal received METH (0.5 mg/kg i.p.) 15 min 
prior to placement in the initially non-preferred compartment, or saline (i.p.) 15 min prior 
to placement in the initially preferred compartment. Next, animals underwent place 
conditioning in twice-daily 30-min conditioning sessions. Saline-conditioning sessions 
were conducted in the morning, and METH-conditioning sessions were conducted in the 
afternoon to avoid carryover effects. Following five sequential conditioning days, 
animals were tested for place preference by allowing free access to both conditioning 
compartments for 30-min. The dependent variable assessed was total CPP score, 
calculated by pre-conditioning time spent in the METH chamber subtracted from post-
conditioning time spent in the METH chamber.  
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APPENDIX E 
IMMUNOBLOT ANALYSIS 
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 Dissected brain tissue (1 mm punch diameter) was placed in a neuronal 
protein extraction reagent (N-PER, G-Biosciences, USA) containing a protease 
inhibitor cocktail. Tissue was homogenized with a Branson sonicator and centrifuged 
at 10,000g at 4°C for 10 min. The supernatant was then stored at -80°C until analysis. 
Protein concentrations were determined using bicinchoninic acid (BCA) protein 
assays (Bio-Rad). For immunoblot analysis, samples (30 g of protein per lane) were 
subjected to sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis using 
4-12% RunBlue gels (Expedeon). Proteins were transferred to nitrocellulose 
membranes, pre-blocked with phosphate-buffered saline (PBS) containing 0.1% (v/v) 
Tween 20 and 5% (w/v) nonfat dried milk powder for 1-hr before overnight 
incubation with primary antibodies polyclonal antibody: rabbit anti-MeCP2 (Abcam; 
1:100 dilution) and as a loading control, rabbit anti- glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) (Abcam; 1:10000 dilution). Membranes were then washed 
and incubated with horseradish peroxidase (HRP)-conjugated donkey anti-rabbit IgG 
antisera (Jackson ImmunoResearch Laboratories Inc., West Grove, PA; 1:1500 
dilution) for 1-hr, and immunoreactive bands were detected by enhanced 
chemilluminescence (Western Lightning Plus) and exposure to Kodak Bio-Max x-ray 
films. Developed films were then scanned into a computer for analysis using ImageJ 
Tool software package. For each sample, the optical density of the MeCP2 band was 
divided by that of the corresponding GAPDH band to yield a MeCP2/total GAPDH 
ratio. 
 
 
 
  
122 
 
APPENDIX F 
IMMUNOHISTOCHEMISTRY 
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 Brain tissues were collected on the day following behavioral testing. Rats were 
deeply anesthetized with either 150 mg/kg i.p. sodium pentobarbital, or exposure to 
isoflurane, and perfused transcardially with ice-cold 0.1 M PBS followed by ice-cold 4% 
w/v paraformaldehyde (PFA) in PBS, pH 7.4. Brains were removed, post-fixed in 4% 
PFA overnight and stored in 30% w/v sucrose in PBS. Brains were sectioned (35 μm 
thickness) in the coronal plane on a cryostat (Leica CM1900, Bannockburn, IL). Sections 
were then rinsed 3 x 10 min in PBS containing 0.1% v/v Tween 20 (PBST) followed by 
incubation in PBST containing 5% v/v normal donkey serum for 1-hr. Sections were then 
incubated overnight under gentile agitation at 4°C in PBST containing a rabbit anti-
methyl CpG binding protein 2 polyclonal antibody (1:200 dilution; Thermo Scientific) 
and then rinsed 3 x 10 min in PBS. Sections were then incubated in PBS containing 
AlexaFluor 488 conjugated donkey anti-rabbit IgG antisera (1:200; Jackson 
ImmunoResearch, West Grove, PA) and then rinsed 3 x 10 min in PBS. Sections were 
mounted on microscope slides using VectaShield mounting media (Vector Labs, 
Burlingame, CA), coverslipped, and stored in darkness until imaging.   
Investigator was blind to treatment condition during microscopic analysis. 
Sections were visualized at 200x magnification. Digital images of the selected area were 
obtained and counted for MeCP2 immunoreactivity by observers blind to treatment 
conditions using the ImageJ Tool software package (National Institutes of Health, 
Bethesda, MD). A total of six sample areas were counted for each subject (i.e., 1 sample 
area/2 hemispheres/3 sections). Care was taken to ensure that the sections for each 
subject that were labeled came from the same anatomical level within each plane. The 
counts from all six sample areas from a particular region were averaged to provide a 
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mean number of immunoreactive cells per animal to be used as an n = 1 for statistical 
analysis (Thiel et al., 2010).  
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APPENDIX G 
JUGULAR VEIN CATHETER SURGICAL PROCEDURES 
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 Rats were implanted with intravenous catheters into the jugular vein on PND60 (± 
1). Rats were anesthetized with isoflurane (2% v/v, Butler Schein Animal Health, Dublin, 
OH) vaporized in oxygen at a flow rate of 2 L/min. Rats received pre-incision injections 
of buprenorphine (0.05 mg/kg, s.c., Reckitt Benckiser, Richmond, VA) and meloxicam (1 
mg/kg, s.c., Boehringer Ingelheim, St. Joseph, MO). Surgical sites were shaved and 
cleaned with 1% iodine. A ~2 cm incision was made in order to isolate the right or left 
jugular vein. A sterile silastic catheter filled with heparinized saline and inserted 2.5 cm 
into the vein. The catheter was secured to the surrounding tissue with sutures, and the 
opposite end of the catheter was tunneled subcutaneously to the dorsum where it exited 
the skin between the scapulae. A mesh collar attached to a threaded vascular access port 
(Plastics One, Roanoke, VA, USA). The wound was then treated with 0.2 ml bupivacaine 
hydrochloride (0.25% v/v), closed with nylon sutures (Ethicon, San Lorenzo, Puerto 
Rico) and topically treated with topical lidocaine and a triple antibiotic gel. The access 
port was sealed with a piece of Tygon tubing closed at one end and a threaded protective 
cap (Plastics One). Rats were given small portions of sweetened cereal to facilitate 
postsurgical rehabilitation. Following surgical procedures, rats were allowed 5-7 days 
minimum of recovery and received daily intravenous infusions of 0.2 ml Timentin in 
sterile heparinized saline to minimize infections and maintain catheter patency. 
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APPENDIX H 
RESTRAINT STRESS AND BLOOD COLLECTION 
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 Dams were placed into cylindrical plastic restraint tubes (8.5 cm diameter x 21.6 
cm length) once for 30 min prior to blood sample collection to be assayed for 
corticosterone levels. Blood samples were obtained from the tail using a 26 gage needle 
to draw 3-4 drops of blood into heparinized blood collection tubes. Blood samples were 
immediately centrifuged for 15 min at 12000 rpm at 4°C. Separated plasma was 
immediately aspirated into new centrifuge tubes and stored at -80°C prior to 
corticosterone assessment.  
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APPENDIX I 
ROTATIONAL MOTOR ACTIVITY 
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 The Rotorat apparatus consisted of a stainless steel bowl (40.6 cm diameter x 
25.4 cm height; model ENV-500, Med Associates, St. Albans, VT) surrounded by 
clear acrylic walls. A spring tether attached to a rotational sensor was suspended from 
the center of the apparatus to record rotational motor activity. A zip-tie collar was 
loosely placed around the neck of the rat and connected to the spring tether via a 
stainless steel alligator clip to record 2,180, and 360 degree movements for 30 
consecutive min.  
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APPENDIX J 
SELF-ADMINISTRATION APPARATUS 
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 Behavioral testing was conducted in SA chambers (ENV-008; Med Associates 
Inc., St. Albans, VT) that were interfaced to a PC computer and located in sound 
attenuating melamine enclosures equipped with ventilation fans.  The chambers (28 x 27 
x 22 cm) consisted of two aluminum walls and two clear Plexiglas walls.  The ceiling 
was also constructed of Plexiglas with a 3 cm diameter hole cut in the center to allow a 
drug delivery tether to pass through. The floor consisted parallel stainless steel rods (0.48 
cm diameter) placed 1.6 cm apart.  Each chamber contained a house light located 1.25 cm 
from the ceiling, a Sonalert speaker that provided an auditory stimulus (~65 dB, 2900 Hz) 
during drug infusion, one retractable response lever, one stationary response lever, and 
two 2.5 cm stimulus cue lights located above each response lever. The retractable lever 
was designated the active lever as an additional cue for drug availability. Response levers 
were located 7 cm above the floor of the chamber. For the data collected in Chapter 2 and 
3, levers were replaced with nose-poke operant response in the same position as the 
levers. Centered between the levers was a 5 x 5 cm food pellet receptacle.  Each chamber 
was outfitted with a single-speed automated drug infusion pump (PHM-100; Med 
Associates). Tygon microbore tubing (0.5 mm ID) was used to connect the syringe 
containing the drug solution to a single-channel liquid swivel that was mounted to the top 
of the chamber enclosure. The swivel was then connected to the vascular access port 
using Tygon microbore tubing that was protected by a stainless steel tether (Plastics One, 
Roanoke, VA). All experimental parameters were controlled using Med PC IV software 
(Med Associates). 
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APPENDIX K 
SELF-ADMINISTRATION, EXTINCTION,  
PROGRESSIVE RATIO,  
AND CUE- AND DRUG-INDUCED REINSTATEMENT 
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 For data collected in Chapter 2, 3 (study 1), and 4, male rats underwent 2-hr daily 
SA sessions whereby active operant responses resulted in delivery of METH (0.05 mg/kg 
per infusion, delivered in a volume of 0.06 ml over a 2-sec period) on an FR1 schedule of 
reinforcement. For data collected in Chapter 3 (study 2), male rats underwent 6 hr daily 
SA sessions whereby active operant responses resulted in delivery of METH (0.05 mg/kg 
per infusion, delivered in a volume of 0.06 ml over a 2-sec period) on a FR1 schedule of 
reinforcement. Rats progressed to FR3 and FR5 schedules of reinforcement after earning 
at least 10 infusions on two consecutive days. Each METH infusion delivery was 
followed by a 20-sec timeout period, during which additional active responses were 
recorded but produced no drug infusions. Each infusion was accompanied by concurrent 
illumination of a stimulus light located directly above the active lever/nose-poke, and 
presentation of an auditory stimulus for 2-sec. SA sessions were conducted 7 days per 
week. METH hydrochloride (Sigma Aldrich, St. Louis, MO) was dissolved in 0.9% 
sterile saline.  
 For data collected in Chapters 2 and 4, after METH self-administration 
procedures ended all animals were subjected to extinction training, whereby active 
responses no longer produced any programmed consequences (i.e., no tone/light 
presentation and no activation of the syringe pump). Extinction training sessions were 2 
hr in length. For data collected in Chapter 2, 3 (sacc trained animals), and 4 on the day 
immediately following the last extinction session, all rats underwent cue-induced 
reinstatement, whereby active responses produced the tone and light cue previously 
presented with a reinforcement, but did not deliver a reinforcer. For data collected in 
Chapter 3, on the 2 days following self-administration all rats were tested on the 
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progressive ratio paradigm, in which the number of lever presses required to obtain an 
infusion of METH was determined by the following equation: responses per reinforcer 
delivery = 5 x e
(injection number x 0.2)
 - 5 (i.e., 1, 2, 4, 6, 9, 12, 15, 20, 25, 32, 40, etc) 
(Richardson and Roberts, 1996). After completion of progressive ratio testing, rats self-
administered METH on an FR1 schedule of reinforcement for two days before starting 
extinction training. On the day following the last extinction training session, rats were 
subjected to drug-primed reinstatement in which they received a 1mg/kg i.p. injection of 
METH 30 min prior to placement in operant chambers.  
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APPENDIX L 
SH-RNA VIRUS DESIGN 
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 A shRNA directed against rat MeCP2 mRNA (Mecp2- = shRNA, target sequence 
ctaaagtag, start position 450, sense strand 5’-tgcctttcgctctaaagtagttcaagagactactttaga-
gcgaaaggcttttttc-3, antisense strand 5’-
tcgagaaaaaagcctttcgctctaaagtagtctcttgaactactttagagcg-aaaggca-3’), was synthesized by 
Virovek (Hayward, CA) as previously described and optimized  by Jin et al. (2008). The 
shRNA was incorporated into vector containing the U6 pol III and cytomegalovirus 
(CMV) promoters along the coding sequence for green fluorescent protein (GFP), and 
packaged into an AAV (serotype 9, 2.25 x 10
13
 particles/ml). The resulting viral vector 
(AAV9-U6-Mecp2-shRNA-CMV-GFP) (sh-MeCP2) was suspended in PBS containing 
0.001% pluronic F-68 and filter sterilized. An empty virus lacking the shRNA sequence 
(AAV9-U6-CMV-GFP, 2.25x10
13
 particles/ml; sh-Control) served as a control. 
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APPENDIX M 
TRANSCARDIAL PERFUSION 
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 Animals were anesthetized using isoflurane. Once the animal became 
unresponsive to the toe pinch-test, a 5-6 cm lateral incision was made through the 
abdominal wall just beneath the rib cage. Care was taken to separate the liver from the 
diaphragm, then a cut through the diaphragm was done to expose the pleural cavity. A 
similar cut was made on the contralateral side. Next, a 15-gauge olive-tipped perfusion 
needle was used to puncture through the heart and enter the ascending aorta. The needle 
was then secured using a hemostat to clamp the heart. Finally, the animal's right atrium 
was cut. The animal was then perfused first with ice cold phosphate-buffered saline 
(PBS) and then ice-cold 4% paraformaldehyde. The brain was then quickly removed and 
stored in 4% PFA in -20C before transferring to a 30% sucrose solution and stored in      
-20C prior to cryosectioning at 35 m thickness using a Leica CM1900 cryostat.   
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Table 1 
Mean ± SEM Lever Presses Across 15 Sessions of METH SA  
Mean ± SEM Across 15 Sessions of METH SA 
  
MS15 
 
MS180 
          
Self-Administration  
    
     Active Lever Presses 
 
175±22 
 
446±108 
Inactive Lever Presses 
 
394±88 
 
362±52 
          
Extinction 
 
   
  
   
Active Lever Presses 
 
147±22 
 
151±10 
Inactive Lever Presses 
 
302±100 
 
117±16 
          
Reinstatement  
 
   
  
   
Active Lever Presses 
 
18±4 
 
24±3 
Inactive Lever Presses 
 
7±3 
 
8±2 
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Table 3 
Effect of Acute Restraint Stress on Plasma CORT Levels   
Effect of Acute Restraint Stress on Plasma CORT Levels (ng/ml)   
Group LS15 LS180 Virgins 
Mean (±SD)  147 (±35) 134 (±48) 95 (±36) 
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Figure 1. MS180 rats earned more METH infusions (0.05 mg/kg) in 15 daily 2 hr 
sessions compared to MS15 rats.  MS15 (n = 9) and MS180 (n = 17) rats. Data represent 
mean ± SEM. *p<0.05 vs. MS15.  
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Figure 2. MS180 rats earned more total METH infusions compared to MS15 rats. Total 
number of METH infusions earned across 15 daily 2-hr sessions in MS15 (n = 9) and 
MS180 (n = 17) rats. Data points represent group mean ± SEM. *p<0.05 vs. MS15. 
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Figure 3. We observed no group differences in active lever presses during extinction 
training. Average number of active lever presses per 2-hr session for 15 consecutive days 
during extinction in MS15 (n = 9) and MS180 (n = 17) rats. Data points represent group 
mean ± SEM.  
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Figure 4. We observed no group differences in active lever presses during cue-induced 
reinstatement testing. Number of active lever presses across the final two days of 
extinction training (black bars) and during cue-induced reinstatement (grey bars) in 
MS15 (n = 9) and MS180 (n = 17) rats. Data points represent group mean ± SEM. 
*p<0.05 vs. extinction. 
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Figure 5. MS15 rats (black bar) exhibited more MeCP2 immunoreactivy in the NAc core 
compared to MS180 rats (white bar). Cell counts for MeCP2 immunoreactivity in the 
NAc core for MS15 (n = 5) and MS180 (n = 5) rats. Data points represent group mean ± 
SEM. *p<0.05 vs. MS15. 
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Figure 6. The total number of active lever presses over 15 days of SA was negatively 
correlated with MeCP2 immunoreactivity in the NAc core (r = -0.836, p = 0.003). 
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Figure 7. Representative photomicrographs of MeCP2 immunolabeling in the NAc core 
of MS15 and MS180 rats.  NAc core was determined using the anterior commissure as a 
landmark. 
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Figure 8. A) Representative photomicrograph of the virus reporter gene GFP and track 
mark in the NAc core of a single male rat. Scale bar 130 µm. B) Brain atlas schematic of 
viral injection sites in the NAc core.  
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Figure 9. The Early Life Stress group earned more infusions compared to the Handled 
Control group. Average number of infusions (0.05 mg/kg) per 2-hr METH self-
administration session for 11 consecutive days in Handled Control (n = 8) and Early Life 
Stress (n = 10). Data points represent group mean ± SEM. *p≤0.05 vs. Handled Control.  
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Figure 10. The Early Life Stress group emitted more active lever presses compared to the 
Handled Control group. Average number of active responses per 2-hr METH self-
administration session for 11 consecutive days in Handled Control (n = 8) and Early Life 
Stress (n = 10). Data points represent group mean ± SEM. *p≤0.05 vs. Handled Control.  
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Figure 11. Cell counts for MeCP2 immunoreactivity in the NAc core per .63 mm
2
 for 
Handled Control Saline (n = 5), Handled Control METH (n = 5), Early Life Stress Saline 
(n = 6), and Early Life Stress METH (n = 7) rats. Data points represent group mean ± 
SEM. *p < 0.05 vs. Handled Control Saline and %p < .05 compared to ELS Saline. 
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Figure 12. 1) Representative photomicrographs of MeCP2 immunoreactive labeling in 
the NAc core of A) Early Life Stress Saline, B) Handled Control Saline, C) Early Life 
Stress METH, and D) Handled Control METH in male rats. Scale bars 90 µm. 2) 
Representative schematic of areas used for cell counts in A) Medial dorsal striatum, B) 
Lateral dorsal striatum, C) Nucleus accumbens core, and D) Nucleus accumbens shell.  
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Figure 13. Cell counts for MeCP2 immunoreactivity per .28 mm
2
 in the NAc shell for 
Handled Control Saline (n = 5), Handled Control METH (n = 5), Early Life Stress Saline 
(n = 6), and Early Life Stress METH (n = 7) rats. Data points represent group mean ± 
SEM. *p < 0.05 vs. Handled Control Saline. 
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Figure 14. Cell counts for MeCP2 immunoreactivity per .22 mm
2
 in the medial dorsal 
striatum for Handled Control Saline (n = 5), Handled Control METH (n = 5), Early Life 
Stress Saline (n = 6), and Early Life Stress METH (n = 7) rats. Data points represent 
group mean ± SEM. *p < 0.05 vs. Handled Control Saline and %p < .05 vs. ELS Saline. 
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Figure 15. Cell counts for MeCP2 immunoreactivity per .22 mm
2
 in the lateral dorsal 
striatum for Handled Control Saline (n = 5), Handled Control METH (n = 5), Early Life 
Stress Saline (n = 6), and Early Life Stress METH (n = 7) rats. Data points represent 
group mean ± SEM. *p < 0.05 vs. Handled Control Saline. 
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Figure 16. AAV-mediated knockdown of MeCP2 in the NAc core reduces METH intake 
in rats with extended access. Average number of infusions per 6-hr METH SA session for 
10 consecutive days in sh-Control (n = 8) and sh-MeCP2 (n = 9). Data points represent 
group mean ± SEM. *p≤0.05 vs. sh-Control.  
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Figure 17. AAV-mediated knockdown of MeCP2 in the NAc core reduces lever pressing 
for METH under progressive ratio conditions. Sessions were terminated when  no 
infusions were earned for 2 hrs. Average total number of active responses during 
progressive ratio tests following METH SA for sh-Control (n = 6) and sh-MeCP2 (n = 9). 
*p < 0.05 vs. sh-Control.   
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Figure 18. AAV-mediated knockdown of MeCP2 in the NAc core reduces the number of 
METH infusions earned under progressive ration conditions. Sessions were terminated 
when no infusions were earned for 2 hrs. Average total number of infusions earned 
during progressive ratio tests following METH SA for sh-Control (n = 6) and sh-MeCP2 
(n = 9). *p < 0.05 vs.sh-Control.   
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Figure 19. We observed no group differences in active lever responses during METH 
primed reinstatement. Rats received 1 mg/kg i.p. METH injection 15-min prior to 
placement in the operant chamber. Number of active responses across SA (FR1, e.g. 
Baseline, white bars), the final two days of Extinction training (black bars), and during 
drug-induced Reinstatement (striped bars) in sh-Control (n = 9) and sh-MeCP2 (n = 9) 
rats. Data points represent group mean ± SEM. *p < 0.05 vs. Baseline and %p < 0.05 vs. 
Reinstatement. 
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Figure 20. AAV-mediated knockdown of MeCP2 in the NAc core reduces saccharin 
intake. Average number of saccharin reinforcements earned per 30-min SA session for 19 
consecutive days in sh-Control (n = 5) and sh-MeCP2 (n = 5). Data points represent 
group mean ± SEM. *p≤0.05 vs. sh-Control.  
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Figure 21. We observed no group differences in active lever responding for saccharin 
reinforcement under progressive ratio conditions. Average total number of active 
responses during progressive ratio tests following sacc SA for sh-Control (n = 5) and sh-
MeCP2 (n = 5). No significant differences between sh-Control and sh-MeCP2 were 
observed.   
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Figure 22. We observed no group differences in saccharin reinforcers earned under 
progressive ratio conditions. Average total number of reinforcers earned during 
progressive ratio tests following sacc SA for sh-Control (n = 5) and sh-MeCP2 (n = 5). 
No significant differences between sh-Control and sh-MeCP2 were observed.    
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Figure 23. We observed no group differences in active lever responses during cue-primed 
reinstatement of saccharin seeking. Number of active responses across SA (FR1, e.g. 
Baseline, white bars), the final two days of Extinction training (black bars), and during 
cue-induced Reinstatement (striped bars) in sh-Control (n = 5) and sh-MeCP2 (n = 5) 
rats. Data points represent group mean ± SEM. *p < 0.05 vs. Baseline and %p < 0.05 vs. 
Reinstatement. 
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Figure 24. No significant differences between Control and MeCP2 knockdown groups 
were observed in rotational motor activity in A) METH naïve rats and B) METH primed 
rats (1mg/kg i.p injection 30-min prior to behavioral tests) 1 week post-reinstatement. 
Measured in (1) 2 turns, (2) 180 turns, and (3) 360 full rotations. Data points represent 
group mean ± SEM. 
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Figure 25. Virally-induced knockdown of MeCP2 expression in the NAc core. A) 
Representative bands of MeCP2 and GAPDH protein expression in AAV empty control 
virus (sh-Control) Vs. AAV expressing a short hairpin RNA against MeCP2 mRNA (sh-
MeCP2), as determined by Western blot luminescence, in the NAc core. B) Mean % (± 
SEM) of MeCP2 luminescence in the NAc core in sh-Control (n = 4) and sh-MeCP2 (n = 
4) *p < .01. Total knockdown was approximately 40%. 
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Figure 26. Early Life Stress animals self-administer more METH compared to other 
experimental groups. Average number of infusions per 2-hr METH SA session for 15 
consecutive days in No Stress (n = 6), Adult Stress (n = 10), Early Life Stress (n = 6), and 
Early Life Stress + Adult Stress (n = 5) rats. Data points represent group mean ± SEM. 
*p≤0.05  vs. Early Life Stress + Adult Stress, #p≤0.05 vs. Adult Stress, and %p≤0.05 vs 
No Stress.  
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Figure 27. Early Life Stress animals exhibit more lever presses for METH reinforcement 
compared to other experimental groups. Average number of active responses per 2-hr 
METH self-administration session for 15 consecutive days in No Stress (n=6), Adult 
Stress (n=10), Early Life Stress (n=6), and Early Life Stress + Adult Stress (n=5) rats. 
Data points represent group mean ± SEM. *p≤0.05  vs. Early Life Stress + Adult Stress, 
#p≤0.05 vs. Adult Stress, and %p≤0.05 vs No Stress.  
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Figure 28. No significant group differences were observed in active lever presses during 
extinction training. Average number of active responses per 2-hr Extinction session for 8 
consecutive days in No Stress (n = 6), Adult Stress (n = 10), Early Life Stress (n = 6), and 
Early Life Stress + Adult Stress (n = 5) rats. Data points represent group mean ± SEM.  
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Figure 29. No significant group differences were observed in active lever pressing during 
cue-induced reinstatement testing. Dashed lines separate experimental groups. Number of 
active lever presses across the final two days of extinction training (white bars) and 
during cue-induced reinstatement (black bars) in No Stress (n = 6), Adult Stress (n = 
10), Early Life Stress (n = 6), and Early Life Stress + Adult Stress (n = 5) rats. Data 
points represent group mean ± SEM. No significant group differences were observed.  
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Figure 30. LS15 female rats displayed a significantly larger CPP magnitude compared to 
LS180 dams and Virgins. CPP score calculated by seconds spent in METH-paired 
chamber pre-conditioning subtracted from time spent in METH-paired chamber post-
conditioning in LS15 (n = 8), LS180 (n = 10), and Virgins (n = 7). Data points represent 
group mean ± SEM. *p ≤ 0.05 vs. LS180 and %p ≤ 0.05 Virgins.  
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Figure 31. Saline CPP score calculated by seconds spent in Saline-paired chamber pre-
conditioning subtracted from seconds spent in Saline-paired chamber post-conditioning 
in LS15 (n = 8), LS180 (n = 10), and Virgins (n = 7). Data points represent group mean ± 
SEM. No significant differences between groups were observed.  
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Figure 32. We observed no group differences in general locomotor activity across five 
conditioning days. Dashed line separates activity following METH or saline priming. 
Locomotor response to intraperitoneal Saline or METH (0.5 mg/kg) across five 
conditioning sessions in LS15, LS180, and Virgin female rats. No significant differences 
between groups were observed.  
 
